<html lang="en" class="pb-page js" data-request-id="94d6bd5503420304-SJC"><head data-pb-dropzone="head"><style type="text/css" nonce="94d6bd5503420304-SJC">@font-face {font-family: "Source Sans Pro";src: url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.ttf) format("truetype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.woff) format("woff"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.otf) format("opentype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.eot) format("embedded-opentype");}.truste_cursor_pointer {cursor: pointer;}.truste_border_none {border: none;}.truste_accessible_link {font-family: "Source Sans Pro", sans-serif;color: #1D4ED8;font-size: 14px;font-weight: 600;text-decoration: underline;}.truste_accessible_link:hover {color: #1D4ED8;text-decoration: none !important;}.truste_accessible_link:focus-visible {outline: none;border-radius: 4px;box-shadow: 0 0 0 1px #FFFFFF, 0 0 0 4px #3699F1;}</style><script src="https://ssl-cdn.janraincapture.com/widget_data/flow.js:7h8bznq6j7bvyvzqcrwvyp8dfb:en-US:20240514181256512029:standard" type="text/javascript"></script><script src="https://cssjs.nejm.org/akamai/capture:login" type="text/javascript"></script><script src="https://ssl-widget-cdn.rpxnow.com/translations/login/en-US" type="text/javascript"></script><script type="text/javascript" id="janrainAuthWidget" src="https://cssjs.nejm.org/akamai/mms-prod.js"></script><script type="text/javascript" src="https://www.nejm.org/t-6o8ubJtMT34HHMW1yvw9O2Q-WmfGg2aVlTWn2C0u-KSUBemq59NhUUq7a2H13rr2yToJ-3lGhvvmMrD2uFQA=="></script>
            

<meta charset="UTF-8">






    
        
            
        
    
        
            
        
    
        
            
        
    
        
            
        
    
        
    
        
    
        
            
                
                
<title>Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | New England Journal of Medicine</title>





                
            
        
    







    
        
            
        
    
        
            
        
    
        
            
                
                



                
            
        
    
        
            
        
    
        
    
        
    
        
            
        
    











    








    

    
    

    
    
    
    
        
            
                <link rel="stylesheet" type="text/css" href="/wro/1125813~article-metrics.css">
            
            
            
        
    

    
    
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_nejm_1-994b0160d1eb33dc79517ef0295aab1b.ico" type="image/x-icon">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_16-4aa032aa775940f725817b7ff42f0e2c.png" type="image/png" sizes="16x16">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_32-0a94fa44823476ffa0bb15bdb320fb34.png" type="image/png" sizes="32x32">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_152-d6c3522864a8e483996b7e9c132c901a.png" sizes="152x152">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_180-f2538afc53a365d4cd3f10ab73c56aad.png" sizes="180x180">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_167-8e888012bbdd31a00c3e54bc5b8ca5b6.png" sizes="167x167">
        
    

    
    
            <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-5b89b331018866a4a965.css" media="all">
        <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/print-5b89b331018866a4a965.css" media="print">
           <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css" media="all" id="article-style-sheet">
    
        <script nonce="94d6bd5503420304-SJC">
        try {
            document.documentElement.classList.add('js');
        } catch (e) {
        }
    </script>
     
    

















    
        
            
                
                
                
                    
                    <!-- TrustArc Scripts -->
<script async="async" src="https://consent.trustarc.com/notice?domain=nejm.com&amp;c=teconsent&amp;js=nj&amp;noticeType=bb&amp;gtm=1&amp;text=true&amp;pcookie" crossorigin="" id="truste_0.4869924554562659"></script>
<script src="https://consent.trustarc.com/autoblockasset/core.min.js?domain=nejm.com"></script>
<script src="https://consent.trustarc.com/autoblockoptout?domain=nejm.com"></script>
<!-- /TrustArc Scripts -->
<!-- BlueConic Scripts -->
<script src="https://bc.nejm.org/script.js"></script>
    <!-- /BlueConic Scripts -->
<!-- Printing Meta Tags -->
    <meta name="articleType" content="Original Article">
<meta name="articleCategory" content="Research">
<meta name="topics" content="Vaccines|Coronavirus">
<meta name="Specialties" content="Infectious Disease"><script type="text/javascript">var mmsData = {"access":{"isFreeCountry":"n"},"ad":{"category":"article"},"imageChallenge":{"id":null},"article":{"doi":"10.1056/NEJMoa2116185","title":"Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico","category":"Research","type":"Original Article","topics":"Vaccines|Coronavirus","specialties":"Infectious Disease","seriesTitle":"","viewType":"Full","age":"2Years-1990","issueDate":"2022-02-10T00:00Z","isFree":"y","broadTopics":"","perspectiveTopics":"","granularTopics":"","methodologicalArea":"","isOnlineFirst":"n","isCurrentIssue":"n","metaTags":"\u003cmeta name\u003d\"articleType\" content\u003d\"Original Article\"/\u003e\n\u003cmeta name\u003d\"articleCategory\" content\u003d\"Research\"/\u003e\n\u003cmeta name\u003d\"topics\" content\u003d\"Vaccines|Coronavirus\"/\u003e\n\u003cmeta name\u003d\"Specialties\" content\u003d\"Infectious Disease\"/\u003e"},"page":{"activity":"showFullText","url":"www.nejm.org/doi/full/10.1056/NEJMoa2116185","viewType":"desktop","journal":"NEJM"},"user":{"ucid":null,"audienceSegment":null,"specialtyGroupCode":null,"meterCountRemaining":null,"totalMeterCount":null},"object":[{"type":"Research Summary","title":"Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico","doi":"10.1056/NEJMdo006370","issueDate":"2022-02-10T00:00Z","age":"6Months-1990","isFree":"n","topics":"Vaccines|Coronavirus","viewType":"Full","specialties":"Infectious Disease"},{"type":"Quick Take","title":"Efficacy and Safety of NVX-CoV2373 in Adults","doi":"10.1056/NEJMdo006369","issueDate":"2022-02-10T00:00Z","age":"6Months-1990","isFree":"n","topics":"Vaccines|Coronavirus","viewType":"Full","specialties":"Infectious Disease"}]};</script>
    <script type="text/javascript">var mmsDataAdd = {"user":{"customerType":"null","accessInstitutionID":"null"}};</script>
    <!-- Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- placeholder id=null, description=Adobe-Target-Prehiding-Snippet --><!--
  Adobe Target - Prehiding Snippet
  v2.0.0
-->
<script nonce="94d6bd5503420304-SJC">
function tgtNoFlicker(e,n,t,o,i,c,l,r){function d(){return n.getElementsByTagName("head")[0]}function a(e,t){if(e){var o=n.getElementById(t);o&&e.removeChild(o)}}function f(e,o){!function(e,t,o){if(e){var i=n.createElement("style");i.id=t,i.innerHTML=o,e.appendChild(i)}}(d(),t,e),setTimeout(function(){a(d(),t)},o)}var m;n.location.href.indexOf(c)>-1?f(l,r):f(o,i),n.location.href.indexOf("mboxDisable")>-1?(a(d(),t),console.log("[TARGET] - Disabled, removing prehiding style")):(m=function(e){e&&(a(d(),t),console.log("[TARGET] - Blocked, removing prehiding style"))},fetch("//cdn.tt.omtrdc.net/cdn/target-vec.js",{method:"HEAD",mode:"no-cors"}).then(e=>m(!1)).catch(e=>m(!0)))}

tgtNoFlicker(window, document, 'at-body-style', 'div[data-location-name="Anonymous Module"], div[data-location-name="Anonymous Banner"], main > div.page-body > div > div > div > div.col-md-2-3.o-col.o-col--primary > div[class*="u-hide"], main > div.page-body > div > div > div > div.col-md-1-3.o-col.o-col--secondary > aside, header > h1#mainContent, a.m-article__link[href*="/10.1056/NEJMoa2116747"] > span.m-article__blurb > p, li.g-nejm-group__user-tool-secondary {opacity: 0 !important}', 3000);

tgtNoFlicker(window, document, 'at-mbox-style', '.N-ad-global-top-right, #N-ad-myNEJM-contextual-top, .N-ad-recentArticles, #N-ad-article-rightRail-1, #N-ad-siteWide-rightRail-1, #N-ad-imageChallenge-rightRail-2 {opacity: 0 !important}', 3000);
</script><!-- /Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- Launch Header Embed Code -->
    <script src="//assets.adobedtm.com/launch-ENcd6450fae3ae4870becbe6a2b01ab2e1.min.js" async="" type="ta-blocked" data-ta-blocked="1"></script>
    <!-- /Launch Header Embed Code -->

                    
                
            
        
    
        
            
                
                
                
                    
                    <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="New England Journal of Medicine"><meta name="dc.Title" content="Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico"><meta name="dc.Creator" content="Lisa M. Dunkle"><meta name="dc.Creator" content="Karen L. Kotloff"><meta name="dc.Creator" content="Cynthia L. Gay"><meta name="dc.Creator" content="Germán Áñez"><meta name="dc.Creator" content="Jeffrey M. Adelglass"><meta name="dc.Creator" content="Alejandro Q. Barrat Hernández"><meta name="dc.Creator" content="Wayne L. Harper"><meta name="dc.Creator" content="Daniel M. Duncanson"><meta name="dc.Creator" content="Monica A. McArthur"><meta name="dc.Creator" content="Diana F. Florescu"><meta name="dc.Creator" content="R. Scott McClelland"><meta name="dc.Creator" content="Veronica Garcia-Fragoso"><meta name="dc.Creator" content="Robert A. Riesenberg"><meta name="dc.Creator" content="David B. Musante"><meta name="dc.Creator" content="David L. Fried"><meta name="dc.Creator" content="Beth E. Safirstein"><meta name="dc.Creator" content="Mark McKenzie"><meta name="dc.Creator" content="Robert J. Jeanfreau"><meta name="dc.Creator" content="Jeffrey K. Kingsley"><meta name="dc.Creator" content="Jeffrey A. Henderson"><meta name="dc.Creator" content="Dakotah C. Lane"><meta name="dc.Creator" content="Guillermo M. Ruíz-Palacios"><meta name="dc.Creator" content="Lawrence Corey"><meta name="dc.Creator" content="Kathleen M. Neuzil"><meta name="dc.Creator" content="Robert W. Coombs"><meta name="dc.Creator" content="Alex L. Greninger"><meta name="dc.Creator" content="Julia Hutter"><meta name="dc.Creator" content="Julie A. Ake"><meta name="dc.Creator" content="Katherine Smith"><meta name="dc.Creator" content="Wayne Woo"><meta name="dc.Creator" content="Iksung Cho"><meta name="dc.Creator" content="Gregory M. Glenn"><meta name="dc.Creator" content="Filip Dubovsky"><meta name="dc.Description" content="NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (Covid-19) in phase 2b–3 trials ..."><meta name="Description" content="NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (Covid-19) in phase 2b–3 trials ..."><meta name="dc.Publisher" content="Massachusetts Medical Society"><meta name="dc.Date" scheme="WTN8601" content="2022-02-10"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1056/NEJMoa2116185"><meta name="dc.Identifier" scheme="publisher-id" content="NJ202202103860607"><meta name="dc.Language" content="EN"><meta name="dc.Relation" content="YXQYoa2116185"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="Copyright © 2021 Massachusetts Medical Society. All rights reserved.">




<link rel="meta" type="application/atom+xml" href="https://doi.org/10.1056%2FNEJMoa2116185">
<link rel="meta" type="application/rdf+json" href="https://doi.org/10.1056%2FNEJMoa2116185">
<link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1056%2FNEJMoa2116185">


                    
                
            
        
    
        
            
                
                
                
                
                
            
        
    
        
            
                
                
                
                    
                    





<meta name="robots" content="noarchive">





    





    
    
        
        <meta name="twitter:title" content="Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | NEJM">
        <meta property="og:title" content="Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | NEJM">
    


    <meta property="og:type" content="article">


    
    
        <meta property="og:url" content="https://www.nejm.org/doi/full/10.1056/NEJMoa2116185">
    
    


    
    
        <meta property="og:image" content="https://www.nejm.org/cms/asset/b7302d10-3534-4e82-b303-ec5864588849/nejmoa2116185_f0.jpg">
        <meta name="twitter:image" content="https://www.nejm.org/cms/asset/b7302d10-3534-4e82-b303-ec5864588849/nejmoa2116185_f0.jpg">
    



    <meta property="og:site_name" content="The New England Journal of Medicine">


    
    
        
        <meta property="og:description" content="NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that
was shown to have clinical efficacy for the prevention of coronavirus disease 2019
(Covid-19) in phase 2b–3 trials ...">
        <meta name="twitter:description" content="NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that
was shown to have clinical efficacy for the prevention of coronavirus disease 2019
(Covid-19) in phase 2b–3 trials ...">
    


    
    
        <meta property="og:image:width" content="2640">
    


    
    
        <meta property="og:image:height" content="3416">
    


    <meta name="twitter:card" content="summary">


    <meta name="twitter:site" content="@NEJM">


<meta name="viewport" content="width=device-width,initial-scale=1"><meta name="citation_fulltext_world_readable" content="">
    <meta name="publication_doi" content="10.1056/NEJMoa2116185">


    















                    
                
            
        
    
        
    
        
    
        
            
                
                
                
                
                
            
        
    




<meta name="format-detection" content="telephone=no">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
    




    
        
        
        <link rel="canonical" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2116185">
    
    







<meta name="pbContext" content=";requestedJournal:journal:nejm;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:doi\:10.1056/NEJMoa2116185;wgroup:string:MMS NextGen Website Group;pageGroup:string:Publication Pages;subPage:string:Full Text;website:website:mms-site;issue:issue:doi\:10.1056/nejm_2022.386.issue-6;journal:journal:nejms">
        <link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-933-8e181dff8b36ea01dc4c.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-34-6ea546d794fb7a1cea52.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-743-ddd329e1530654ec0846.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-305-9eee37798fdfe5196307.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-388-bb098c62445f518c0b46.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-556-8e58ca05fb5497e541ef.css"><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/0-dfd243c732a07d3608f6.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/7-10d355ba95f7ec1fddf2.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/11-04bf2a0da30146b4a5d0.js"></script><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><link rel="preconnect" href="https://use.typekit.net"><link rel="stylesheet" href="https://quilt-cdn.janrain.com/HEAD/providers.css" type="text/css"><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><script id="altmetric-embed-js" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-288192a491f0ad9cc434f05ea175659426f5ab0cfd6befb3f3592f96bb90b0d1.js"></script><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css"></head>
    

    



    
        
        
        
            <body class="pb-ui website-mms-site loaded">
            






    
    
        





    
    
        
        
    
    
    







<input type="hidden" id="isRoMode" name="isRoMode" value="false">

        <div id="pb-page-content" data-ng-non-bindable="">
                
            <div data-pb-dropzone="main" data-pb-dropzone-name="Main">
                
                    
                        



        
        <header data-sticky="false" class="ng-header js_stickyAd"><a href="#mainContent" class="ng-skipToMainContent">Skip to main content</a><div class="ng-header_topAd"><div class="ng-header_topAd-content d-flex justify-content-center align-items-center">



        
        <div id="DTM_Position_Topbanner" class="ad">
 <!--emptycomment-->
</div>
</div></div><div class="ng-header_journal-navbar"><div class="ng-header_journal-navbar-content"><div class="container-fluid"><div class="row"><div class="ng-header_journal-navbar_left col-lg-8 col-sm-12 pr-lg-0 d-flex align-items-center"><div data-location="nejm_group_product_nav" class="ng-header_journalNavMenu">



        
        <nav data-location="nejm_group_product_nav" role="navigation" class="ng-journalNavMenu">
<ul class="ng-journalNavMenu_list">
<li class="ng-journalNavMenu_list-item"><a href="/" class="ng-journalNavMenu_mainLink active" aria-current="page" aria-label="The New England Journal of Medicine selected item"><span class="ng-journalNavMenu_mainLink-text d-lg-block d-none">The New England Journal of Medicine</span><span class="ng-journalNavMenu_mainLink-text d-lg-none d-block">NEJM</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://evidence.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Evidence</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://ai.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> AI</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://catalyst.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Catalyst</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://www.jwatch.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Journal Watch</span></a></li>
</ul>
</nav>

</div></div><div class="ng-header_journal-navbar_right col-lg-4 pl-lg-0 d-none d-xl-flex align-items-center justify-content-end"><div class="ng-header_loginBar d-xl-flex align-items-lg-center">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2116185" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div></div><div class="ng-header_instBanner d-none d-lg-block"></div><div class="ng-header_logoBar"><div class="container-fluid"><div class="row"><div data-location="logo" class="ng-header_logoBar_left col-lg-4 col-6 d-flex align-items-center justify-content-start"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-logo-166667e91992a5212bc723b03e45d39f.svg" alt="The New England Journal of Medicine homepage" width="366" height="58" class="ng-header_logo-image"></a></div><div class="ng-header_logoBar_right ng-header_navBar col-lg-8 col-sm-12 p-lg-0 align-items-center justify-content-end"><div class="ng-header_navBar-content"><div class="container-fluid"><div class="row"><div class="ng-header_instBanner-md col-12 d-block d-lg-none"></div><div class="ng-header_loginBar-md col-12 d-block d-xl-none">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2116185" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div><div class="ng-header_navBar_left col-lg-8 col-sm-12 d-flex align-items-center"><div class="ng-header_stickyLogo mr-32"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-small-logo-070df7a3f4d8cfa2e71c3c45bb4b172f.svg" alt="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-image"></a></div><div class="ng-header_mainMenu">









    
    
        <div data-widget-def="menuWidget" data-widget-id="97fb3983-db63-4b0b-97dd-d9bb7929fce1" data-location="main_nav">
        



        
        <nav class="ng-menu"><ul class="ng-menu_list ng-simple-menu"><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/toc/nejm/current" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">current issue</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/toc/nejm/current" class="ng-simple-menu_list-link">VIEW CURRENT ISSUE</a></li><li class="ng-simple-menu_list-item"><a href="/toc/nejm/recently-published" class="ng-simple-menu_list-link">BROWSE RECENTLY PUBLISHED</a></li><li class="ng-simple-menu_list-item"><a href="/loi/nejm" class="ng-simple-menu_list-link">BROWSE ALL ISSUES</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/medical-specialties" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">SPECIALTIES</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/browse/specialty/cardiology" class="ng-simple-menu_list-link">Cardiology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/clinical-medicine" class="ng-simple-menu_list-link">Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/endocrinology" class="ng-simple-menu_list-link">Endocrinology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/gastroenterology" class="ng-simple-menu_list-link">Gastroenterology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/hematology-oncology" class="ng-simple-menu_list-link">Hematology/Oncology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/infectious-disease" class="ng-simple-menu_list-link">Infectious Disease</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/nephrology" class="ng-simple-menu_list-link">Nephrology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/neurology-neurosurgery" class="ng-simple-menu_list-link">Neurology/Neurosurgery</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/obstetrics-gynecology" class="ng-simple-menu_list-link">Obstetrics/Gynecology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pediatrics" class="ng-simple-menu_list-link">Pediatrics</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pulmonary-critical-care" class="ng-simple-menu_list-link">Pulmonary/Critical Care</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/surgery" class="ng-simple-menu_list-link">Surgery</a></li><li class="ng-simple-menu_list-item"><a href="/medical-specialties" class="ng-simple-menu_list-link">View All Specialties</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/topics" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">TOPICS</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/ai-in-medicine" class="ng-simple-menu_list-link">AI in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/climate-change" class="ng-simple-menu_list-link">Climate Change</a></li><li class="ng-simple-menu_list-item"><a href="/coronavirus" class="ng-simple-menu_list-link">Coronavirus</a></li><li class="ng-simple-menu_list-item"><a href="/equity" class="ng-simple-menu_list-link">Efforts toward Equity</a></li><li class="ng-simple-menu_list-item"><a href="/firearm-injury-prevention" class="ng-simple-menu_list-link">Firearm Injury Prevention</a></li><li class="ng-simple-menu_list-item"><a href="/nam" class="ng-simple-menu_list-link">From the National Academy of Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/fundamentals-of-medical-ethics" class="ng-simple-menu_list-link">Fundamentals of Medical Ethics</a></li><li class="ng-simple-menu_list-item"><a href="/gray-matters" class="ng-simple-menu_list-link">Gray Matters</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/health-policy" class="ng-simple-menu_list-link">Health Policy</a></li><li class="ng-simple-menu_list-item"><a href="/medicine-and-society" class="ng-simple-menu_list-link">Medicine and Society</a></li><li class="ng-simple-menu_list-item"><a href="/nutrition-in-medicine" class="ng-simple-menu_list-link">Nutrition in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/outbreaks" class="ng-simple-menu_list-link">Outbreaks Center</a></li><li class="ng-simple-menu_list-item"><a href="/race-and-medicine" class="ng-simple-menu_list-link">Race and Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/recognizing-historical-injustices" class="ng-simple-menu_list-link">Recognizing Historical Injustices and the Journal</a></li><li class="ng-simple-menu_list-item"><a href="/tobacco-use-reduction" class="ng-simple-menu_list-link">Tobacco Use Reduction</a></li><li class="ng-simple-menu_list-item"><a href="/topics" class="ng-simple-menu_list-link">View All Topics</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/multimedia" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">MULTIMEDIA</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/rss-feed" class="ng-simple-menu_list-link">Podcasts</a></li><li class="ng-simple-menu_list-item"><a href="/double-take" class="ng-simple-menu_list-link">Double Takes</a></li><li class="ng-simple-menu_list-item"><a href="https://illustrated-glossary.nejm.org/" class="ng-simple-menu_list-link">Illustrated Glossary</a></li><li class="ng-simple-menu_list-item"><a href="/image-challenge" class="ng-simple-menu_list-link">Image Challenge</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/images-in-clinical-medicine" class="ng-simple-menu_list-link">Images in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/interactive-medical-case" class="ng-simple-menu_list-link">Interactive Medical Cases</a></li><li class="ng-simple-menu_list-item"><a href="/plain-language-research-summaries" class="ng-simple-menu_list-link">Plain Language/Research Summaries</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia/quick-take-video" class="ng-simple-menu_list-link">Quick Takes</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/videos-in-clinical-medicine" class="ng-simple-menu_list-link">Videos in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia" class="ng-simple-menu_list-link">View All Multimedia</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/learning" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">LEARNING/CME</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/continuing-medical-education" class="ng-simple-menu_list-link">Weekly CME</a></li><li class="ng-simple-menu_list-item"><a href="/cme-ce/obesity" class="ng-simple-menu_list-link">Obesity CME/CE</a></li><li class="ng-simple-menu_list-item"><a href="/learning" class="ng-simple-menu_list-link">VIEW ALL LEARNING/CME</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item"><a href="/author-center/home" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">AUTHOR CENTER</span></a></li></ul></nav>

        </div>
    

</div><button aria-label="Search" class="ng-header_searchBtn searchBtnNav d-block ml-24"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button></div><div class="ng-header_loginBar ng-header_loginBar-sticky col-4">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2116185" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div><div class="ng-header_logoBar_right-lg col-lg-8 col-6 d-flex align-items-center justify-content-end d-xl-none"><button aria-label="Search" class="ng-header_searchBtn d-flex justify-content-end"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><div class="ng-header_openCloseBtns d-flex align-items-center justify-content-end"><button aria-label="Open" class="ng-header_openBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#burger"></use></svg></span></button><button aria-label="Close" class="ng-header_closeBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></button></div></div><div class="ng-header_quickSearch col-12"><div class="ng-header_quickSearch-content">



        
        <div class="ng-quick-search js-ng-quick-search"><form action="/search" method="get" class="ng-quick-search_form js-form"><div class="ng-quick-search_inputArea js-inputArea"><input type="search" name="q" placeholder="Enter keyword, author, title or citation" autocomplete="off" value="" required="required" class="ng-quick-search_allField ng-large-text-input js-allField js-allField-def-tmpl ui-autocomplete-input"><button type="submit" aria-label="Search Button" class="ng-quick-search_iconBtn d-xl-none d-block js-submitBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" style="display: none;"></ul></div><div class="ng-quick-search_btnsArea d-none d-xl-flex align-items-center justify-content-end"><a href="/search/advanced" class="ng-quick-search_advSearchLink ng-btn_link js-advancedSearchLink">Advanced Search</a><button type="submit" class="ng-quick-search_textBtn ng-btn_secondary ng-btn_iconRight js-submitBtn"><span class="ng-btn_text">SEARCH</span><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-right"></use></svg></span></button></div></form></div>
</div></div></div></div></div></header><div class="ng-header_overlay"></div><div class="ng-header_after">









    
    
        <div data-widget-def="literatumAd" data-widget-id="4931ddbd-d46e-4597-b4fd-92549e9847ca" id="ad-global-banner-FULLx64-1">
        



        
        



    

    

    
        
    



        </div>
    

</div>

                    
                        



        
        <div>









    
    
        <main data-widget-def="axelPublicationContent" data-widget-id="fcdb5261-d6a2-4a9c-81d5-3a3e2304e9c1" id="mainContent">
        



        
        <div class="article-tools__savePopup"><div class="ng-save"><input type="hidden" value="/action/getSavedTags" class="getKeywordsServiceUrl"><input type="hidden" value="/action/mmsSaveItemsService?itemType=article" class="saveServiceUrl"><input type="hidden" value="article" class="saveType"><input type="hidden" value="10.1056/NEJMoa2116185" class="inputDoi"><input type="hidden" value="L.M. Dunkle and Others" class="inputAuthor"><input type="hidden" value="N Engl J Med 2022;386:531-543" class="inputCitation"><input type="hidden" value="12-15-2021" class="inputEPubDate"><input type="hidden" value="February 2022" class="inputCoverDate"><input type="hidden" value="Original Article" class="inputContentType"><input type="hidden" value="Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico" class="inputArticleTitle"><input type="hidden" value="/browse/nejm-article-type/original-article" class="inputContentTypeUrl"><button type="button" id="saveArticleShowPopupBtn" aria-hidden="true" tabindex="-1" class="ng-save-btn ng-btn_secondary isLoggedOut">Save</button></div></div><div class="article-tools__articleAlertPopup"><div id="articleAlertModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="articleAlertModalTitle" class="ng-modal_title modal-title">Create an E-mail Alert for This Article</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><div class="ng-do-media_popup"><div id="doPopup" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" data-type="research-article" vocab="http://schema.org/" typeof="ScholarlyArticle" lang="en" dir="ltr"><header data-extent="frontmatter" data-location="header_article"><div class="core-container"><div data-article-access="free" data-article-access-type="free" class="meta-panel"><div class="meta-panel__left-content"><div class="meta-panel__type"><a href="/browse/nejm-article-type/original-article">Original Article</a></div></div><div class="meta-panel__right-content"><div class="meta-panel__share">









    
    
        <div data-widget-def="UX3share" data-widget-id="eee5f139-16f2-48f8-97ea-1b114367da16" data-location="share_tools_article">
        



        
        <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js" nonce="94d6bd5503420304-SJC"></script><div class="share"><div class="share__block share__inline-links"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="d-flex list-unstyled a2a a2a_kit a2a_default_style mb-0 a2a_kit_size_32" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Facebook" data-interactiontype="social" class="share__link a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-facebook"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="X (formerly Twitter)" data-interactiontype="social" class="share__link a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-twitter"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Linked In" data-interactiontype="social" class="share__link a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-linkedin"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Email" data-interactiontype="content_email_click" class="share__link a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-email"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" data-interactiontype="social" class="share__link a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-bluesky"></use></svg></span></a></li></ul></div></div>

        </div>
    

</div></div></div><h1 property="name">Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico</h1><div class="core-relations my-3"></div><div class="contributors"><span class="authors"><span class="heading">Authors</span>: <span role="list"><span property="author" typeof="Person" role="listitem"><span property="givenName">Lisa M.</span> <span property="familyName">Dunkle</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Karen L.</span> <span property="familyName">Kotloff</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Cynthia L.</span> <span property="familyName">Gay</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Germán</span> <span property="familyName">Áñez</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Jeffrey M.</span> <span property="familyName">Adelglass</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Alejandro Q.</span> <span property="familyName">Barrat Hernández</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Wayne L.</span> <span property="familyName">Harper</span>, <span property="honorificSuffix">M.D.</span></span><span data-displayed-on="all">, <span data-action="reveal" tabindex="0" role="listitem">+26</span> </span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Daniel M.</span> <span property="familyName">Duncanson</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Monica A.</span> <span property="familyName">McArthur</span>, <span property="honorificSuffix">M.D., Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Diana F.</span> <span property="familyName">Florescu</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">R. Scott</span> <span property="familyName">McClelland</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Veronica</span> <span property="familyName">Garcia-Fragoso</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Robert A.</span> <span property="familyName">Riesenberg</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">David B.</span> <span property="familyName">Musante</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">David L.</span> <span property="familyName">Fried</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Beth E.</span> <span property="familyName">Safirstein</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Mark</span> <span property="familyName">McKenzie</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Robert J.</span> <span property="familyName">Jeanfreau</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Jeffrey K.</span> <span property="familyName">Kingsley</span>, <span property="honorificSuffix">D.O.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Jeffrey A.</span> <span property="familyName">Henderson</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Dakotah C.</span> <span property="familyName">Lane</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Guillermo M.</span> <span property="familyName">Ruíz-Palacios</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Lawrence</span> <span property="familyName">Corey</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-2179-2436" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-2179-2436</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Kathleen M.</span> <span property="familyName">Neuzil</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Robert W.</span> <span property="familyName">Coombs</span>, <span property="honorificSuffix">M.D., Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Alex L.</span> <span property="familyName">Greninger</span>, <span property="honorificSuffix">M.D., Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Julia</span> <span property="familyName">Hutter</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Julie A.</span> <span property="familyName">Ake</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Katherine</span> <span property="familyName">Smith</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Wayne</span> <span property="familyName">Woo</span>, <span property="honorificSuffix">M.S.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Iksung</span> <span property="familyName">Cho</span>, <span property="honorificSuffix">M.S.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Gregory M.</span> <span property="familyName">Glenn</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, and <span property="author" typeof="Person" role="listitem"><span property="givenName">Filip</span> <span property="familyName">Dubovsky</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span></span>, for <span property="author" typeof="Person" role="listitem">the 2019nCoV-301 Study Group<sup><a href="#fn1" role="doc-noteref">*</a></sup></span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">-26</span></span></span></span><a href="#tab-contributors" class="to-authors-affiliations" data-id="article-authors-viewall">Author Info &amp; Affiliations</a></div><div class="core-self-citation"><div class="core-date-published">Published <span property="datePublished">December 15, 2021</span></div><div property="isPartOf" typeof="Periodical"><span property="name">N Engl J Med</span> 2022<span property="isPartOf" typeof="PublicationVolume">;<span property="volumeNumber">386</span></span>:<span property="pageStart">531</span>-<span property="pageEnd">543</span></div><div class="doi">DOI: 10.1056/NEJMoa2116185</div><div class="core-enumeration"><a href="/toc/nejm/386/6"><span property="isPartOf" typeof="PublicationVolume">VOL. <span property="volumeNumber">386</span></span> <span property="isPartOf" typeof="PublicationIssue">NO. <span property="issueNumber">6</span></span></a></div><div><a href="#tab-information">Copyright © 2021</a></div></div><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__metrics info-panel__item"></div></div><div data-location="tools_article" class="info-panel__right-content"><div class="info-panel__article_tools info-panel__item">



        
        <div data-permission="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DLisa%2BM.%2BDunkle%252C%2BKaren%2BL.%2BKotloff%252C%2BCynthia%2BL.%2BGay%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D386%26issueNum%3D6%26contentID%3D10.1056%252FNEJMoa2116185%26title%3DEfficacy%2Band%2BSafety%2Bof%2BNVX-CoV2373%2Bin%2BAdults%2Bin%2Bthe%2BUnited%2BStates%2Band%2BMexico%26publicationDate%3D02%252F10%252F2022" class="article-tools"><button id="articleToolsAlertBtn" data-url="/action/addCitationAlert?doi=10.1056%2FNEJMoa2116185" data-toggle="" data-target="#articleAlertModal" aria-label="Sign in or create account to add an article alert" data-interactiontype="article_alert" class="article-tools__citation btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to add an article alert"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#alerts"></use></svg></span></span></button><button id="articleToolsSaveBtn" data-toggle="modal" data-target="#saveArticle" aria-label="Sign in or create account to save this article" data-interactiontype="article_tools_save_click" class="article-tools__favorite btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to save this article"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#bookmarkFilled"></use></svg></span></span></button><a href="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DLisa%2BM.%2BDunkle%252C%2BKaren%2BL.%2BKotloff%252C%2BCynthia%2BL.%2BGay%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D386%26issueNum%3D6%26contentID%3D10.1056%252FNEJMoa2116185%26title%3DEfficacy%2Band%2BSafety%2Bof%2BNVX-CoV2373%2Bin%2BAdults%2Bin%2Bthe%2BUnited%2BStates%2Band%2BMexico%26publicationDate%3D02%252F10%252F2022" target="_blank" title="" data-toggle="tooltip" aria-label="Permissions" data-interactiontype="article_tools_permissions_click" class="article-tools__permissions btn btn--slim" data-original-title="Permissions"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#permissions"></use></svg></span></a><a href="/about-nejm/reprints" title="" data-toggle="tooltip" aria-label="Reprints" data-interactiontype="article_tools_reprints_click" class="article-tools__reprints btn btn--slim" data-original-title="Reprints"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#reprints"></use></svg></span></a><a href="/cms/asset/3893c113-64f4-4756-96db-feada359c09f/nejmoa2116185.pptx" target="_blank" title="" data-toggle="tooltip" aria-label="Download Slides" data-interactiontype="article_tools_slide_set_download" data-multimedia-type="Article Slideset" data-multimedia-filename="nejmoa2116185.pptx" class="article-tools__downloadSlides btn btn--slim" data-original-title="Download Slides"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#download"></use></svg></span></a><div class="article-tools__permissionsPopup"><div id="permissionsModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="permissionsModalTitle" class="ng-modal_title modal-title">Permissions</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body">For permission requests, please contact NEJM Reprints at <a href="mailto:reprints@nejm.org">reprints@nejm.org</a></div></div></div></div></div></div>
</div><div class="info-panel__citations info-panel__item"><a href="#tab-citations" class="btn btn--slim" aria-label="View Citations" data-toggle="tooltip" data-original-title="View Citations" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><i aria-hidden="true" class="icon-format_quote"></i></a></div><div class="info-panel__formats info-panel__item"><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2116185" class="btn btn--pdf btn--slim" aria-label="View PDF" data-toggle="tooltip" data-original-title="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2116185" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2116185.pdf"><i aria-hidden="true" class="icon-PDF"></i></a></div></div></div></div></header><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Contents</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><ul><li><a href="#summary-abstract" aria-current="true">Abstract</a></li><li><a href="#sec-1" aria-current="false">Methods</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li class="bordered"><a href="#backnotes" aria-current="false">Notes</a></li><li><a href="#supplementary-materials" aria-current="false">Supplementary Material</a></li><li><a href="#bibliography" aria-current="false">References</a></li></ul></nav></div><nav id="article_collateral_menu"><ul data-core-nav="collateral" class="collateral-pill" style="margin-top: 0px;"><li><a href="#core-collateral-info" data-id="article-nav-menubar-info" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Information &amp; Authors"><i aria-hidden="true" class="icon-info"></i><span class="sr-only">Information &amp; Authors</span></a></li><li><a href="#core-collateral-metrics" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Metrics &amp; Citations"><i aria-hidden="true" class="icon-timeline"></i><span class="sr-only">Metrics &amp; Citations</span></a></li><li><a href="#core-collateral-fulltext-options" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="View Options"><i aria-hidden="true" class="icon-eye"></i><span class="sr-only">View Options</span></a></li><li><a href="#core-collateral-references" data-id="article-nav-menubar-references" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="References"><i aria-hidden="true" class="icon-references"></i><span class="sr-only">References</span></a></li><li><a href="#core-collateral-media" data-id="article-nav-menubar-media" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Media"><i aria-hidden="true" class="icon-photo"></i><span class="sr-only">Media</span></a></li><li><a href="#core-collateral-tables" data-id="article-nav-menubar-tables" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Tables"><i aria-hidden="true" class="icon-tables"></i><span class="sr-only">Tables</span></a></li><li><a href="#core-collateral-share" data-id="article-nav-menubar-share" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Share"><i aria-hidden="true" class="icon-share"></i><span class="sr-only">Share</span></a></li></ul></nav></div></div><div data-core-wrapper="content"><div id="abstracts" data-extent="frontmatter" data-location="articleTab_article"><div class="core-container"><section id="summary-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Abstract</h2><section id="abs-sec-1"><h3>Background</h3><div role="paragraph">NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (Covid-19) in phase 2b–3 trials in the United Kingdom and South Africa, but its efficacy had not yet been tested in North America.</div></section><section id="abs-sec-2"><h3>Methods</h3><div role="paragraph">We conducted a phase 3, randomized, observer-blinded, placebo-controlled trial in the United States and Mexico during the first half of 2021 to evaluate the efficacy and safety of NVX-CoV2373 in adults (≥18 years of age) who had not had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Participants were randomly assigned in a 2:1 ratio to receive two doses of NVX-CoV2373 or placebo 21 days apart. The primary objective was to determine vaccine efficacy against reverse-transcriptase–polymerase-chain-reaction–confirmed Covid-19 occurring at least 7 days after the second dose. Vaccine efficacy against moderate-to-severe disease and against different variants was also assessed.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><!-- There is no content. --><nav><a href="#f0" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f0.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f0" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f0.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/b7302d10-3534-4e82-b303-ec5864588849/assets/images/large/nejmoa2116185_f0.jpg" height="3416" width="2640" aria-labelledby="f0" loading="lazy"></a><figcaption>Download a PDF of the <a href="#ap0">Research Summary</a>.</figcaption></figure></div></section><section id="abs-sec-3"><h3>Results</h3><div role="paragraph">Of the 29,949 participants who underwent randomization between December 27, 2020, and February 18, 2021, a total of 29,582 (median age, 47 years; 12.6% ≥65 years of age) received at least one dose: 19,714 received vaccine and 9868 placebo. Over a period of 3 months, 77 cases of Covid-19 were noted — 14 among vaccine recipients and 63 among placebo recipients (vaccine efficacy, 90.4%; 95% confidence interval [CI], 82.9 to 94.6; P&lt;0.001). Ten moderate and 4 severe cases occurred, all in placebo recipients, yielding vaccine efficacy against moderate-to-severe disease of 100% (95% CI, 87.0 to 100). Most sequenced viral genomes (48 of 61, 79%) were variants of concern or interest — largely B.1.1.7 (alpha) (31 of the 35 genomes for variants of concern, 89%). Vaccine efficacy against any variant of concern or interest was 92.6% (95% CI, 83.6 to 96.7). Reactogenicity was mostly mild to moderate and transient but was more frequent among NVX-CoV2373 recipients than among placebo recipients and was more frequent after the second dose than after the first dose.</div></section><section id="abs-sec-4"><h3>Conclusions</h3><div role="paragraph">NVX-CoV2373 was safe and effective for the prevention of Covid-19. Most breakthrough cases were caused by contemporary variant strains. (Funded by Novavax and others; PREVENT-19 ClinicalTrials.gov number, <a href="http://clinicaltrials.gov/show/NCT04611802" target="_blank">NCT04611802</a>.)</div></section></section><div class="core-digital-object quick-take">
<div class="ng-do-media" style="border-top: 1px solid #e5e5e5; padding-top: 1.5rem;" data-location="inlineArticlePreview">
    <div class="ng-do-media_item">
        <div class="ng-do-media_item-left">
            <a href="/do/10.1056/NEJMdo006369/full/" class="ng-do-media_item-img-link">
                <img src="/cms/asset/7d73cdff-0608-4a64-b7c1-5514836057b6/media/NEJMdo006369_300x200.jpg" class="ng-do-media_item-img">
                <span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#tooltip-video"></use></svg></span>
            </a>
        </div>
        <div class="ng-do-media_item-right">
            <div class="ng-do-media_item-type">
                <a href="/browse/nejm-media-type/quick-take" class="ng-do-media_item-type-link">Quick Take</a>
            </div>
            <h6 class="ng-do-media_item-title">
                <a href="/do/10.1056/NEJMdo006369/full/" class="ng-do-media_item-title-link">Efficacy and Safety of NVX-CoV2373 in Adults</a>
            </h6>
            <div class="ng-do-media_item-duration">1m 47s</div>
        </div>
    </div>
</div>
</div></div></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text" data-location="articleTab_article"><div class="core-container"><div role="paragraph">The global pandemic of coronavirus disease 2019 (Covid-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been met with an unprecedented response in vaccine development.<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-1" href-manipulated="true" aria-label="Reference 1">1</a></sup> Several Covid-19 vaccines based on different technologies are available, all of which use the SARS-CoV-2 spike protein, usually based on the ancestral strain, as an antigen.<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r3 r4 r5" id="body-ref-r5" href-manipulated="true">2-5</a></sup> Although these vaccines have been shown to provide a remarkable reduction in disease burden in clinical trials, development efforts must continue to address global supply shortages and the emergence of variants that affect virulence or susceptibility to vaccine-induced immunity (variants of concern or variants of interest).<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6 r7 r8" id="body-ref-r8-1" href-manipulated="true">6-8</a></sup></div><div role="paragraph">NVX-CoV2373 (Novavax), a SARS-CoV-2 vaccine made up of full-length, stabilized, prefusion, recombinant spike protein trimers produced from the Wuhan-Hu-1 sequence, is assembled into nanoparticles coformulated with a saponin-based adjuvant (Matrix-M). The vaccine, which is stable at refrigerated temperatures (2 to 8°C), may help to address the continually evolving Covid-19 pandemic and the concurrent global vaccine shortage.<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9" href-manipulated="true" aria-label="Reference 9">9</a></sup></div><div role="paragraph">NVX-CoV2373 was found to be safe and immunogenic in adults<sup><a href="#core-r10" role="doc-biblioref" data-xml-rid="r10 r11" id="body-ref-r11" href-manipulated="true">10,11</a></sup> and provided high vaccine efficacy against severe disease caused by the B.1.351 (beta) variant of concern in a phase 2b trial in South Africa<sup><a href="#core-r12" role="doc-biblioref" data-xml-rid="r12" id="body-ref-r12-1" href-manipulated="true" aria-label="Reference 12">12</a></sup> and against Covid-19 of any severity caused by the B.1.1.7 (alpha) variant of concern in a phase 3 trial in the United Kingdom.<sup><a href="#core-r13" role="doc-biblioref" data-xml-rid="r13" id="body-ref-r13-1" href-manipulated="true" aria-label="Reference 13">13</a></sup> We describe the results of PREVENT-19 (Prefusion Protein Subunit Vaccine Efficacy Novavax Trial–COVID-19), a phase 3 trial of NVX-CoV2373 involving adults 18 years of age or older in the United States and Mexico conducted during a period in which the circulating variants were predominantly alpha, beta, P.1 (gamma), B.1.427 and B.1.429 (epsilon), and B.1.526 (iota).<sup><a href="#core-r14" role="doc-biblioref" data-xml-rid="r14" id="body-ref-r14-1" href-manipulated="true" aria-label="Reference 14">14</a></sup></div><section id="sec-1" data-type="methods"><h2>Methods</h2><section id="sec-1-1"><h3>Trial Design, Participants, Procedures, and Oversight</h3><div role="paragraph">We conducted this phase 3, randomized, observer-blinded, placebo-controlled trial at 113 clinical sites in the United States and 6 in Mexico to evaluate the efficacy and safety of NVX-CoV2373. Adults 18 years of age or older who were healthy or who had stable chronic medical conditions, including chronic pulmonary, renal, or cardiovascular disease, diabetes mellitus type 2, or well-controlled human immunodeficiency virus (HIV) infection, were eligible for participation. Key exclusion criteria included known previous laboratory-confirmed SARS-CoV-2 infection or known immunosuppression. In accordance with the Food and Drug Administration (FDA) and funding agency guidance,<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1 r15" id="body-ref-r15-1" href-manipulated="true">1,15</a></sup> enrollment targets were specified for the inclusion of racial and ethnic minorities, and site selection prioritized accessibility to participants at high risk for acquisition or complications of Covid-19. Participants received initial injections between December 27, 2020, and February 18, 2021, and were followed through April 19, 2021. During this period, the predominant viral variants detected in the United States and Mexico were alpha, beta, gamma, epsilon, and iota.<sup><a href="#core-r14" role="doc-biblioref" data-xml-rid="r14" id="body-ref-r14-2" href-manipulated="true" aria-label="Reference 14">14</a></sup> Additional details regarding trial design, conduct, oversight, and analyses are provided in the <a href="#ap2">Supplementary Appendix</a> and in the <a href="#ap1">protocol</a> and statistical analysis plan, available with the full text of this article at NEJM.org.</div><div role="paragraph">Participants provided written informed consent before enrollment, were stratified according to age (18 to 64 years or ≥65 years), and were randomly assigned with the use of a Web-based interactive response system in a 2:1 ratio to receive two 0.5-ml intramuscular injections of either NVX-CoV2373 (5 μg of SARS-CoV-2 recombinant spike protein adjuvanted with 50 μg of Matrix-M) or saline placebo 21 days apart. Site personnel who were aware of the randomization assignments managed the logistics of the injections and the preparation of the vaccine and placebo but had no other role in trial conduct. Novavax was the trial sponsor and was responsible for the trial design and for the development and manufacture of the NVX-CoV2373 clinical trial material. The trial was part of the U.S. Government–funded harmonized trial program. Site selection, monitoring of clinical data, data collection and analysis, and preparation of the manuscript (the first draft of which was written by authors who are employees of Novavax) were conducted in collaboration with the Biomedical Advanced Research and Development Authority, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, the Covid-19 Prevention Network, and the trial cochairs.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16" id="body-ref-r16" href-manipulated="true" aria-label="Reference 16">16</a></sup> Trial data were available to all the authors, who vouch for the accuracy and completeness of the data and for the fidelity of the trial to the protocol. The trial is continuing after the time of this analysis, and investigators and Novavax clinical team remain unaware of the participant-level randomization assignments. The protocol, amendments, and overall oversight were provided by institutional review boards and ethics committees according to local regulations. Safety oversight was provided by an NIAID-sponsored protocol safety review team, and safety, efficacy, and potential vaccine-induced harm were monitored through regular review of unblinded data by the NIAID-sponsored data and safety monitoring board.<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17" id="body-ref-r17" href-manipulated="true" aria-label="Reference 17">17</a></sup></div></section><section id="sec-1-2"><h3>Efficacy Assessments</h3><div role="paragraph">The aim of the trial was to estimate, as the primary end point, the efficacy of NVX-CoV2373 for the prevention of a first occurrence of reverse-transcriptase–polymerase-chain-reaction (RT-PCR)–confirmed symptomatic mild, moderate, or severe Covid-19 (defined with the use of FDA criteria<sup><a href="#core-r15" role="doc-biblioref" data-xml-rid="r15" id="body-ref-r15-2" href-manipulated="true" aria-label="Reference 15">15</a></sup>) (Table S3 in the <a href="#ap2">Supplementary Appendix</a>) with onset at least 7 days after the second dose. The primary end point was assessed in the per-protocol efficacy analysis population, which included participants who underwent randomization and received both doses as assigned, were seronegative for anti–SARS-CoV-2 nucleoprotein and had a SARS-CoV-2 RNA RT-PCR–negative nasal swab at baseline, and did not have a censoring event at any time before 7 days after the second injection. Symptoms of suspected Covid-19 (Table S2) were reported daily by participants using an electronic diary. When specified symptoms were reported for 2 or more consecutive days, participants were instructed to obtain three nasal swab specimens themselves daily and to undergo in-clinic medical evaluation, including collection of a nasal swab specimen for SARS-CoV-2 testing at a central laboratory. Covid-19 cases for end-point assessment were considered to be confirmed when at least one of four nasal swab specimens tested positive for SARS-CoV-2 RNA by RT-PCR at the central laboratory. Whole-genome sequencing and clade and lineage assignment were performed on RT-PCR–positive samples with sufficient viral RNA loads (see the <a href="#ap2">Supplementary Appendix</a>).</div><div role="paragraph">The key secondary objective was to determine the vaccine efficacy of NVX-CoV2373 for the prevention of RT-PCR–confirmed Covid-19 cases caused by SARS-CoV-2 that was neither a variant of concern nor a variant of interest (i.e., virus that did not have mutations associated with variants of concern or interest), which could be considered to most closely resemble the ancestral Wuhan-Hu-1 strain. Conversely, vaccine efficacy against RT-PCR–confirmed Covid-19 caused by variants of concern or variants of interest, as defined by the Centers for Disease Control and Prevention (CDC) at the time of end-point case accrual,<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6" id="body-ref-r6-2" href-manipulated="true" aria-label="Reference 6">6</a></sup> was estimated as an exploratory end point.</div><div role="paragraph">We also estimated vaccine efficacy against moderate and severe Covid-19 as secondary end points, with moderate Covid-19 defined as high fever and objective evidence of lower respiratory tract infection and severe Covid-19 defined as the presence of clinically significant tachypnea, tachycardia, or hypoxia; receipt of intensive respiratory support; major dysfunction of one or more organ systems; admission to an intensive care unit; or death. Additional analyses of vaccine efficacy, although they were not statistically powered, were performed in relevant subgroups (based on race, ethnic group, age, and coexisting conditions associated with an increased risk of severe Covid-19 complications according to CDC criteria,<sup><a href="#core-r18" role="doc-biblioref" data-xml-rid="r18" id="body-ref-r18-1" href-manipulated="true" aria-label="Reference 18">18</a></sup> as well as on the risk of exposure related to occupation or living conditions).</div><div role="paragraph">Covid-19 severity as an end point was assessed by investigators and trial physicians; severe cases were confirmed by an external independent end-point review committee. All evaluations were blinded to randomization assignments.</div></section><section id="sec-1-3"><h3>Safety Assessments</h3><div role="paragraph">Data on solicited local and systemic adverse events were collected with the use of a participant-recorded electronic diary for 7 days after each injection. Data on unsolicited adverse events were collected from the first dose through 28 days after the second dose; data on serious adverse events, adverse events of special interest, and medically attended adverse events were collected from the first dose through data cutoff (secondary end points).</div><div role="paragraph">Data on solicited local and systemic adverse events were assessed for severity (according to FDA criteria<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19" id="body-ref-r19-1" href-manipulated="true" aria-label="Reference 19">19</a></sup>) and duration after each injection. Unsolicited adverse events were coded according to preferred term and system organ class with the use of the <i>Medical Dictionary for Regulatory Activities</i>, version 23.1, and were summarized according to severity and relationship to vaccine or placebo.</div></section><section id="sec-1-4"><h3>Statistical Analysis</h3><div role="paragraph">Vaccine efficacy was assessed in both the full analysis population (i.e., all participants who underwent randomization and received at least one dose of vaccine or placebo) and the per-protocol efficacy analysis population (defined above in “Efficacy Assessments”). In analyses involving the full analysis population, two observation periods were used — one starting at dose 1 and the other starting 7 days after dose 2. In analyses involving the per-protocol efficacy population, only the observation period that started 7 days after dose 2 was used.</div><div role="paragraph">The primary efficacy analysis was based on the per-protocol efficacy analysis population. Vaccine efficacy was defined as (1−RR)×100, where RR is the relative risk of the end point of interest based on the incidence in the NVX-CoV2373 group as compared with that in the placebo group. The estimated relative risk and two-sided 95% confidence interval were derived with the use of a Poisson regression with robust error variance. The prespecified criteria for success in the primary efficacy analysis were a lower bound of the two-sided 95% confidence interval for vaccine efficacy of greater than 30% and a point estimate for vaccine efficacy of 50% or greater.<sup><a href="#core-r15" role="doc-biblioref" data-xml-rid="r15" id="body-ref-r15-3" href-manipulated="true" aria-label="Reference 15">15</a></sup></div><div role="paragraph">The trial was designed to evaluate efficacy on the basis of the number of events expected to be required in order to achieve significance with respect to the primary end point, originally estimated to be 144 cases meeting the definition of the primary end point. However, to maintain the viability of the trial and retain participants in the face of nationwide availability of vaccines under emergency use authorization, a blinded crossover (i.e., participants who had originally been randomly assigned to receive placebo were administered NVX-CoV2373 and vice versa) was implemented. This coincided with the accumulation of a median of 2 months of safety follow-up and ensured that all participants received active vaccine at the earliest possible time without compromising FDA-required placebo-controlled safety follow-up. The final analysis of the placebo-controlled portion of the trial, which was approved by the data and safety monitoring board before general access to unblinded data and is reported here, includes the number of confirmed cases of Covid-19 fulfilling the definition of the primary end point that occurred before the crossover. As a result of the blinded crossover, the two initially planned formal interim analyses of efficacy and futility were replaced with a single analysis of efficacy in which the full two-sided type I error of 5% was used for the primary end point.</div><div role="paragraph">The safety analysis population included all participants who received at least one dose of vaccine or placebo. Data on safety were summarized descriptively.</div></section></section><section id="sec-2" data-type="results"><h2>Results</h2><section id="sec-2-1"><h3>Participants</h3><div role="paragraph">Of the 31,588 participants who were screened, 29,949 underwent randomization between December 27, 2020, and February 18, 2021 (<a href="#f1">Figure 1</a>). Among the 29,582 participants who received at least one dose of NVX-CoV2373 (19,714 participants) or placebo (9868 participants) and were included in the full analysis population (median age, 47 years; 12.6% ≥65 years of age), 25,452 participants (17,312 NVX-CoV2373 recipients and 8140 placebo recipients) were included in the per-protocol efficacy analysis population. The main reasons for exclusion from the per-protocol efficacy analysis population included baseline positivity for anti–SARS-CoV-2 nucleoprotein or SARS-CoV-2 RNA on RT-PCR testing, failure to receive both doses as prescribed, unblinding, or other censoring event (Table S18). At baseline, 6.3% of the NVX-CoV2373 recipients and 6.9% of the placebo recipients in the safety analysis population were seropositive or RT-PCR–positive for SARS-CoV-2 (Table S4).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 1</div><nav><a href="#f1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f1" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f1.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/83aa99a0-c09a-495e-97e9-ffb8a3711e31/assets/images/large/nejmoa2116185_f1.jpg" height="3343" width="2640" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Screening, Randomization, and Follow-up.</div><div class="notes"><div role="doc-footnote">The full analysis population included all participants who underwent randomization and received at least one dose of vaccine or placebo, regardless of protocol violations or missing data; participants in the full analysis population are included in the analysis according to the group to which they were randomly assigned. The safety analysis population included all participants who received at least one dose of vaccine or placebo. The per-protocol efficacy analysis population included all participants who underwent randomization and received both doses as assigned, were seronegative for anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein and had a SARS-CoV-2 RNA reverse-transcriptase–polymerase-chain-reaction (RT-PCR)–negative nasal swab at baseline, and did not have a censoring event at any time before 7 days after the second injection. Data from participants at two sites (193 assigned to receive NVX-CoV2373 and 93 assigned to receive placebo) were excluded from analyses because of Good Clinical Practice quality concerns. The window for the first dose of vaccine or placebo was December 20, 2020, to February 18, 2021.</div></div></figcaption></figure></div><div role="paragraph">The demographic characteristics of the participants in the per-protocol efficacy analysis population were well balanced between the treatment groups; 48.2% identified as female, 75.9% as White, 11.0% as Black or African American, 6.2% as Native American or Alaska Native (including American Indians and Native Mexicans), and 21.5% as Hispanic or Latino. One or more coexisting conditions<sup><a href="#core-r18" role="doc-biblioref" data-xml-rid="r18" id="body-ref-r18-2" href-manipulated="true" aria-label="Reference 18">18</a></sup> were reported by 47.3% of the participants. The median age was 47 years, and 11.8% of the participants were 65 years of age or older (<a href="#t1">Table 1</a>).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 1</div><nav><a href="#t1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2116185_t1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t1" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2116185_t1.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/1255cb77-e117-4314-8f64-a8caab2503d0/assets/images/large/nejmoa2116185_t1.jpg" height="2802" width="1999" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Characteristic</th><th class="txxx-borders">NVX-CoV2373<br>(N=17,312)</th><th class="txxx-borders">Placebo<br>(N=8140)</th><th class="txxr-borders">Total<br>(N=25,452)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging03 shading" data-xml-align="left">Median age (range) — yr</td><td class="xxxx-borders shading">47.0 (18–95)</td><td class="xxxx-borders shading">47.0 (18–90)</td><td class="xxxr-borders shading">47.0 (18–95)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Age group — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">18 to 64 yr</td><td class="xxxx-borders shading">15,264 (88.2)</td><td class="xxxx-borders shading">7,194 (88.4)</td><td class="xxxr-borders shading">22,458 (88.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">≥65 yr</td><td class="xxxx-borders">2,048 (11.8)</td><td class="xxxx-borders">946 (11.6)</td><td class="xxxr-borders">2,994 (11.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Sex — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Male</td><td class="xxxx-borders">9,050 (52.3)</td><td class="xxxx-borders">4,131 (50.7)</td><td class="xxxr-borders">13,181 (51.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Female</td><td class="xxxx-borders shading">8,262 (47.7)</td><td class="xxxx-borders shading">4,009 (49.3)</td><td class="xxxr-borders shading">12,271 (48.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Race or ethnic group — no. (%)<a href="#t1fn2" role="doc-noteref">†</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">White</td><td class="xxxx-borders shading">13,140 (75.9)</td><td class="xxxx-borders shading">6,184 (76.0)</td><td class="xxxr-borders shading">19,324 (75.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Black or African American</td><td class="xxxx-borders">1,893 (10.9)</td><td class="xxxx-borders">900 (11.1)</td><td class="xxxr-borders">2,798 (11.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">American Indian or Alaska Native, including Mexican Natives</td><td class="xxxx-borders shading">1,074 (6.2)</td><td class="xxxx-borders shading">498 (6.1)</td><td class="xxxr-borders shading">1,572 (6.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Asian</td><td class="xxxx-borders">761 (4.4)</td><td class="xxxx-borders">366 (4.5)</td><td class="xxxr-borders">1,127 (4.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Multiple</td><td class="xxxx-borders shading">293 (1.7)</td><td class="xxxx-borders shading">132 (1.6)</td><td class="xxxr-borders shading">425 (1.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Native Hawaiian or other Pacific Islander</td><td class="xxxx-borders">47 (0.3)</td><td class="xxxx-borders">10 (0.1)</td><td class="xxxr-borders">57 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Not reported</td><td class="xxxx-borders shading">104 (0.6)</td><td class="xxxx-borders shading">45 (0.6)</td><td class="xxxr-borders shading">149 (0.6)</td></tr><tr data-type="row"><td class="xxlx-borders hanging13">Hispanic or Latino</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">No</td><td class="xxxx-borders shading">13,538 (78.2)</td><td class="xxxx-borders shading">6,379 (78.4)</td><td class="xxxr-borders shading">19,917 (78.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">Yes</td><td class="xxxx-borders">3,733 (21.6)</td><td class="xxxx-borders">1,751 (21.5)</td><td class="xxxr-borders">5,484 (21.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">Not reported</td><td class="xxxx-borders shading">22 (0.1)</td><td class="xxxx-borders shading">9 (0.1)</td><td class="xxxr-borders shading">31 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">Unknown</td><td class="xxxx-borders">19 (0.1)</td><td class="xxxx-borders">1 (&lt;0.1)</td><td class="xxxr-borders">20 (0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Overall high risk of Covid-19 — no. (%)<a href="#t1fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Yes</td><td class="xxxx-borders">16,493 (95.3)</td><td class="xxxx-borders">7,737 (95.0)</td><td class="xxxr-borders">24,230 (95.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">No</td><td class="xxxx-borders shading">819 (4.7)</td><td class="xxxx-borders shading">403 (5.0)</td><td class="xxxr-borders shading">1,222 (4.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">High risk of severe Covid-19 — no. (%)<a href="#t1fn4" role="doc-noteref">§</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Yes</td><td class="xxxx-borders shading">9,046 (52.3)</td><td class="xxxx-borders shading">4,294 (52.8)</td><td class="xxxr-borders shading">13,340 (52.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">No</td><td class="xxxx-borders">8,266 (47.7)</td><td class="xxxx-borders">3,846 (47.2)</td><td class="xxxr-borders">12,112 (47.6)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Coexisting conditions — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Any</td><td class="xxxx-borders">8,117 (46.9)</td><td class="xxxx-borders">3,910 (48.0)</td><td class="xxxr-borders">12,027 (47.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Obesity</td><td class="xxxx-borders shading">6,400 (37.0)</td><td class="xxxx-borders shading">3,070 (37.7)</td><td class="xxxr-borders shading">9,470 (37.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Chronic lung disease</td><td class="xxxx-borders">2,442 (14.1)</td><td class="xxxx-borders">1,218 (15.0)</td><td class="xxxr-borders">3,660 (14.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Diabetes mellitus type 2</td><td class="xxxx-borders shading">1,303 (7.5)</td><td class="xxxx-borders shading">677 (8.3)</td><td class="xxxr-borders shading">1,980 (7.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Cardiovascular disease</td><td class="xxxx-borders">191 (1.1)</td><td class="xxxx-borders">91 (1.1)</td><td class="xxxr-borders">282 (1.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Chronic kidney disease</td><td class="xxxx-borders shading">109 (0.6)</td><td class="xxxx-borders shading">50 (0.6)</td><td class="xxxr-borders shading">159 (0.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging03" data-xml-align="left">HIV infection — no. (%)</td><td class="xxxx-borders">128 (0.7)</td><td class="xxxx-borders">38 (0.5)</td><td class="xxxr-borders">166 (0.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Country — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">United States</td><td class="xxxx-borders">16,294 (94.1)</td><td class="xxxx-borders">7,638 (93.8)</td><td class="xxxr-borders">23,932 (94.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging13 shading" data-xml-align="left">Mexico</td><td class="xbxx-borders shading">1,018 (5.9)</td><td class="xbxx-borders shading">502 (6.2)</td><td class="xbxr-borders shading">1,520 (6.0)</td></tr></tbody></table></div><figcaption><div class="caption">Demographic and Clinical Characteristics of the Participants at Baseline (Per-Protocol Efficacy Analysis Population).<a href="#t1fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t1fn1" role="paragraph">The per-protocol efficacy analysis population included all participants who underwent randomization and received both doses as assigned, were seronegative for anti–SARS-CoV-2 nucleoprotein and had a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA RT-PCR–negative nasal swab at baseline, and did not have a censoring event at any time before 7 days after the second injection. HIV denotes human immunodeficiency virus.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t1fn2" role="paragraph">Race and ethnic group were reported by the participants.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="t1fn3" role="paragraph">Participants at overall high risk included those 65 years of age or older and those of any age with chronic health conditions or an increased risk for Covid-19 because of work or living conditions.</div></div><div role="doc-footnote" data-has="label"><div class="label">§</div><div id="t1fn4" role="paragraph">Participants were classified as having a high risk of severe Covid-19 if they had one or more of the following coexisting conditions: obesity (defined as a body-mass index [the weight in kilograms divided by the square of the height in meters] of ≥30.0), chronic lung disease, diabetes mellitus type 2, cardiovascular disease, or chronic kidney disease.</div></div></div></figcaption></figure></div></section><section id="sec-2-2"><h3>Efficacy</h3><div role="paragraph">In the full analysis population, the incidence of Covid-19 was 21.2 cases per 1000 person-years (95% confidence interval [CI], 16.2 to 27.7) in the NVX-CoV2373 group and 51.9 cases per 1000 person-years (95% CI, 40.9 to 66.0) in the placebo group when the observation period started after dose 1. The cumulative incidence curves separated between days 14 and 21 (<a href="#f2">Figure 2A</a>).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 2</div><nav><a href="#f2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f2" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f2.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/fad7cf1b-de92-43b1-8169-9e46f8f8da1d/assets/images/large/nejmoa2116185_f2.jpg" height="3399" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Overall Efficacy of NVX-CoV2373 against Covid-19.</div><div class="notes"><div role="doc-footnote">Shown is the cumulative incidence of symptomatic (mild, moderate, or severe) coronavirus disease 2019 (Covid-19). Panel A shows all participants in the full analysis population during the period of surveillance that started at the first dose of NVX-CoV2373 or placebo. Panel B shows all participants in the per-protocol efficacy analysis population during the period of surveillance starting 7 days after the second dose (i.e., up to 28 days after the first dose) through approximately 3 months of follow-up, until unblinding, or until receipt of a vaccine under emergency use authorization. Panel C shows all participants in the full analysis population during the period of surveillance that started 7 days after the second dose. Panel D shows all participants in the per-protocol efficacy analysis population with cases of Covid-19 due to variants that are not considered variants of concern (VOC) or variants of interest (VOI). Panel E shows all participants in the per-protocol efficacy analysis population with cases of Covid-19 due to VOC or VOI.</div></div></figcaption></figure></div><div role="paragraph">Among the 25,452 participants in the per-protocol efficacy analysis population who were followed through April 19, 2021 (median follow-up for efficacy, approximately 3 months), 77 central laboratory–confirmed Covid-19 cases occurred: 14 cases in NVX-CoV2373 recipients and 63 in placebo recipients (incidence, 3.3 cases per 1000 person-years [95% CI, 1.6 to 6.9] and 34.0 cases per 1000 person-years [95% CI, 20.7 to 55.9], respectively). These results yielded a vaccine efficacy of 90.4% (95% CI, 82.9 to 94.6; P&lt;0.001) (<a href="#f2">Figure 2B</a> and Table S5). The rate of new Covid-19 cases among NVX-CoV2373 recipients was higher during the first 42 days of follow-up than during the remainder of the accrual period covered in this report. Subsequently, the incidence of new cases declined among vaccine recipients and increased among placebo recipients (<a href="#f2">Figure 2B</a>).</div><div role="paragraph">Similar results for vaccine efficacy were obtained in the full analysis population when the observation period started 7 days after the second dose: 85 Covid-19 cases occurred (16 in NVX-CoV2373 recipients and 69 in placebo recipients; incidence, 3.7 cases per 1000 person-years [95% CI, 1.8 to 7.4] and 34.6 cases per 1000 person-years [95% CI, 22.3 to 53.6], respectively). These results yielded a vaccine efficacy of 89.3% (95% CI, 81.6 to 93.8) (<a href="#f2">Figure 2C</a> and Table S17).</div><div role="paragraph">All the cases reported in NVX-CoV2373 recipients were mild in severity, whereas 14 moderate-to-severe cases (10 moderate and 4 severe) occurred in the placebo group, yielding a vaccine efficacy against moderate-to-severe Covid-19 of 100% (95% CI, 87.0 to 100) (Table S7). Vaccine efficacy against severe Covid-19 alone (4 cases) was 100% (95% CI, 34.6 to 100 in a post hoc analysis). Vaccine efficacy against confirmed Covid-19 meeting the definition of the primary end point among participants who were at high risk for acquisition or complications of Covid-19 was 91.0% (95% CI, 83.6 to 95.0) (<a href="#f3">Figure 3</a>). Vaccine efficacy in several prespecified demographic subgroups was in most cases found to be similarly high. Among Black participants, vaccine efficacy was 100% (95% CI, 67.9 to 100) (<a href="#f3">Figure 3</a>). Hispanic or Latino participants were the only demographic group in which vaccine efficacy was lower than in other subgroups (67.3%; 95% CI, 18.7 to 86.8) (<a href="#f3">Figure 3</a>).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 3</div><nav><a href="#f3" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f3.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f3" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f3.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/ff51d420-fc15-47a3-bf05-300515e5b9ea/assets/images/large/nejmoa2116185_f3.jpg" height="1377" width="2640" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Vaccine Efficacy of NVX-CoV2373 in Specific Subgroups (Per-Protocol Efficacy Analysis Population).</div><div class="notes"><div role="doc-footnote">Vaccine efficacy was defined as 1 minus the relative risk (NVX-CoV2373 minus placebo). Non-White race included end-point cases in participants from all other races to ensure that these subgroups would be large enough for meaningful analyses. The assessment of coexisting conditions is based on the Centers for Disease Control and Prevention definitions<sup><a href="#core-r18" role="doc-biblioref" data-xml-rid="r18" id="body-ref-r18-3" href-manipulated="true" aria-label="Reference 18">18</a></sup> of persons at risk for complications of Covid-19. Participants at overall high risk for Covid-19 included those 65 years of age or older and those of any age with chronic health conditions or an increased risk for Covid-19 because of work or living conditions.</div></div></figcaption></figure></div><div role="paragraph">Nasal swabs from 61 of 77 participants (79%) with RT-PCR–confirmed Covid-19 yielded sequences by whole-genome sequencing. Sequences from 48 of these 61 specimens were identified as variants of concern or interest, and 13 were identified as other variants (Fig. S1); vaccine efficacy against the latter variants was 100% (95% CI, 85.8 to 100) (<a href="#f2">Figure 2D</a>). The alpha variant accounted for most specimens with sequences that were identified as variants of concern (31 of 35, 89%); vaccine efficacy against the alpha variant was 93.6% (95% CI, 81.7 to 97.8 in a post hoc analysis), and vaccine efficacy against any variant of concern or interest was 92.6% (95% CI, 83.6 to 96.7) (<a href="#f2">Figure 2E</a>). An assessment of vaccine efficacy for cases that yielded no sequence information (16 of 77, 21%) was not conducted.</div></section><section id="sec-2-3"><h3>Safety</h3><div role="paragraph">Solicited local and systemic adverse events were predominantly mild to moderate and transient. These events occurred more frequently among NVX-CoV2373 recipients than among placebo recipients (any local adverse event, 58.0% and 21.1%, respectively, after dose 1 and 78.9% and 21.7% after dose 2; any systemic adverse event, 47.7% and 40.0%, respectively, after dose 1 and 69.5% and 35.9% after dose 2).</div><div role="paragraph">After each dose, the most frequently reported solicited local adverse events were tenderness and injection-site pain. The median duration of these events was 2 days or less (Table S11). Severe (grade ≥3) local reactions were infrequent overall but were more common among NVX-CoV2373 recipients than among placebo recipients, particularly after dose 2 (1.1% of NVX-CoV2373 recipients and &lt;1% of placebo recipients after dose 1 and 6.7% and &lt;1%, respectively, after dose 2) (<a href="#f4">Figure 4</a> and Table S10).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 4</div><nav><a href="#f4" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f4.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f4" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f4" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f4.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/b6d2d735-3357-45f6-acc5-1ec22fe11d6f/assets/images/large/nejmoa2116185_f4.jpg" height="3438" width="1717" aria-labelledby="f4" loading="lazy"></a><figcaption><div class="caption">Solicited Local and Systemic Adverse Events (Safety Analysis Population).</div><div class="notes"><div role="doc-footnote">The percentage of participants in each group with solicited local and systemic adverse events during the 7 days after each dose is plotted according to Food and Drug Administration toxicity grade, either as any grade (mild, moderate, severe, or potentially life-threatening) or as grade 3 or higher (severe or potentially life-threatening).<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19" id="body-ref-r19-2" href-manipulated="true" aria-label="Reference 19">19</a></sup> An expanded x axis is used for events of grade 3 or higher to highlight differences between small percentages.</div></div></figcaption></figure></div><div role="paragraph">The most common solicited systemic adverse events were headache, myalgia, fatigue, and malaise, which were detected more frequently among NVX-CoV2373 recipients and after the second injection and lasted for a median duration of 1 day or less (Table S13). Fever of any severity was rare (&lt;1%) and was similarly distributed in the vaccine and placebo groups after each dose. Severe systemic reactions were more common among NVX-CoV2373 recipients, particularly after dose 2 (2.4% of NVX-CoV2373 recipients and 2.1% of placebo recipients after dose 1 and 12.1% and 2.1%, respectively, after dose 2) (<a href="#f4">Figure 4</a> and Table S12), but they were less frequent than has been reported for other Covid-19 vaccines.<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2" id="body-ref-r2-2" href-manipulated="true" aria-label="Reference 2">2</a></sup></div><div role="paragraph">In this preliminary safety “snapshot,” unsolicited adverse events were slightly more frequent among NVX-CoV2373 recipients than among placebo recipients (16.3% and 14.8%, respectively), although the imbalance appeared to include duplicate reporting by investigators of reactogenicity that had also been derived from participant-reported outcomes. The frequencies of medically attended adverse events, serious adverse events, severe adverse events, adverse events of special interest related to Covid-19, and potential immune-mediated medical conditions were balanced between the two groups (Table S9). No episodes of anaphylaxis, no evidence of vaccine-associated enhanced Covid-19, and no events that triggered prespecified pause rules were observed. No episodes of the Guillain–Barré syndrome<sup><a href="#core-r20" role="doc-biblioref" data-xml-rid="r20" id="body-ref-r20-1" href-manipulated="true" aria-label="Reference 20">20</a></sup> and no imbalance in myocarditis or pericarditis<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-1" href-manipulated="true" aria-label="Reference 21">21</a></sup> or in vaccine-induced immune thrombosis with thrombocytopenia<sup><a href="#core-r22" role="doc-biblioref" data-xml-rid="r22" id="body-ref-r22-1" href-manipulated="true" aria-label="Reference 22">22</a></sup> were observed during the relatively short safety follow-up period reported here (Tables S14 through S16). All-cause mortality was balanced: nine deaths occurred among NVX-CoV2373 recipients (0.5%), and five occurred among placebo recipients (0.5%).</div></section></section><section id="sec-3" data-type="discussion"><h2>Discussion</h2><div role="paragraph">In this randomized, controlled trial assessing the efficacy and safety of an adjuvanted SARS-CoV-2 recombinant spike protein vaccine in approximately 30,000 participants, we continue to assess, in a blinded fashion, the duration of protection after blinded crossover, as well as the overall safety profile in the trial participants. The trial includes a demographically diverse population in the United States and Mexico and provides strong evidence of high short-term vaccine efficacy of NVX-CoV2373 for the prevention of Covid-19 (&gt;90%) and for the prevention of moderate-to-severe disease (100%).</div><div role="paragraph">NVX-CoV2373 was safe during a median safety follow-up of 2 months and showed mild-to-moderate, transient reactogenicity. No safety concerns related to vaccination were seen, as indicated by the similar percentages of participants reporting unsolicited adverse events in the NVX-CoV2373 group and the placebo group. None of the safety signals under observation with other Covid-19 vaccines<sup><a href="#core-r20" role="doc-biblioref" data-xml-rid="r20 r21 r22" id="body-ref-r22-2" href-manipulated="true">20-22</a></sup> were reported in this trial in the limited safety follow-up period reported here. Long-term safety monitoring is planned to continue through 24 months after initial vaccination.</div><div role="paragraph">Our trial expands the understanding of NVX-CoV2373 efficacy in the evolving pandemic. SARS-CoV-2 has undergone extensive genetic evolution since it was first reported in December 2019, resulting in the emergence of multiple variants that may cause evasion of spike protein–based vaccine-induced immunity.<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6 r7 r8" id="body-ref-r8-2" href-manipulated="true">6-8</a></sup> NVX-CoV2373 showed vaccine efficacy of greater than 90% against variants circulating during case accrual in the United States and Mexico, largely represented by the alpha variant. Similar protection against this variant was observed in the earlier phase 3 trial conducted in the United Kingdom<sup><a href="#core-r13" role="doc-biblioref" data-xml-rid="r13" id="body-ref-r13-2" href-manipulated="true" aria-label="Reference 13">13</a></sup> (vaccine efficacy, 93.6% in the current trial and 86.3% in the U.K. trial). Moreover, efficacy against the alpha variant in both trials was similar to that against the 13 variants that were not variants of concern or interest and that may more closely resemble the ancestral Wuhan-Hu-1 spike sequence from which the vaccine antigen was derived; this suggests that the vaccine induces protective immunity to a broad spectrum of variants beyond the prototype strain.<sup><a href="#core-r12" role="doc-biblioref" data-xml-rid="r12" id="body-ref-r12-2" href-manipulated="true" aria-label="Reference 12">12</a></sup></div><div role="paragraph">Some additional strengths of the current trial include the demographic diversity of the trial population, which permitted an assessment of vaccine efficacy among racial and ethnic minorities reflecting U.S. and Mexican populations that are particularly affected by the pandemic, including Black persons, among whom vaccine efficacy was 100% (95% CI, 67.9 to 100). Vaccine efficacy among Hispanic or Latino persons in the United States was lower than that in other demographic groups (albeit still higher than the prespecified success criterion for vaccine efficacy); this could be related to chance alone or to unidentified viral or host factors, although the former appears to be more plausible biologically. All end-point cases in Hispanic or Latino NVX-CoV2373 recipients were mild in severity. A similar trend was reported for another Covid-19 vaccine, but these findings were not explicitly addressed.<sup><a href="#core-r23" role="doc-biblioref" data-xml-rid="r23" id="body-ref-r23" href-manipulated="true" aria-label="Reference 23">23</a></sup></div><div role="paragraph">Several limitations of this trial are noteworthy. Covid-19 vaccines became available under emergency use authorization concurrently with the initiation of this trial, reducing the enrollment of older adult participants, which then resulted in only four end-point cases in participants 65 years of age or older and prevented a useful estimation of vaccine efficacy in older adults. However, the U.K. phase 3 trial of NVX-CoV2373 enrolled enough older adults to establish a vaccine efficacy of 88.9%, similar to that among younger adults.<sup><a href="#core-r13" role="doc-biblioref" data-xml-rid="r13" id="body-ref-r13-3" href-manipulated="true" aria-label="Reference 13">13</a></sup></div><div role="paragraph">Another limitation is the imbalance in the number of unblinding requests by trial participants at early stages of the trial. This coincided with the introduction of vaccines under emergency use authorization in the United States. Participants who apparently surmised, on the basis of an absence of reactogenicity symptoms, that they had received placebo requested unblinding more often than did those who had received NVX-CoV2373. This led to the exclusion of a higher number of placebo recipients from the per-protocol population for the assessment of efficacy. The limited efficacy follow-up period (approximately 3 months) was another limitation of this analysis; however, this period is consistent with the limited vaccine efficacy follow-up requested for emergency use authorization<sup><a href="#core-r15" role="doc-biblioref" data-xml-rid="r15" id="body-ref-r15-4" href-manipulated="true" aria-label="Reference 15">15</a></sup> and with data that supported all other authorized Covid-19 vaccines.</div><div role="paragraph">In this trial, we implemented a blinded crossover approximately 3 to 4 months after the first vaccination series to allow all trial participants to receive NVX-CoV2373, after vaccine efficacy and required safety had been established and reviewed by the data and safety monitoring board. To address the durability of vaccine efficacy and long-term safety after blinded crossover, hazard models have been proposed for subsequent analyses<sup><a href="#core-r24" role="doc-biblioref" data-xml-rid="r24" id="body-ref-r24" href-manipulated="true" aria-label="Reference 24">24</a></sup>; this will allow comparisons between groups of participants who were vaccinated early and those vaccinated later, although the estimate of the durability of vaccine efficacy after the crossover may be less reliable than it would have been if continued placebo-controlled follow-up had been feasible.</div><div role="paragraph">Finally, as with all major Covid-19 vaccine trials, vaccine efficacy was assessed over a relatively short period during a rapidly evolving pandemic. Initial trials of messenger RNA vaccines in the United States<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r3" id="body-ref-r3-2" href-manipulated="true">2,3</a></sup> tested vaccine efficacy largely against viral variants that were not substantially different from the source vaccine antigen and showed high levels of vaccine efficacy against Covid-19 of any severity. The vaccine efficacy results from our trial not only recapitulate the overall high vaccine efficacy observed in earlier trials but also indicate that vaccine efficacy was high regardless of the then-circulating variant strains: 100% (95% CI, 85.8 to 100) against those that are not variants of concern or interest and 92.6% (95% CI, 83.6 to 96.7) against any circulating variant of concern or interest. Because case accrual for this analysis occurred during the first half of 2021, when the delta variant of concern had not been widely established throughout the United States or Mexico,<sup><a href="#core-r14" role="doc-biblioref" data-xml-rid="r14" id="body-ref-r14-3" href-manipulated="true" aria-label="Reference 14">14</a></sup> no Covid-19 efficacy end-point cases due to this variant were accrued, and thus the vaccine efficacy against delta and other newer variants could not be established.</div><div role="paragraph">NVX-CoV2373 is a new adjuvanted recombinant protein vaccine that can be added to the portfolio of vaccines that are safe and highly protective against contemporary SARS-CoV-2 strains and that have an acceptable side-effect profile. The extended stability and easy storage requirements (up to 6 months at refrigerator temperatures) make it well suited for global deployment. The efficacy of NVX-CoV2373 in preventing moderate-to-severe Covid-19 as well as any symptomatic Covid-19 in people at high risk for acquisition and complications of Covid-19 will make this vaccine a valuable tool in controlling the pandemic and its most serious health and economic consequences.</div></section>



        
        
</div></section><section id="backmatter" data-extent="backmatter" data-location="articleTab_article"><div class="core-container"><section id="backnotes" data-location="notes_article"><h2>Notes</h2><div data-type="published/updated" role="paragraph">This article was published on December 15, 2021, at NEJM.org.</div><div data-type="data-sharing" role="paragraph">A <a href="#ap4">data sharing statement</a> provided by the authors is available with the full text of this article at NEJM.org.</div><div role="paragraph">Supported by <span class="named-content" data-type="funder">Novavax</span>; the <span class="named-content" data-type="funder">Office of the Assistant Secretary for Preparedness and Response</span>, <span class="named-content" data-type="funder">Biomedical Advanced Research and Development Authority</span> (contract Operation Warp Speed: <span class="named-content" data-type="funder">Novavax</span> Project Agreement number 1 under Medical CBRN [Chemical, Biological, Radiological, and Nuclear] Defense Consortium base agreement no. 2020-530; Department of Defense no. W911QY20C0077); and the National Institute of Allergy and Infectious Diseases (<span class="named-content" data-type="funder">NIAID</span>), National Institutes of Health. The <span class="named-content" data-type="funder">NIAID</span> provides grant funding to the HIV Vaccine Trials Network (HVTN) Leadership and Operations Center (UM1 AI68614), the HVTN Statistics and Data Management Center (UM1 AI68635), the HVTN Laboratory Center (UM1 AI68618), the HIV Prevention Trials Network Leadership and Operations Center (UM1 AI68619), the AIDS Clinical Trials Group Leadership and Operations Center (UM1 AI68636), and the Infectious Diseases Clinical Research Consortium leadership group (UM1 AI148684).</div><div role="paragraph"><a href="#ap3">Disclosure forms</a> provided by the authors are available with the full text of the article at NEJM.org.</div><div role="paragraph">We thank all the participants who volunteered for the trial and who have contributed their clinical experience to the assessment of the safety and efficacy of NVX-CoV-2373; the members of the NIAID data and safety monitoring board and the protocol safety review team, whose monitoring of all trial data contributed to ensuring the safety and well-being of the trial participants; our NIAID and National Institutes of Health colleagues, who provided valuable infrastructure support for the NIAID-affiliated investigative sites; community leadership groups throughout the country who assisted with community engagement and recruitment; unnamed colleagues at each of the trial sites who generously contributed to the trial in many ways; and all our unnamed colleagues at Novavax who worked tirelessly and gave unlimited efforts to the development, testing, and support for this trial. Editorial assistance with the preparation of an earlier version of this manuscript was provided by Phase Five Communications, supported by Novavax.</div></section><section id="supplementary-materials" class="core-supplementary-materials"><h2>Supplementary Material</h2><div role="list"><div id="ap0" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Research Summary</span> <span class="core-filename">(nejmoa2116185_research-summary.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2116185/suppl_file/nejmoa2116185_research-summary.pdf" download="nejmoa2116185_research-summary.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2116185_research-summary.pdf" data-doi="10.1056/NEJMoa2116185">Download</a></li><li>1.45 MB</li></ul></div></div><div id="ap1" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Protocol</span> <span class="core-filename">(nejmoa2116185_protocol.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2116185/suppl_file/nejmoa2116185_protocol.pdf" download="nejmoa2116185_protocol.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2116185_protocol.pdf" data-doi="10.1056/NEJMoa2116185">Download</a></li><li>5.38 MB</li></ul></div></div><div id="ap2" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Supplementary Appendix</span> <span class="core-filename">(nejmoa2116185_appendix.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2116185/suppl_file/nejmoa2116185_appendix.pdf" download="nejmoa2116185_appendix.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2116185_appendix.pdf" data-doi="10.1056/NEJMoa2116185">Download</a></li><li>1.01 MB</li></ul></div></div><div id="ap3" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Disclosure Forms</span> <span class="core-filename">(nejmoa2116185_disclosures.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2116185/suppl_file/nejmoa2116185_disclosures.pdf" download="nejmoa2116185_disclosures.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2116185_disclosures.pdf" data-doi="10.1056/NEJMoa2116185">Download</a></li><li>911.86 KB</li></ul></div></div><div id="ap4" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Data Sharing Statement</span> <span class="core-filename">(nejmoa2116185_data-sharing.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2116185/suppl_file/nejmoa2116185_data-sharing.pdf" download="nejmoa2116185_data-sharing.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2116185_data-sharing.pdf" data-doi="10.1056/NEJMoa2116185">Download</a></li><li>70.16 KB</li></ul></div></div></div></section><section id="bibliography" class="core-reference-list" role="doc-bibliography" data-location="references_article"><h2>References</h2><div role="list" data-method="clamp" id="collapsible-text"><div role="listitem" data-has="label"><div class="label">1.</div><div id="r1" class="citations"><div class="citation"><div class="citation-content">Slaoui M, Hepburn M. Developing safe and effective Covid vaccines — Operation Warp Speed’s strategy and approach. <em>N Engl J Med</em> 2020;383:1701-1703.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r1" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_2_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMp2027405&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32846056/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000587740100007" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Developing+safe+and+effective+Covid+vaccines+%E2%80%94+Operation+Warp+Speed%E2%80%99s+strategy+and+approach.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=1701-1703&amp;doi=10.1056%2FNEJMp2027405&amp;pmid=32846056" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r1" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r1-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] response in vaccine development. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] (FDA) and funding agency guidance, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="r2" class="citations"><div class="citation"><div class="citation-content">Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. <em>N Engl J Med</em> 2021;384:403-416.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r2" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_3_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2035389&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33378609/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000629333200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+the+mRNA-1273+SARS-CoV-2+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=403-416&amp;doi=10.1056%2FNEJMoa2035389&amp;pmid=33378609" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r2" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] on the ancestral strain, as an antigen. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r2-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] been reported for other Covid-19 vaccines. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] messenger RNA vaccines in the United States </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="r3" class="citations"><div class="citation"><div class="citation-content">Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <em>N Engl J Med</em> 2020;383:2603-2615.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2034577&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33301246/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000605648000010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2603-2615&amp;doi=10.1056%2FNEJMoa2034577&amp;pmid=33301246" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] on the ancestral strain, as an antigen. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] messenger RNA vaccines in the United States </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="r4" class="citations"><div class="citation"><div class="citation-content">Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. <em>Lancet</em> 2021;397:671-681.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)00234-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33545094/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000620991800029" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+an+rAd26+and+rAd5+vector-based+heterologous+prime-boost+COVID-19+vaccine%3A+an+interim+analysis+of+a+randomised+controlled+phase+3+trial+in+Russia.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=671-681&amp;doi=10.1016%2FS0140-6736%2821%2900234-8&amp;pmid=33545094" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="r5" class="citations"><div class="citation"><div class="citation-content">Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. <em>Lancet</em> 2021;397:99-111.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(20)32661-1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33306989/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000607269000027" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+ChAdOx1+nCoV-19+vaccine+%28AZD1222%29+against+SARS-CoV-2%3A+an+interim+analysis+of+four+randomised+controlled+trials+in+Brazil%2C+South+Africa%2C+and+the+UK.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=99-111&amp;doi=10.1016%2FS0140-6736%2820%2932661-1&amp;pmid=33306989" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="r6" class="citations"><div class="citation"><div class="citation-content">SARS-CoV-2 variant classifications and definitions. Atlanta: Centers for Disease Control and Prevention, 2021 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html">https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r6" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variant+classifications+and+definitions&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r6" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r8-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] of concern or variants of interest). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r6-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] at the time of end-point case accrual, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r8-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] protein–based vaccine-induced immunity. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="r7" class="citations"><div class="citation"><div class="citation-content">Harvey WT, Carabelli AM, Jackson B, et al. SARS-CoV-2 variants, spike mutations and immune escape. <em>Nat Rev Microbiol</em> 2021;19:409-424.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r7" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41579-021-00573-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34075212/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000656810800002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants%2C+spike+mutations+and+immune+escape.&amp;publication_year=2021&amp;journal=Nat+Rev+Microbiol&amp;pages=409-424&amp;doi=10.1038%2Fs41579-021-00573-0&amp;pmid=34075212" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r7" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r8-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] of concern or variants of interest). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r8-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] protein–based vaccine-induced immunity. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="r8" class="citations"><div class="citation"><div class="citation-content">Krause PR, Fleming TR, Longini IM, et al. SARS-CoV-2 variants and vaccines. <em>N Engl J Med</em> 2021;385:179-186.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r8" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_9_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMsr2105280&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34161052/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000667320500001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+and+vaccines.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=179-186&amp;doi=10.1056%2FNEJMsr2105280&amp;pmid=34161052" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r8" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r8-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] of concern or variants of interest). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r8-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] protein–based vaccine-induced immunity. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="r9" class="citations"><div class="citation"><div class="citation-content">Holder J. Tracking coronavirus vaccinations around the world. <em>New York Times</em>. 2021 (<a href="https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html">https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r9"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Tracking+coronavirus+vaccinations+around+the+world.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="r10" class="citations"><div class="citation"><div class="citation-content">Keech C, Albert G, Cho I, et al. Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine. <em>N Engl J Med</em> 2020;383:2320-2332.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_11_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2026920&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32877576/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000627165900011" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Phase+1%E2%80%932+trial+of+a+SARS-CoV-2+recombinant+spike+protein+nanoparticle+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2320-2332&amp;doi=10.1056%2FNEJMoa2026920&amp;pmid=32877576" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="r11" class="citations"><div class="citation"><div class="citation-content">Formica N, Mallory R, Albert G, et al. Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: a phase 2 randomized placebo-controlled trial. <em>PLoS Med</em> 2021;18(10):e1003769-e1003769.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1003769" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34597298/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000750871900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Different+dose+regimens+of+a+SARS-CoV-2+recombinant+spike+protein+vaccine+%28NVX-CoV2373%29+in+younger+and+older+adults%3A+a+phase+2+randomized+placebo-controlled+trial.&amp;publication_year=2021&amp;journal=PLoS+Med&amp;pages=e1003769-e1003769&amp;doi=10.1371%2Fjournal.pmed.1003769&amp;pmid=34597298" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="r12" class="citations"><div class="citation"><div class="citation-content">Shinde V, Bhikha S, Hoosain Z, et al. Efficacy of NVX-CoV2373 Covid-19 vaccine against the B.1.351 variant. <em>N Engl J Med</em> 2021;384:1899-1909.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r12" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_13_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2103055&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33951374/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647808400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+NVX-CoV2373+Covid-19+vaccine+against+the+B.1.351+variant.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1899-1909&amp;doi=10.1056%2FNEJMoa2103055&amp;pmid=33951374" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r12" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] concern in a phase 2b trial in South Africa </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] of variants beyond the prototype strain. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="r13" class="citations"><div class="citation"><div class="citation-content">Heath PT, Galiza EP, Baxter DN, et al. Safety and efficacy of the NVX-CoV2373 Covid-19 vaccine. <em>N Engl J Med</em> 2021;385:1172-1183.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r13" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_14_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2107659&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34192426/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000669588900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+NVX-CoV2373+Covid-19+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1172-1183&amp;doi=10.1056%2FNEJMoa2107659&amp;pmid=34192426" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r13" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r13-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] in a phase 3 trial in the United Kingdom. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r13-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 3 trial conducted in the United Kingdom </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r13-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] similar to that among younger adults. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="r14" class="citations"><div class="citation"><div class="citation-content">Nexstrain. Genomic epidemiology of novel coronavirus — global subsampling. 2021 (<a href="https://nextstrain.org/ncov/gisaid/global">https://nextstrain.org/ncov/gisaid/global</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r14" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Genomic+epidemiology+of+novel+coronavirus+%E2%80%94+global+subsampling&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r14" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r14-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and B.1.429 (epsilon), and B.1.526 (iota). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] were alpha, beta, gamma, epsilon, and iota. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] throughout the United States or Mexico, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="r15" class="citations"><div class="citation"><div class="citation-content">Guidance for industry: development and licensure of vaccines to prevent COVID-19. Silver Spring, MD: Food and Drug Administration, June 2020 (<a href="https://www.fda.gov/media/139638/download">https://www.fda.gov/media/139638/download</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r15" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Guidance+for+industry%3A+development+and+licensure+of+vaccines+to+prevent+COVID-19&amp;publication_year=2020" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r15" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r15-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] (FDA) and funding agency guidance, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] (defined with the use of FDA criteria </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for vaccine efficacy of 50% or greater. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] requested for emergency use authorization </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="r16" class="citations"><div class="citation"><div class="citation-content">Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&amp;D. <em>Science</em> 2020;368:948-950.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abc5312" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32393526/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000538332600030" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+strategic+approach+to+COVID-19+vaccine+R%26D.&amp;publication_year=2020&amp;journal=Science&amp;pages=948-950&amp;doi=10.1126%2Fscience.abc5312&amp;pmid=32393526" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="r17" class="citations"><div class="citation"><div class="citation-content">Joffe S, Babiker A, Ellenberg SS, et al. Data and safety monitoring of COVID-19 vaccine clinical trials. <em>J Infect Dis</em> 2021 May 19 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiab263" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34008027/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000753487400002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Data+and+safety+monitoring+of+COVID-19+vaccine+clinical+trials.&amp;publication_year=2021&amp;journal=J+Infect+Dis&amp;doi=10.1093%2Finfdis%2Fjiab263&amp;pmid=34008027" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="r18" class="citations"><div class="citation"><div class="citation-content">People with certain medical conditions. Atlanta: Centers for Disease Control and Prevention, 2021 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html">https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r18" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=People+with+certain+medical+conditions&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r18" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r18-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] complications according to CDC criteria, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r18-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] Latino. One or more coexisting conditions </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f3" role="menuitem" data-target="#fv-body-ref-r18-3"><i aria-hidden="true" class="icon-return"></i><span>c [...] Disease Control and Prevention definitions </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="r19" class="citations"><div class="citation"><div class="citation-content">Center for Biologics Evaluation and Research. Guidance for industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. Silver Spring, MD: Food and Drug Administration, September 2007 (<a href="https://www.fda.gov/media/73679/download">https://www.fda.gov/media/73679/download</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r19" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Guidance+for+industry%3A+toxicity+grading+scale+for+healthy+adult+and+adolescent+volunteers+enrolled+in+preventive+vaccine+clinical+trials&amp;publication_year=2007" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r19" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] for severity (according to FDA criteria </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f4" role="menuitem" data-target="#fv-body-ref-r19-2"><i aria-hidden="true" class="icon-return"></i><span>b [...] (severe or potentially life-threatening). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="r20" class="citations"><div class="citation"><div class="citation-content">Coronavirus (COVID-19) update. Silver Spring, MD: Food and Drug Administration, July 13, 2021 (<a href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-13-2021">https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-13-2021</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r20" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Coronavirus+%28COVID-19%29+update&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r20" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] No episodes of the Guillain–Barré syndrome </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] observation with other Covid-19 vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="r21" class="citations"><div class="citation"><div class="citation-content">Myocarditis and pericarditis after mRNA COVID-19 vaccination. Atlanta: Centers for Disease Control and Prevention, 2021 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html">https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r21" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Myocarditis+and+pericarditis+after+mRNA+COVID-19+vaccination&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r21" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r21-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] no imbalance in myocarditis or pericarditis </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] observation with other Covid-19 vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="r22" class="citations"><div class="citation"><div class="citation-content">Hunter PR. Thrombosis after covid-19 vaccination. <em>BMJ</em> 2021;373:n958-n958.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r22" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.n958" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33853865/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640565900003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Thrombosis+after+covid-19+vaccination.&amp;publication_year=2021&amp;journal=BMJ&amp;pages=n958-n958&amp;doi=10.1136%2Fbmj.n958&amp;pmid=33853865" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r22" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r22-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] immune thrombosis with thrombocytopenia </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] observation with other Covid-19 vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="r23" class="citations"><div class="citation"><div class="citation-content">Falsey AR, Sobieszczyk ME, Hirsch I, et al. Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine. <em>N Engl J Med</em> 2021;385:2348-2360.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r23"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_24_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2105290&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34587382/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000701157100001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Phase+3+safety+and+efficacy+of+AZD1222+%28ChAdOx1+nCoV-19%29+Covid-19+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=2348-2360&amp;doi=10.1056%2FNEJMoa2105290&amp;pmid=34587382" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="r24" class="citations"><div class="citation"><div class="citation-content">Follmann D, Fintzi J, Fay MP, et al. A deferred-vaccination design to assess durability of COVID-19 vaccine effect after the placebo group is vaccinated. <em>Ann Intern Med</em> 2021;174:1118-1125.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.7326/M20-8149" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33844575/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000695277800022" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+deferred-vaccination+design+to+assess+durability+of+COVID-19+vaccine+effect+after+the+placebo+group+is+vaccinated.&amp;publication_year=2021&amp;journal=Ann+Intern+Med&amp;pages=1118-1125&amp;doi=10.7326%2FM20-8149&amp;pmid=33844575" target="_blank">Google Scholar</a></div></div></div></div></div></div><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary" aria-expanded="false" aria-controls="collapsible-text"><span>Show all references</span></button></div></section></div></section></div><div class="core-collateral"><div id="core-collateral-info" role="tabpanel" data-core-tabs="core-collateral-info" tabindex="-1" aria-labelledby="pane-core-collateral-info"><header><h2 id="pane-core-collateral-info"><i class="icon-info" aria-hidden="true"></i>Information &amp; Authors</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-information" role="tab" id="tab-information-label" aria-selected="true" class="active">Information</button><button aria-controls="tab-contributors" role="tab" id="tab-contributors-label" tabindex="-1" aria-selected="false">Authors</button></div><section id="tab-information" aria-labelledby="tab-information-label" role="tabpanel" tabindex="0"><h3>Information</h3><section class="core-self-citation"><h4>Published In</h4><div class="core-journal-presentation"><div class="core-journal-description"><div property="isPartOf" typeof="Periodical"><span property="name">New England Journal of Medicine</span></div><div class="core-enumeration"><a href="/toc/nejm/386/6"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">386</span></span> • <span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">6</span></span> • <span property="datePublished">February 10, 2022</span></a></div><div class="core-pagination"><span class="heading">Pages</span>: <span class="content"><span property="pageStart">531</span>-<span property="pageEnd">543</span></span></div></div></div></section><section class="core-copyright"><h4>Copyright</h4><div role="paragraph">Copyright © 2021 Massachusetts Medical Society. All rights reserved.</div><div>For personal use only. Any commercial reuse of NEJM Group content requires <a href="mailto:permissions@nejm.org">permission</a>.</div></section><section data-translation="YXQYoa2116185" class="core-component-translation hidden"><h4>Translation</h4><div role="paragraph"><a target="_blank" href="">Chinese Translation 中文翻译</a></div></section><section class="core-history"><h4>History</h4><div><b class="core-label">Published online</b>: December 15, 2021</div><div><b class="core-label">Published in issue</b>: February 10, 2022</div></section><section data-location="recirc_topics_article" class="core-classifications"><h4>Topics</h4><div class="keywords"><ol><li><a href="/browse/topic/coronavirus" alt="View article keyword Coronavirus" data-interactiontype="article_recirculation_click">Coronavirus</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="/browse/topic/vaccines" alt="View article keyword Vaccines" data-interactiontype="article_recirculation_click">Vaccines</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li></ol></div></section></section><section id="tab-contributors" aria-labelledby="tab-contributors-label" role="tabpanel" tabindex="-1"><h3>Authors</h3><section class="core-authors"><h4>Authors</h4><div role="paragraph"><span property="author" typeof="Person"><span property="givenName">Lisa M.</span> <span property="familyName">Dunkle</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Karen L.</span> <span property="familyName">Kotloff</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Cynthia L.</span> <span property="familyName">Gay</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span>, <span property="author" typeof="Person"><span property="givenName">Germán</span> <span property="familyName">Áñez</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Jeffrey M.</span> <span property="familyName">Adelglass</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Alejandro Q.</span> <span property="familyName">Barrat Hernández</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Wayne L.</span> <span property="familyName">Harper</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Daniel M.</span> <span property="familyName">Duncanson</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Monica A.</span> <span property="familyName">McArthur</span>, <span property="honorificSuffix">M.D., Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Diana F.</span> <span property="familyName">Florescu</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">R. Scott</span> <span property="familyName">McClelland</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span>, <span property="author" typeof="Person"><span property="givenName">Veronica</span> <span property="familyName">Garcia-Fragoso</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Robert A.</span> <span property="familyName">Riesenberg</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">David B.</span> <span property="familyName">Musante</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">David L.</span> <span property="familyName">Fried</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Beth E.</span> <span property="familyName">Safirstein</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Mark</span> <span property="familyName">McKenzie</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Robert J.</span> <span property="familyName">Jeanfreau</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Jeffrey K.</span> <span property="familyName">Kingsley</span>, <span property="honorificSuffix">D.O.</span></span>, <span property="author" typeof="Person"><span property="givenName">Jeffrey A.</span> <span property="familyName">Henderson</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span>, <span property="author" typeof="Person"><span property="givenName">Dakotah C.</span> <span property="familyName">Lane</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Guillermo M.</span> <span property="familyName">Ruíz-Palacios</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Lawrence</span> <span property="familyName">Corey</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-2179-2436" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-2179-2436</a></span>, <span property="author" typeof="Person"><span property="givenName">Kathleen M.</span> <span property="familyName">Neuzil</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span>, <span property="author" typeof="Person"><span property="givenName">Robert W.</span> <span property="familyName">Coombs</span>, <span property="honorificSuffix">M.D., Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Alex L.</span> <span property="familyName">Greninger</span>, <span property="honorificSuffix">M.D., Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Julia</span> <span property="familyName">Hutter</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Julie A.</span> <span property="familyName">Ake</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Katherine</span> <span property="familyName">Smith</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Wayne</span> <span property="familyName">Woo</span>, <span property="honorificSuffix">M.S.</span></span>, <span property="author" typeof="Person"><span property="givenName">Iksung</span> <span property="familyName">Cho</span>, <span property="honorificSuffix">M.S.</span></span>, <span property="author" typeof="Person"><span property="givenName">Gregory M.</span> <span property="familyName">Glenn</span>, <span property="honorificSuffix">M.D.</span></span>, and <span property="author" typeof="Person"><span property="givenName">Filip</span> <span property="familyName">Dubovsky</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span>, for <span property="author" typeof="Person">the 2019nCoV-301 Study Group<sup><a href="#fn1" role="doc-noteref">*</a></sup></span></div></section><section class="core-affiliations"><h4>Affiliations</h4><div property="affiliation" typeof="Organization"><span property="name">From Novavax, Gaithersburg (L.M.D., G.A., K.S., W.W., I.C., G.M.G., F.D.), the University of Maryland School of Medicine, Baltimore (K.L.K., M.A.M., K.M.N.), the National Institute of Allergy and Infectious Diseases, Bethesda (J.H.), and Walter Reed Army Institute of Research, Silver Spring (J.A.A.) — all in Maryland; FAICIC Clinical Research, Veracruz (A.Q.B.H.), and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City (G.M.R.-P.) — both in Mexico; Research Your Health, Plano (J.M.A.) and the Texas Center for Drug Development, Houston (V.G.-F.) — both in Texas; M3-Wake Research, Raleigh (W.L.H.), M3-Emerging Medical Research, Durham (D.B.M.), and the University of North Carolina School of Medicine, Chapel Hill (C.L.G.) — all in North Carolina; SIMEDHealth, Gainesville (D.M.D.), and Velocity Clinical Research, Hallandale Beach (B.E.S.) — both in Florida; the University of Nebraska Medical Center, Omaha (D.F.F.); the University of Washington Medical Center (R.S.M., R.W.C., A.L.G.) and Fred Hutchinson Cancer Research Center (L.C.), Seattle, and Lummi Indian Health Center, Bellingham (D.C.L.) — all in Washington; the Atlanta Center for Medical Research, Atlanta (R.A.R.), and IACT Health, Columbus (J.K.K.) — both in Georgia; Velocity Clinical Research–Providence, Warwick, RI (D.L.F.); WR ClinSearch, Chattanooga, TN (M.M.); MedPharmics, Metairie, LA (R.J.J.); and Black Hills Center for American Indian Health, Rapid City, SD (J.A.H.).</span></div></section><section class="core-authors-notes"><h4>Notes</h4><div role="doc-footnote">Dr. Dunkle can be contacted at <a href="mailto:ldunkle@novavax.com">ldunkle@novavax.com</a> or at Novavax, 21 Firstfield Rd., Gaithersburg, MD 20878.</div><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="fn1" role="paragraph">The members of the 2019nCoV-301 Study Group are listed in the <a href="#ap2">Supplementary Appendix</a>, available at NEJM.org.</div></div><div role="doc-footnote"><div id="fn2" role="paragraph">Drs. Dunkle, Kotloff, and Gay contributed equally to this article.</div></div></section></section></div><div id="core-collateral-metrics" role="tabpanel" data-core-tabs="core-collateral-metrics" tabindex="-1" aria-labelledby="pane-core-collateral-metrics"><header><h2 id="pane-core-collateral-metrics"><i class="icon-timeline" aria-hidden="true"></i>Metrics &amp; Citations</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-metrics-inner" role="tab" id="tab-metrics-inner-label" aria-selected="true" class="active" data-interactiontype="article_tab" data-tabname="metricsWindow">Metrics</button><button aria-controls="tab-citations" role="tab" id="tab-citations-label" tabindex="-1" aria-selected="false" data-interactiontype="article_tab" data-tabname="metricsWindow">Citations<span class="citations-count">308</span></button></div><section id="tab-metrics-inner" aria-labelledby="tab-metrics-inner-label" role="tabpanel" tabindex="0"><h3>Metrics</h3><section>









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="95ea9f58-ec0e-4db2-b2ab-280fc876af53" data-location="article_metrics_article">
        



        
            <h4 class="">
                Altmetrics
            </h4>
        
        <div data-badge-details="right" data-badge-type="large-donut" data-doi="10.1056/NEJMoa2116185" data-hide-no-mentions="true" data-link-target="_blank" class="altmetric-embed" data-uuid="3dcf8f03-11b5-a221-3f38-28661c867a2d"><div style="overflow:hidden;">
    <div class="altmetric-normal-legend">
        <a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345" style="display:inline-block;">
                <img alt="Article has an altmetric score of 4012" src="https://badges.altmetric.com/?size=320&amp;score=4012&amp;types=mbrtwfud" width="180" height="180" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el_3dcf8f03-11b5-a221-3f38-28661c867a2d" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345&amp;tab=news">
          Picked up by <b>317</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345&amp;tab=blogs">
          Blogged by <b>11</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #9f79f2;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345&amp;tab=policy-documents">
          Referenced in <b>4</b> policy sources
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345&amp;tab=twitter">
          Posted by <b>2536</b> X users
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345&amp;tab=facebook">
          On <b>6</b> Facebook pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #958899;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345&amp;tab=wikipedia">
          Referenced in <b>3</b> Wikipedia pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #D5E8F0;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345&amp;tab=reddit">
          Reddited by <b>3</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #94DB5E;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345&amp;tab=video">
          On <b>3</b> videos
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #70B1FF;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=119041345&amp;tab=bluesky">
          Referenced by <b>12</b> Bluesky users
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>507</b> readers on Mendeley
          </div>
    </div>

                </div>
            </div>
        </div>
    </div>
</div></div>
<script async="" type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" nonce="94d6bd5503420304-SJC"></script>

        </div>
    

</section></section><section id="tab-citations" aria-labelledby="tab-citations-label" role="tabpanel" tabindex="-1"><h3>Citations</h3><section>



        
            <h4 class="">
                Export citation
            </h4>
        
        <div class="citation-download cd-sec">
<p class="citation-download_msg">Select the format you want to export the citation of this publication.</p>
<form action="/action/downloadCitation" name="frmCitmgr" method="post" target="_self" class="citation-download_form"><input type="hidden" name="doi" value="10.1056/NEJMoa2116185"> <input type="hidden" name="downloadFileName" value="csp_386_"> <input type="hidden" name="include" value="abs">
<div class="dropdown dropdown-selectable dropdown-selectable--form-control"><input type="hidden" name="format" value=""> <label class="form-label">Format*</label> <button id="slct_format" type="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="btn dropdown-toggle d-flex align-items-center justify-content-between">Please Select </button>
<div aria-labelledby="slct_format" role="listbox" class="dropdown-menu"><a href="#" data-value="ris" class="dropdown-item">RIS (ProCite, Reference Manager)</a><a href="#" data-value="endnote" class="dropdown-item">EndNote</a><a href="#" data-value="bibtex" class="dropdown-item">BibTex</a><a href="#" data-value="medlars" class="dropdown-item">Medlars</a><a href="#" data-value="refworks" class="dropdown-item">RefWorks</a></div>
<div class="invalid-feedback">Please select an item in the list</div>
</div>
<div class="citation-download_checkbox"><label class="checkbox--primary"><input type="checkbox" name="direct" value="true"><span class="checkbox--primary-icons"><span class="checkbox--primary-unchecked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxUnchecked"></use></svg></span></span><span class="checkbox--primary-checked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxChecked"></use></svg></span></span></span><span class="checkbox--primary-label"><span class="checkbox--primary-label-text">Direct Import</span></span></label></div>
<div class="citation-download_btn"><button type="submit" name="submit" value="Download" class="ng-btn_default ng-btn_iconLeft" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#citations"></use></svg></span><span class="ng-btn_text">Export citation</span></button></div>
</form></div>
</section><section>









    
    
        <div data-widget-def="UX3CitedByWidget" data-widget-id="efb4df9a-8e1a-47f9-bfb7-271959277a9f" data-location="citedby_article">
        



        
            <h4 class="">
                Cited by
            </h4>
        
        <section id="cited-by" class="cited-by"><div class="cited-by__wrapper"><div id="cited-by__content" class="cited-by__content"><ol data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2116185%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2022.386.issue-6%3Bjournal%3Ajournal%3Anejms" data-lazyload="false" data-total="308" class="cited-by__list list-unstyled"><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Lisen Lu, </li><li class="list-inline-item cited-by__entry__author">Muyang Yang, </li><li class="list-inline-item cited-by__entry__author">Deqiang Deng, </li><li class="list-inline-item cited-by__entry__author">Xiujuan Shi, </li><li class="list-inline-item cited-by__entry__author">Jonathan F. Lovell, </li><li class="list-inline-item cited-by__entry__author">Honglin Jin, </li></ul><span class="cited-by__entry__title">Nanovaccines: Antigen selection, stabilization, adjuvantation, formulation, and evaluation, </span><span class="cited-by__entry__series-title">Coordination Chemistry Reviews, </span><span class="cited-by__entry__volume"><strong>541</strong>, </span><span class="cited-by__entry__page-range">(216806), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.ccr.2025.216806" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.ccr.2025.216806</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.ccr.2025.216806" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Germán Áñez, </li><li class="list-inline-item cited-by__entry__author">Alice McGarry, </li><li class="list-inline-item cited-by__entry__author">Wayne Woo, </li><li class="list-inline-item cited-by__entry__author">Karen L. Kotloff, </li><li class="list-inline-item cited-by__entry__author">Cynthia L. Gay, </li><li class="list-inline-item cited-by__entry__author">Mingzhu Zhu, </li><li class="list-inline-item cited-by__entry__author">Shane Cloney-Clark, </li><li class="list-inline-item cited-by__entry__author">Joy Nelson, </li><li class="list-inline-item cited-by__entry__author">Haoua Dunbar, </li><li class="list-inline-item cited-by__entry__author">Miranda R. Cai, </li><li class="list-inline-item cited-by__entry__author">Iksung Cho, </li><li class="list-inline-item cited-by__entry__author">Zhaohui Cai, </li><li class="list-inline-item cited-by__entry__author">Raj Kalkeri, </li><li class="list-inline-item cited-by__entry__author">Joyce S. Plested, </li><li class="list-inline-item cited-by__entry__author">Nita Patel, </li><li class="list-inline-item cited-by__entry__author">Katherine Smith, </li><li class="list-inline-item cited-by__entry__author">Anthony M. Marchese, </li><li class="list-inline-item cited-by__entry__author">Gregory M. Glenn, </li><li class="list-inline-item cited-by__entry__author">Raburn M. Mallory, </li><li class="list-inline-item cited-by__entry__author">Lisa M. Dunkle, </li></ul><span class="cited-by__entry__title">Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19), </span><span class="cited-by__entry__series-title">Vaccine, </span><span class="cited-by__entry__volume"><strong>61</strong>, </span><span class="cited-by__entry__page-range">(127362), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.vaccine.2025.127362" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.vaccine.2025.127362</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.vaccine.2025.127362" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Jeffrey M. Adelglass, </li><li class="list-inline-item cited-by__entry__author">Paul Bradley, </li><li class="list-inline-item cited-by__entry__author">Miranda R. Cai, </li><li class="list-inline-item cited-by__entry__author">Gordon Chau, </li><li class="list-inline-item cited-by__entry__author">Raj Kalkeri, </li><li class="list-inline-item cited-by__entry__author">Shane Cloney-Clark, </li><li class="list-inline-item cited-by__entry__author">Mingzhu Zhu, </li><li class="list-inline-item cited-by__entry__author">Zhaohui Cai, </li><li class="list-inline-item cited-by__entry__author">Mark Eickhoff, </li><li class="list-inline-item cited-by__entry__author">Joyce S. Plested, </li><li class="list-inline-item cited-by__entry__author">Raburn M. Mallory, </li><li class="list-inline-item cited-by__entry__author">Lisa M. Dunkle, </li></ul><span class="cited-by__entry__title">Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine doses, </span><span class="cited-by__entry__series-title">Journal of Allergy and Clinical Immunology, </span><span class="cited-by__entry__volume"><strong>155</strong>, </span><span class="cited-by__entry__issue">6, </span><span class="cited-by__entry__page-range">(2063-2074.e6), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.jaci.2025.03.015" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.jaci.2025.03.015</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.jaci.2025.03.015" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Leah I. B. Andrews, </li><li class="list-inline-item cited-by__entry__author">M. Elizabeth Halloran, </li><li class="list-inline-item cited-by__entry__author">Kathleen M. Neuzil, </li><li class="list-inline-item cited-by__entry__author">Lars van der Laan, </li><li class="list-inline-item cited-by__entry__author">Yunda Huang, </li><li class="list-inline-item cited-by__entry__author">Jessica Andriesen, </li><li class="list-inline-item cited-by__entry__author">Mayur Patel, </li><li class="list-inline-item cited-by__entry__author">Leigh H. Fisher, </li><li class="list-inline-item cited-by__entry__author">Holly Janes, </li><li class="list-inline-item cited-by__entry__author">Nadine Rouphael, </li><li class="list-inline-item cited-by__entry__author">Stephen R. Walsh, </li><li class="list-inline-item cited-by__entry__author">Deborah A. Theodore, </li><li class="list-inline-item cited-by__entry__author">Hong-Van Tieu, </li><li class="list-inline-item cited-by__entry__author">Magdalena Sobieszczyk, </li><li class="list-inline-item cited-by__entry__author">Hana M. El Sahly, </li><li class="list-inline-item cited-by__entry__author">Lindsey R. Baden, </li><li class="list-inline-item cited-by__entry__author">Ann R. Falsey, </li><li class="list-inline-item cited-by__entry__author">Thomas B. Campbell, </li><li class="list-inline-item cited-by__entry__author">Colleen F. Kelley, </li><li class="list-inline-item cited-by__entry__author">Catherine Mary Healy, </li><li class="list-inline-item cited-by__entry__author">Lilly Immergluck, </li><li class="list-inline-item cited-by__entry__author">Benjamin Luft, </li><li class="list-inline-item cited-by__entry__author">Ian Hirsch, </li><li class="list-inline-item cited-by__entry__author">Guy de Bruyn, </li><li class="list-inline-item cited-by__entry__author">Carla Truyers, </li><li class="list-inline-item cited-by__entry__author">Frances Priddy, </li><li class="list-inline-item cited-by__entry__author">Kelsey M. Sumner, </li><li class="list-inline-item cited-by__entry__author">Brendan Flannery, </li><li class="list-inline-item cited-by__entry__author">Dean Follmann, </li><li class="list-inline-item cited-by__entry__author">Peter B. Gilbert, </li><li class="list-inline-item cited-by__entry__author">Vanessa Abad, </li><li class="list-inline-item cited-by__entry__author">Karina Abalos, </li><li class="list-inline-item cited-by__entry__author">Getahun Abate, </li><li class="list-inline-item cited-by__entry__author">Anum Abbas, </li><li class="list-inline-item cited-by__entry__author">Jose Accini, </li><li class="list-inline-item cited-by__entry__author">Ronald Ackerman, </li><li class="list-inline-item cited-by__entry__author">Jamie Ackerman, </li><li class="list-inline-item cited-by__entry__author">Jeremy Ackermann, </li><li class="list-inline-item cited-by__entry__author">Atoya Adams, </li><li class="list-inline-item cited-by__entry__author">Michael R. Adams, </li><li class="list-inline-item cited-by__entry__author">Mark S. Adams, </li><li class="list-inline-item cited-by__entry__author">Michael Adams, </li><li class="list-inline-item cited-by__entry__author">Jeffrey M. Adelglass, </li><li class="list-inline-item cited-by__entry__author">Sarah Afework, </li><li class="list-inline-item cited-by__entry__author">Nina Ahmad, </li><li class="list-inline-item cited-by__entry__author">Christine Akamine, </li><li class="list-inline-item cited-by__entry__author">Julie A. Ake, </li><li class="list-inline-item cited-by__entry__author">Gary Albert, </li><li class="list-inline-item cited-by__entry__author">Maria L. Alcaide, </li><li class="list-inline-item cited-by__entry__author">Nathan Alderson, </li><li class="list-inline-item cited-by__entry__author">Lily Aleman, </li><li class="list-inline-item cited-by__entry__author">José O. Alemán, </li><li class="list-inline-item cited-by__entry__author">Mohamed S. Al-Ibrahim, </li><li class="list-inline-item cited-by__entry__author">Mohammed Allaw, </li><li class="list-inline-item cited-by__entry__author">Leland N. Allen, </li><li class="list-inline-item cited-by__entry__author">Mary Allen, </li><li class="list-inline-item cited-by__entry__author">Naveena Aloysia, </li><li class="list-inline-item cited-by__entry__author">Hilario Alvarado, </li><li class="list-inline-item cited-by__entry__author">Winniberg Stephany Alvarez León, </li><li class="list-inline-item cited-by__entry__author">Carmen Amador, </li><li class="list-inline-item cited-by__entry__author">John Humphrey Amuasi, </li><li class="list-inline-item cited-by__entry__author">James Andersen, </li><li class="list-inline-item cited-by__entry__author">Evan J. Anderson, </li><li class="list-inline-item cited-by__entry__author">Corey G. Anderson, </li><li class="list-inline-item cited-by__entry__author">Victoria R. Anderson, </li><li class="list-inline-item cited-by__entry__author">David R. Andes, </li><li class="list-inline-item cited-by__entry__author">Michele P. Andrasik, </li><li class="list-inline-item cited-by__entry__author">Stephanie Andree, </li><li class="list-inline-item cited-by__entry__author">Jeb Andrews, </li><li class="list-inline-item cited-by__entry__author">Jessica G. Andriesen, </li><li class="list-inline-item cited-by__entry__author">Victoria Andriulis, </li><li class="list-inline-item cited-by__entry__author">Germán Áñez, </li><li class="list-inline-item cited-by__entry__author">Maria Angeles&nbsp;Ceregido, </li><li class="list-inline-item cited-by__entry__author">Nana Akosua Ansah, </li><li class="list-inline-item cited-by__entry__author">Jessica L. Ansel, </li><li class="list-inline-item cited-by__entry__author">Codi M. Anthony, </li><li class="list-inline-item cited-by__entry__author">Johannes Antony, </li><li class="list-inline-item cited-by__entry__author">Mohammed Antwi, </li><li class="list-inline-item cited-by__entry__author">Roberto C. Arduino, </li><li class="list-inline-item cited-by__entry__author">Florida Aristy, </li><li class="list-inline-item cited-by__entry__author">Valerie K. Arnold, </li><li class="list-inline-item cited-by__entry__author">Alicia Arrazcaeta, </li><li class="list-inline-item cited-by__entry__author">Hugo Macareno Arroyo, </li><li class="list-inline-item cited-by__entry__author">Kwaku Poku Asante, </li><li class="list-inline-item cited-by__entry__author">Robert L. Atmar, </li><li class="list-inline-item cited-by__entry__author">Allison August, </li><li class="list-inline-item cited-by__entry__author">Ayoade Avworo, </li><li class="list-inline-item cited-by__entry__author">Christina Bacher, </li><li class="list-inline-item cited-by__entry__author">Martín Bäcker, </li><li class="list-inline-item cited-by__entry__author">Lindsay R. Baden, </li><li class="list-inline-item cited-by__entry__author">Diana Badillo, </li><li class="list-inline-item cited-by__entry__author">Emma Bainbridge, </li><li class="list-inline-item cited-by__entry__author">Michele Baka, </li><li class="list-inline-item cited-by__entry__author">Sherrie Baker, </li><li class="list-inline-item cited-by__entry__author">Bindu Balani, </li><li class="list-inline-item cited-by__entry__author">Brandy Ball, </li><li class="list-inline-item cited-by__entry__author">Mira Baron, </li><li class="list-inline-item cited-by__entry__author">Dan H. Barouch, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Barranco-Santana, </li><li class="list-inline-item cited-by__entry__author">Alejandro Quintín Barrat Hernández, </li><li class="list-inline-item cited-by__entry__author">Darlene Bartilucci, </li><li class="list-inline-item cited-by__entry__author">Jennifer Bashour, </li><li class="list-inline-item cited-by__entry__author">Teresa A. Batteiger, </li><li class="list-inline-item cited-by__entry__author">Clarisse Baudelaire, </li><li class="list-inline-item cited-by__entry__author">George H. Bauer, </li><li class="list-inline-item cited-by__entry__author">Jose A. Bazan, </li><li class="list-inline-item cited-by__entry__author">Maria G. Becerra, </li><li class="list-inline-item cited-by__entry__author">Cynthia Becher Strout, </li><li class="list-inline-item cited-by__entry__author">Teresa Becker, </li><li class="list-inline-item cited-by__entry__author">David Beckmann, </li><li class="list-inline-item cited-by__entry__author">Roger J. Bedimo, </li><li class="list-inline-item cited-by__entry__author">Linda R. Belhorn, </li><li class="list-inline-item cited-by__entry__author">Genevieve Beninati, </li><li class="list-inline-item cited-by__entry__author">Jorge A. Benitez, </li><li class="list-inline-item cited-by__entry__author">David Benkeser, </li><li class="list-inline-item cited-by__entry__author">Annette R. Bennett, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Bennett, </li><li class="list-inline-item cited-by__entry__author">Tatiana Beresnev, </li><li class="list-inline-item cited-by__entry__author">Aude Berge, </li><li class="list-inline-item cited-by__entry__author">Megan Berman, </li><li class="list-inline-item cited-by__entry__author">Maria I. Bermudez, </li><li class="list-inline-item cited-by__entry__author">Marcia Bernard, </li><li class="list-inline-item cited-by__entry__author">David I. Bernstein, </li><li class="list-inline-item cited-by__entry__author">Jennifer Berry, </li><li class="list-inline-item cited-by__entry__author">Andrea Berry, </li><li class="list-inline-item cited-by__entry__author">Vladimir Berthaud, </li><li class="list-inline-item cited-by__entry__author">Hanna Beyko, </li><li class="list-inline-item cited-by__entry__author">Kristin Bialobok, </li><li class="list-inline-item cited-by__entry__author">Joanne L. Billings, </li><li class="list-inline-item cited-by__entry__author">Oleksandra Bilotkach, </li><li class="list-inline-item cited-by__entry__author">Zachary Bittner, </li><li class="list-inline-item cited-by__entry__author">Jeanne Blevins, </li><li class="list-inline-item cited-by__entry__author">Jill Blumenthal, </li><li class="list-inline-item cited-by__entry__author">Rebecca Boas, </li><li class="list-inline-item cited-by__entry__author">Joseph Bocchini, </li><li class="list-inline-item cited-by__entry__author">Tyler D. Bold, </li><li class="list-inline-item cited-by__entry__author">Matthew I. Bonaparte, </li><li class="list-inline-item cited-by__entry__author">Alison Bondell, </li><li class="list-inline-item cited-by__entry__author">Paul Bondy, </li><li class="list-inline-item cited-by__entry__author">Alberto Cadena Bonfanti, </li><li class="list-inline-item cited-by__entry__author">Judith Borger, </li><li class="list-inline-item cited-by__entry__author">Scott Borgetti, </li><li class="list-inline-item cited-by__entry__author">Joseph Boscia, </li><li class="list-inline-item cited-by__entry__author">Dean M. Boswell, </li><li class="list-inline-item cited-by__entry__author">Tana Bourgeois, </li><li class="list-inline-item cited-by__entry__author">Maggie Bowers, </li><li class="list-inline-item cited-by__entry__author">Paul S Bradley, </li><li class="list-inline-item cited-by__entry__author">Judith Brady, </li><li class="list-inline-item cited-by__entry__author">Riemke Brakema, </li><li class="list-inline-item cited-by__entry__author">Andres Bran, </li><li class="list-inline-item cited-by__entry__author">Angela R. Branche, </li><li class="list-inline-item cited-by__entry__author">Boerries Brandenburg, </li><li class="list-inline-item cited-by__entry__author">Donald M. Brandon, </li><li class="list-inline-item cited-by__entry__author">Eric Bravo, </li><li class="list-inline-item cited-by__entry__author">Thomas Breuer, </li><li class="list-inline-item cited-by__entry__author">Margaret Brewinski Isaacs, </li><li class="list-inline-item cited-by__entry__author">Liz Briesemeister, </li><li class="list-inline-item cited-by__entry__author">Toby Briskin, </li><li class="list-inline-item cited-by__entry__author">Gail Broder, </li><li class="list-inline-item cited-by__entry__author">Adam B. Brosz, </li><li class="list-inline-item cited-by__entry__author">David Browder, </li><li class="list-inline-item cited-by__entry__author">Lesley Browder, </li><li class="list-inline-item cited-by__entry__author">Jeremy Brown, </li><li class="list-inline-item cited-by__entry__author">Cynthia Brown, </li><li class="list-inline-item cited-by__entry__author">Robert Brownlee, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Bruce, </li><li class="list-inline-item cited-by__entry__author">Susan Buchbinder, </li><li class="list-inline-item cited-by__entry__author">Cynthia Bueno, </li><li class="list-inline-item cited-by__entry__author">Elisabeth Bukusi, </li><li class="list-inline-item cited-by__entry__author">Delia Bullock, </li><li class="list-inline-item cited-by__entry__author">Catherine A. Bunce, </li><li class="list-inline-item cited-by__entry__author">Cortney Burch, </li><li class="list-inline-item cited-by__entry__author">Michelle L. Burgett, </li><li class="list-inline-item cited-by__entry__author">Abram Burgher, </li><li class="list-inline-item cited-by__entry__author">Larry Bush, </li><li class="list-inline-item cited-by__entry__author">Michael B. Butcher, </li><li class="list-inline-item cited-by__entry__author">Robert J. Buynak, </li><li class="list-inline-item cited-by__entry__author">LaShondra Cade, </li><li class="list-inline-item cited-by__entry__author">Rafael Calderon, </li><li class="list-inline-item cited-by__entry__author">Richard Calderone, </li><li class="list-inline-item cited-by__entry__author">Amy Caldwell, </li><li class="list-inline-item cited-by__entry__author">Cornell Calinescu, </li><li class="list-inline-item cited-by__entry__author">Robert S. Call, </li><li class="list-inline-item cited-by__entry__author">Jim Callis, </li><li class="list-inline-item cited-by__entry__author">Laura Julia Camacho Choza, </li><li class="list-inline-item cited-by__entry__author">Andres Camacho-Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Thomas B. Campbell, </li><li class="list-inline-item cited-by__entry__author">Wesley Campbell, </li><li class="list-inline-item cited-by__entry__author">Michael Cancilla, </li><li class="list-inline-item cited-by__entry__author">Kevin D. Cannon, </li><li class="list-inline-item cited-by__entry__author">Karina Cano Martínez, </li><li class="list-inline-item cited-by__entry__author">Richard Canter, </li><li class="list-inline-item cited-by__entry__author">Valeria D. Cantos, </li><li class="list-inline-item cited-by__entry__author">Vicky Cárdenas, </li><li class="list-inline-item cited-by__entry__author">Martha Carmen Medina, </li><li class="list-inline-item cited-by__entry__author">Ellie Carmody, </li><li class="list-inline-item cited-by__entry__author">Christopher Carpenter, </li><li class="list-inline-item cited-by__entry__author">Melissa Carr, </li><li class="list-inline-item cited-by__entry__author">Monica B. Carrascal, </li><li class="list-inline-item cited-by__entry__author">Jaime Augusto Carrillo, </li><li class="list-inline-item cited-by__entry__author">Steven E. Carsons, </li><li class="list-inline-item cited-by__entry__author">Marianela Carvajal, </li><li class="list-inline-item cited-by__entry__author">Denise Casey, </li><li class="list-inline-item cited-by__entry__author">Jorge Caso, </li><li class="list-inline-item cited-by__entry__author">Flora Castellino, </li><li class="list-inline-item cited-by__entry__author">Marvin Castellon, </li><li class="list-inline-item cited-by__entry__author">Jose Castillo Mancilla, </li><li class="list-inline-item cited-by__entry__author">Mario Castro, </li><li class="list-inline-item cited-by__entry__author">Hannah Catan, </li><li class="list-inline-item cited-by__entry__author">Nancy Cauwenberghs, </li><li class="list-inline-item cited-by__entry__author">Winston Cavert, </li><li class="list-inline-item cited-by__entry__author">Médéric Celle, </li><li class="list-inline-item cited-by__entry__author">Jorge A. Chacón, </li><li class="list-inline-item cited-by__entry__author">Mesha M. Chadwick, </li><li class="list-inline-item cited-by__entry__author">Amy Chamberlain, </li><li class="list-inline-item cited-by__entry__author">Austin Chan, </li><li class="list-inline-item cited-by__entry__author">Jennifer Chang, </li><li class="list-inline-item cited-by__entry__author">Danaya Chansinghakul, </li><li class="list-inline-item cited-by__entry__author">Mouna G. Chebib, </li><li class="list-inline-item cited-by__entry__author">Corey M. Chen, </li><li class="list-inline-item cited-by__entry__author">Aiying Chen, </li><li class="list-inline-item cited-by__entry__author">Margaret Cheng, </li><li class="list-inline-item cited-by__entry__author">Roman M. Chicz, </li><li class="list-inline-item cited-by__entry__author">Iksung Cho, </li><li class="list-inline-item cited-by__entry__author">Karin Choquette, </li><li class="list-inline-item cited-by__entry__author">R. Michelle Chouteau, </li><li class="list-inline-item cited-by__entry__author">Brian D. W. Chow, </li><li class="list-inline-item cited-by__entry__author">Lisa Chrisley, </li><li class="list-inline-item cited-by__entry__author">Shane G. Christensen, </li><li class="list-inline-item cited-by__entry__author">Laurence Chu, </li><li class="list-inline-item cited-by__entry__author">Hanh Chu, </li><li class="list-inline-item cited-by__entry__author">Waseem Chughtai, </li><li class="list-inline-item cited-by__entry__author">Michael Chung, </li><li class="list-inline-item cited-by__entry__author">Annie Ciambruschini, </li><li class="list-inline-item cited-by__entry__author">Cristina Cicogna, </li><li class="list-inline-item cited-by__entry__author">Alexander Clark, </li><li class="list-inline-item cited-by__entry__author">Jesse L. Clark, </li><li class="list-inline-item cited-by__entry__author">Phillip Claybrook, </li><li class="list-inline-item cited-by__entry__author">Andrea Clement, </li><li class="list-inline-item cited-by__entry__author">Lauren Clement, </li><li class="list-inline-item cited-by__entry__author">Steve Clemons, </li><li class="list-inline-item cited-by__entry__author">Heather Clouting, </li><li class="list-inline-item cited-by__entry__author">Lisa Cohen, </li><li class="list-inline-item cited-by__entry__author">Stuart H. Cohen, </li><li class="list-inline-item cited-by__entry__author">Jacob Coleman, </li><li class="list-inline-item cited-by__entry__author">Joseph P. Connor, </li><li class="list-inline-item cited-by__entry__author">James H. Conway, </li><li class="list-inline-item cited-by__entry__author">Erin Cooksey, </li><li class="list-inline-item cited-by__entry__author">Robert W. Coombs, </li><li class="list-inline-item cited-by__entry__author">Maureen Cooney, </li><li class="list-inline-item cited-by__entry__author">Deanna Cooper, </li><li class="list-inline-item cited-by__entry__author">Paul Coplan, </li><li class="list-inline-item cited-by__entry__author">Lawrence Corey, </li><li class="list-inline-item cited-by__entry__author">Raymond Cornelison, </li><li class="list-inline-item cited-by__entry__author">Barbara Corral, </li><li class="list-inline-item cited-by__entry__author">Jordan Coslet, </li><li class="list-inline-item cited-by__entry__author">Erin Coston, </li><li class="list-inline-item cited-by__entry__author">Michael J. Cotugno, </li><li class="list-inline-item cited-by__entry__author">Florence Coux, </li><li class="list-inline-item cited-by__entry__author">Jessica Cowden, </li><li class="list-inline-item cited-by__entry__author">Paul Cramer, </li><li class="list-inline-item cited-by__entry__author">Clarence B. Creech, </li><li class="list-inline-item cited-by__entry__author">Charnell Cromer, </li><li class="list-inline-item cited-by__entry__author">Marshall A. Cross, </li><li class="list-inline-item cited-by__entry__author">Aurelio Cruz-Valdez, </li><li class="list-inline-item cited-by__entry__author">Marcel Curlin, </li><li class="list-inline-item cited-by__entry__author">LaKondria Curry, </li><li class="list-inline-item cited-by__entry__author">Jerome Custers, </li><li class="list-inline-item cited-by__entry__author">Erika A. Cutz, </li><li class="list-inline-item cited-by__entry__author">Eric S. Daar, </li><li class="list-inline-item cited-by__entry__author">Michelle DallaPiazza, </li><li class="list-inline-item cited-by__entry__author">Dima Dandachi, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Danford, </li><li class="list-inline-item cited-by__entry__author">Lyly Dang, </li><li class="list-inline-item cited-by__entry__author">Stephen Daniels, </li><li class="list-inline-item cited-by__entry__author">Chandan Das, </li><li class="list-inline-item cited-by__entry__author">Santa Kumar Das, </li><li class="list-inline-item cited-by__entry__author">Matthew Davies, </li><li class="list-inline-item cited-by__entry__author">Yvonne Davis, </li><li class="list-inline-item cited-by__entry__author">Joseph D. Davis, </li><li class="list-inline-item cited-by__entry__author">William S. Davis, </li><li class="list-inline-item cited-by__entry__author">William B. Davis, </li><li class="list-inline-item cited-by__entry__author">Matthew G. Davis, </li><li class="list-inline-item cited-by__entry__author">Rajesh K. Davit, </li><li class="list-inline-item cited-by__entry__author">Gustavo H. Dayan, </li><li class="list-inline-item cited-by__entry__author">Anne Marit de Groot, </li><li class="list-inline-item cited-by__entry__author">Luis I. De La Cruz, </li><li class="list-inline-item cited-by__entry__author">Claudia De La Matta Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Ian De Proost, </li><li class="list-inline-item cited-by__entry__author">Christopher Dedon, </li><li class="list-inline-item cited-by__entry__author">Jon F. Dedon, </li><li class="list-inline-item cited-by__entry__author">Teresa Deese, </li><li class="list-inline-item cited-by__entry__author">Emily Degan, </li><li class="list-inline-item cited-by__entry__author">Elliot DeHaan, </li><li class="list-inline-item cited-by__entry__author">Edwin DeJesus, </li><li class="list-inline-item cited-by__entry__author">Carlos del Rio, </li><li class="list-inline-item cited-by__entry__author">Michael Delgado, </li><li class="list-inline-item cited-by__entry__author">Mike Delgado, </li><li class="list-inline-item cited-by__entry__author">Ernesto Delgado, </li><li class="list-inline-item cited-by__entry__author">David Dellaero, </li><li class="list-inline-item cited-by__entry__author">Weiping Deng, </li><li class="list-inline-item cited-by__entry__author">Douglas S. Denham, </li><li class="list-inline-item cited-by__entry__author">Chinar Desai, </li><li class="list-inline-item cited-by__entry__author">Parul Desai, </li><li class="list-inline-item cited-by__entry__author">Michael Desjardins, </li><li class="list-inline-item cited-by__entry__author">Karen Deutsch, </li><li class="list-inline-item cited-by__entry__author">Michael E. Dever, </li><li class="list-inline-item cited-by__entry__author">Naomi Devine, </li><li class="list-inline-item cited-by__entry__author">Louis Devlin, </li><li class="list-inline-item cited-by__entry__author">Carlos A. Diazgranados, </li><li class="list-inline-item cited-by__entry__author">Secia Díaz-Miralrio, </li><li class="list-inline-item cited-by__entry__author">Michelle Dickey, </li><li class="list-inline-item cited-by__entry__author">David J. Diemert, </li><li class="list-inline-item cited-by__entry__author">Craig Dietz, </li><li class="list-inline-item cited-by__entry__author">Susanne Doblecki-Lewis, </li><li class="list-inline-item cited-by__entry__author">Dmytro Dobrianskyi, </li><li class="list-inline-item cited-by__entry__author">Jennifer L Dong, </li><li class="list-inline-item cited-by__entry__author">Tambra Dora, </li><li class="list-inline-item cited-by__entry__author">Brenda Dorcely, </li><li class="list-inline-item cited-by__entry__author">Macaya Douoguih, </li><li class="list-inline-item cited-by__entry__author">Matthew W. Doust, </li><li class="list-inline-item cited-by__entry__author">Frances Downing, </li><li class="list-inline-item cited-by__entry__author">Michael P. Dube, </li><li class="list-inline-item cited-by__entry__author">Filip Dubovsky, </li><li class="list-inline-item cited-by__entry__author">Pete Ducheneaux, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Dugas, </li><li class="list-inline-item cited-by__entry__author">Aeiress Duhart, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Duke, </li><li class="list-inline-item cited-by__entry__author">Debora Dunbar, </li><li class="list-inline-item cited-by__entry__author">Haoua Dunbar, </li><li class="list-inline-item cited-by__entry__author">Daniel M. Duncanson, </li><li class="list-inline-item cited-by__entry__author">Lisa M. Dunkle, </li><li class="list-inline-item cited-by__entry__author">Hillary Dunlevy, </li><li class="list-inline-item cited-by__entry__author">Anna Durbin, </li><li class="list-inline-item cited-by__entry__author">Amy Dye, </li><li class="list-inline-item cited-by__entry__author">Carmel B. Dyer, </li><li class="list-inline-item cited-by__entry__author">Sarah Dzigiel, </li><li class="list-inline-item cited-by__entry__author">Mary Easley, </li><li class="list-inline-item cited-by__entry__author">Niles Eaton, </li><li class="list-inline-item cited-by__entry__author">Valentine M. Ebuh, </li><li class="list-inline-item cited-by__entry__author">Georgette Ebuh, </li><li class="list-inline-item cited-by__entry__author">Lynn Eckert, </li><li class="list-inline-item cited-by__entry__author">Benjamin Eckhardt, </li><li class="list-inline-item cited-by__entry__author">Frank S. Eder, </li><li class="list-inline-item cited-by__entry__author">Srilatha Edupuganti, </li><li class="list-inline-item cited-by__entry__author">Leslie A. Edwards, </li><li class="list-inline-item cited-by__entry__author">Mark Eickhoff, </li><li class="list-inline-item cited-by__entry__author">Hana M. El Sahly, </li><li class="list-inline-item cited-by__entry__author">Edward Ellerbeck, </li><li class="list-inline-item cited-by__entry__author">Grant Ellsworth, </li><li class="list-inline-item cited-by__entry__author">Elwaleed Elnagar, </li><li class="list-inline-item cited-by__entry__author">Victoria Engler, </li><li class="list-inline-item cited-by__entry__author">Kendra Enright, </li><li class="list-inline-item cited-by__entry__author">David J. Ensz, </li><li class="list-inline-item cited-by__entry__author">Sally Eppenbach, </li><li class="list-inline-item cited-by__entry__author">Sandra Erickson, </li><li class="list-inline-item cited-by__entry__author">Joseph Eron, </li><li class="list-inline-item cited-by__entry__author">Joseph J. Eron, </li><li class="list-inline-item cited-by__entry__author">Tiffany Esinhart, </li><li class="list-inline-item cited-by__entry__author">Claudia Espinosa, </li><li class="list-inline-item cited-by__entry__author">Luis Espinoza, </li><li class="list-inline-item cited-by__entry__author">Brandon J. Essink, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Everette, </li><li class="list-inline-item cited-by__entry__author">Evan C. Ewers, </li><li class="list-inline-item cited-by__entry__author">Beverly Ewing, </li><li class="list-inline-item cited-by__entry__author">Amy Falk, </li><li class="list-inline-item cited-by__entry__author">Ann R. Falsey, </li><li class="list-inline-item cited-by__entry__author">Norberto Fas, </li><li class="list-inline-item cited-by__entry__author">Michael Fay, </li><li class="list-inline-item cited-by__entry__author">Szheckera Fearon, </li><li class="list-inline-item cited-by__entry__author">Brittany Feijoo, </li><li class="list-inline-item cited-by__entry__author">Gregory J. Feldman, </li><li class="list-inline-item cited-by__entry__author">Uriel R. Felsen, </li><li class="list-inline-item cited-by__entry__author">Hein Fennema, </li><li class="list-inline-item cited-by__entry__author">Carl J. Fichtenbaum, </li><li class="list-inline-item cited-by__entry__author">Tom Fiel, </li><li class="list-inline-item cited-by__entry__author">Carlos A. Fierro, </li><li class="list-inline-item cited-by__entry__author">Kenneth Finkelstein, </li><li class="list-inline-item cited-by__entry__author">Jon Finley, </li><li class="list-inline-item cited-by__entry__author">Suzanne Fiorillo, </li><li class="list-inline-item cited-by__entry__author">David Fitz-Patrick, </li><li class="list-inline-item cited-by__entry__author">Diana F. Florescu, </li><li class="list-inline-item cited-by__entry__author">Patrick Flume, </li><li class="list-inline-item cited-by__entry__author">Charles M. Fogarty, </li><li class="list-inline-item cited-by__entry__author">Jennifer Foley, </li><li class="list-inline-item cited-by__entry__author">Dean Follmann, </li><li class="list-inline-item cited-by__entry__author">Pink Folmar, </li><li class="list-inline-item cited-by__entry__author">Lyndsea Folsom, </li><li class="list-inline-item cited-by__entry__author">Youyi Fong, </li><li class="list-inline-item cited-by__entry__author">Stacy Ford, </li><li class="list-inline-item cited-by__entry__author">Lina M. Forero, </li><li class="list-inline-item cited-by__entry__author">Les B. Forgosh, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Formentini, </li><li class="list-inline-item cited-by__entry__author">Rhodna Fouts, </li><li class="list-inline-item cited-by__entry__author">Carina Frago, </li><li class="list-inline-item cited-by__entry__author">Veronica G. Fragoso, </li><li class="list-inline-item cited-by__entry__author">Doris Franco-Vitteri, </li><li class="list-inline-item cited-by__entry__author">Ian Frank, </li><li class="list-inline-item cited-by__entry__author">George H. Freeman, </li><li class="list-inline-item cited-by__entry__author">Lena R. Freese, </li><li class="list-inline-item cited-by__entry__author">Robert W. Frenck, </li><li class="list-inline-item cited-by__entry__author">Karen Freudemann, </li><li class="list-inline-item cited-by__entry__author">Sharon E. Frey, </li><li class="list-inline-item cited-by__entry__author">David L. Fried, </li><li class="list-inline-item cited-by__entry__author">Luke Friesen, </li><li class="list-inline-item cited-by__entry__author">James Fry, </li><li class="list-inline-item cited-by__entry__author">Bo Fu, </li><li class="list-inline-item cited-by__entry__author">Hiroyuki Fukase, </li><li class="list-inline-item cited-by__entry__author">Dawn Furey, </li><li class="list-inline-item cited-by__entry__author">Christopher Galloway, </li><li class="list-inline-item cited-by__entry__author">Sarah Galloway, </li><li class="list-inline-item cited-by__entry__author">Edgar Garcia, </li><li class="list-inline-item cited-by__entry__author">Jenina Garcia, </li><li class="list-inline-item cited-by__entry__author">Iris García, </li><li class="list-inline-item cited-by__entry__author">Sebastian Garcia Escallon, </li><li class="list-inline-item cited-by__entry__author">Veronica Garcia-Fragoso, </li><li class="list-inline-item cited-by__entry__author">Agnes Garinga, </li><li class="list-inline-item cited-by__entry__author">Janet Garvey, </li><li class="list-inline-item cited-by__entry__author">Cynthia L. Gay, </li><li class="list-inline-item cited-by__entry__author">Bruce C. Gebhardt, </li><li class="list-inline-item cited-by__entry__author">Grant Geiger, </li><li class="list-inline-item cited-by__entry__author">Huub G. Gelderblom, </li><li class="list-inline-item cited-by__entry__author">Georgettea Geuss, </li><li class="list-inline-item cited-by__entry__author">Elham Ghadishah, </li><li class="list-inline-item cited-by__entry__author">Elie Gharib, </li><li class="list-inline-item cited-by__entry__author">Suzanne Gharib, </li><li class="list-inline-item cited-by__entry__author">Richard L. Gibson, </li><li class="list-inline-item cited-by__entry__author">Peter B. Gilbert, </li><li class="list-inline-item cited-by__entry__author">Alfredo Gilberto Guerreros Benavides, </li><li class="list-inline-item cited-by__entry__author">Teletha Gipson, </li><li class="list-inline-item cited-by__entry__author">Eneyda Giuvanela Llerena Zegarra, </li><li class="list-inline-item cited-by__entry__author">Gregory M. Glenn, </li><li class="list-inline-item cited-by__entry__author">Richard M. Glover, </li><li class="list-inline-item cited-by__entry__author">Erin A. Goecker, </li><li class="list-inline-item cited-by__entry__author">Paul A. Goepfert, </li><li class="list-inline-item cited-by__entry__author">James N. Goldenberg, </li><li class="list-inline-item cited-by__entry__author">Blanca Gomez, </li><li class="list-inline-item cited-by__entry__author">Martha Cecilia Gómora Madrid, </li><li class="list-inline-item cited-by__entry__author">Jose Gonzales-Zamora, </li><li class="list-inline-item cited-by__entry__author">Celia Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Lazaro Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Viviana Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Claudia Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Luis H. González, </li><li class="list-inline-item cited-by__entry__author">Denisse Alejandra González Estrada, </li><li class="list-inline-item cited-by__entry__author">Antonio Gonzalez-Lopez, </li><li class="list-inline-item cited-by__entry__author">Sarah Gordon, </li><li class="list-inline-item cited-by__entry__author">Bryan Gordon, </li><li class="list-inline-item cited-by__entry__author">Richard Gorman, </li><li class="list-inline-item cited-by__entry__author">Gregory M. Gottschlich, </li><li class="list-inline-item cited-by__entry__author">Melissa Gottschlich, </li><li class="list-inline-item cited-by__entry__author">Shanda Gower, </li><li class="list-inline-item cited-by__entry__author">Daniel S. Graciaa, </li><li class="list-inline-item cited-by__entry__author">Barney S. Graham, </li><li class="list-inline-item cited-by__entry__author">Irene Graham, </li><li class="list-inline-item cited-by__entry__author">Maria Angelica Granados, </li><li class="list-inline-item cited-by__entry__author">Amber Grant, </li><li class="list-inline-item cited-by__entry__author">Brett Gray, </li><li class="list-inline-item cited-by__entry__author">Glenda Gray, </li><li class="list-inline-item cited-by__entry__author">Roni Gray, </li><li class="list-inline-item cited-by__entry__author">Sinikka L. Green, </li><li class="list-inline-item cited-by__entry__author">Allison Green, </li><li class="list-inline-item cited-by__entry__author">Justin A. Green, </li><li class="list-inline-item cited-by__entry__author">Rusty Greene, </li><li class="list-inline-item cited-by__entry__author">Caroline Greene, </li><li class="list-inline-item cited-by__entry__author">Cathy Greiwe, </li><li class="list-inline-item cited-by__entry__author">Alex Greninger, </li><li class="list-inline-item cited-by__entry__author">Carl P. Griffin, </li><li class="list-inline-item cited-by__entry__author">Marie-Helene Grillet, </li><li class="list-inline-item cited-by__entry__author">Joseph Grillo, </li><li class="list-inline-item cited-by__entry__author">Beatriz Grinsztejn, </li><li class="list-inline-item cited-by__entry__author">Robert M. Grossberg, </li><li class="list-inline-item cited-by__entry__author">Nicole Grunenberg, </li><li class="list-inline-item cited-by__entry__author">Bernard Grunstra, </li><li class="list-inline-item cited-by__entry__author">Juan V. Guanira-Carranza, </li><li class="list-inline-item cited-by__entry__author">Sonia Guerrero, </li><li class="list-inline-item cited-by__entry__author">Lea Guillery, </li><li class="list-inline-item cited-by__entry__author">Clint C. Guillory, </li><li class="list-inline-item cited-by__entry__author">Caitlin J. Guiney, </li><li class="list-inline-item cited-by__entry__author">Catherine Q. Gular, </li><li class="list-inline-item cited-by__entry__author">Shauna H. Gunaratne, </li><li class="list-inline-item cited-by__entry__author">Sanjay Gurunathan, </li><li class="list-inline-item cited-by__entry__author">Milton Haber, </li><li class="list-inline-item cited-by__entry__author">Greg Hachigian, </li><li class="list-inline-item cited-by__entry__author">Amina Z. Haggag, </li><li class="list-inline-item cited-by__entry__author">William Hahn, </li><li class="list-inline-item cited-by__entry__author">Evelyn Hall, </li><li class="list-inline-item cited-by__entry__author">Jessicalee Hall, </li><li class="list-inline-item cited-by__entry__author">David Halpert, </li><li class="list-inline-item cited-by__entry__author">Holli Hamilton, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Hammershaimb, </li><li class="list-inline-item cited-by__entry__author">Shu Han, </li><li class="list-inline-item cited-by__entry__author">Laurie J. Han-Conrad, </li><li class="list-inline-item cited-by__entry__author">Kate Harden, </li><li class="list-inline-item cited-by__entry__author">Karin Hardt, </li><li class="list-inline-item cited-by__entry__author">Esther L. Harmon, </li><li class="list-inline-item cited-by__entry__author">Wayne L. Harper, </li><li class="list-inline-item cited-by__entry__author">Charles Harper, </li><li class="list-inline-item cited-by__entry__author">Nicole Harrell, </li><li class="list-inline-item cited-by__entry__author">Hannah Harrington, </li><li class="list-inline-item cited-by__entry__author">Tavane Harrison, </li><li class="list-inline-item cited-by__entry__author">Kristina Harrison, </li><li class="list-inline-item cited-by__entry__author">Shana Harshell, </li><li class="list-inline-item cited-by__entry__author">William R. Hartman, </li><li class="list-inline-item cited-by__entry__author">Robyn Hartvickson, </li><li class="list-inline-item cited-by__entry__author">Michael Hassman, </li><li class="list-inline-item cited-by__entry__author">Timothy J. Hatlen, </li><li class="list-inline-item cited-by__entry__author">Kirsten Hauge, </li><li class="list-inline-item cited-by__entry__author">Lynne A. Haughey, </li><li class="list-inline-item cited-by__entry__author">Michelle Haynes, </li><li class="list-inline-item cited-by__entry__author">Gary Headden, </li><li class="list-inline-item cited-by__entry__author">C. Mary Healy, </li><li class="list-inline-item cited-by__entry__author">Parke Hedges, </li><li class="list-inline-item cited-by__entry__author">Dirk Heerwegh, </li><li class="list-inline-item cited-by__entry__author">Theresa Hegmann, </li><li class="list-inline-item cited-by__entry__author">Jessica Heimonen, </li><li class="list-inline-item cited-by__entry__author">Destiny S. Heinzig-Cartwright, </li><li class="list-inline-item cited-by__entry__author">Sheryl L. Henderson, </li><li class="list-inline-item cited-by__entry__author">Jeffrey A. Henderson, </li><li class="list-inline-item cited-by__entry__author">Renea Henderson, </li><li class="list-inline-item cited-by__entry__author">Jenny Hendriks, </li><li class="list-inline-item cited-by__entry__author">Gayle D. Hennekes, </li><li class="list-inline-item cited-by__entry__author">Matthew Hepburn, </li><li class="list-inline-item cited-by__entry__author">Ramin Herati, </li><li class="list-inline-item cited-by__entry__author">Erica Herc, </li><li class="list-inline-item cited-by__entry__author">Will Hernandez, </li><li class="list-inline-item cited-by__entry__author">Laura Hernandez Guarin, </li><li class="list-inline-item cited-by__entry__author">Maria Hernandez Moran, </li><li class="list-inline-item cited-by__entry__author">Robin Hilder, </li><li class="list-inline-item cited-by__entry__author">John M. Hill, </li><li class="list-inline-item cited-by__entry__author">Janet Hill, </li><li class="list-inline-item cited-by__entry__author">Ian Hirsch, </li><li class="list-inline-item cited-by__entry__author">Ken Ho, </li><li class="list-inline-item cited-by__entry__author">Alejandro Hoberman, </li><li class="list-inline-item cited-by__entry__author">Daniel Hoft, </li><li class="list-inline-item cited-by__entry__author">Leila Hojat, </li><li class="list-inline-item cited-by__entry__author">Troy Holdeman, </li><li class="list-inline-item cited-by__entry__author">Ripley R. Hollister, </li><li class="list-inline-item cited-by__entry__author">Lisa Holloway, </li><li class="list-inline-item cited-by__entry__author">Gregory Holt, </li><li class="list-inline-item cited-by__entry__author">Matthew Hong, </li><li class="list-inline-item cited-by__entry__author">Stephan Hong, </li><li class="list-inline-item cited-by__entry__author">Rosamond Hong, </li><li class="list-inline-item cited-by__entry__author">Amanda Horn, </li><li class="list-inline-item cited-by__entry__author">Manisha Horton, </li><li class="list-inline-item cited-by__entry__author">Gary Horwith, </li><li class="list-inline-item cited-by__entry__author">Sybil G. Hosek, </li><li class="list-inline-item cited-by__entry__author">Cyrus Hoseyni, </li><li class="list-inline-item cited-by__entry__author">Patty Howenstine, </li><li class="list-inline-item cited-by__entry__author">Yunda Huang, </li><li class="list-inline-item cited-by__entry__author">Ying Huang, </li><li class="list-inline-item cited-by__entry__author">Kathy Hudzina, </li><li class="list-inline-item cited-by__entry__author">Cory J. Huffine, </li><li class="list-inline-item cited-by__entry__author">Esther S. Huffine, </li><li class="list-inline-item cited-by__entry__author">Christine Hull, </li><li class="list-inline-item cited-by__entry__author">Julie Hunt, </li><li class="list-inline-item cited-by__entry__author">John Hural, </li><li class="list-inline-item cited-by__entry__author">James W. Hurst, </li><li class="list-inline-item cited-by__entry__author">Shamika Huskey, </li><li class="list-inline-item cited-by__entry__author">Mary Hussain, </li><li class="list-inline-item cited-by__entry__author">Julie Hussey, </li><li class="list-inline-item cited-by__entry__author">Morgan Hussey, </li><li class="list-inline-item cited-by__entry__author">Mark Hutchens, </li><li class="list-inline-item cited-by__entry__author">Tanya Hutchins, </li><li class="list-inline-item cited-by__entry__author">Julia Hutter, </li><li class="list-inline-item cited-by__entry__author">Vincent Huynh, </li><li class="list-inline-item cited-by__entry__author">Jessica Ibarra, </li><li class="list-inline-item cited-by__entry__author">Lilly Immergluck, </li><li class="list-inline-item cited-by__entry__author">Dilek Ince, </li><li class="list-inline-item cited-by__entry__author">Sarah M. Ingalsbe-Geno, </li><li class="list-inline-item cited-by__entry__author">Asha Inniss, </li><li class="list-inline-item cited-by__entry__author">Farah Irani, </li><li class="list-inline-item cited-by__entry__author">Mashrur Islam Majumder, </li><li class="list-inline-item cited-by__entry__author">Ryan Israelsen, </li><li class="list-inline-item cited-by__entry__author">Leslie Iverson, </li><li class="list-inline-item cited-by__entry__author">Genevieve Iwuala, </li><li class="list-inline-item cited-by__entry__author">Lisa A. Jackson, </li><li class="list-inline-item cited-by__entry__author">Peta-Gay Jackson-Booth, </li><li class="list-inline-item cited-by__entry__author">Michael Jacobs, </li><li class="list-inline-item cited-by__entry__author">Colleen Jacobsen, </li><li class="list-inline-item cited-by__entry__author">Jeffrey M. Jacobson, </li><li class="list-inline-item cited-by__entry__author">Jeffry Jacqmein, </li><li class="list-inline-item cited-by__entry__author">Kate Jaegle, </li><li class="list-inline-item cited-by__entry__author">Shireen H. Jaffer, </li><li class="list-inline-item cited-by__entry__author">Maryam Jahromi, </li><li class="list-inline-item cited-by__entry__author">Manish Jain, </li><li class="list-inline-item cited-by__entry__author">Frank James, </li><li class="list-inline-item cited-by__entry__author">Holly Janes, </li><li class="list-inline-item cited-by__entry__author">Melanie Jay, </li><li class="list-inline-item cited-by__entry__author">Robert Jeanfreau, </li><li class="list-inline-item cited-by__entry__author">Susan Jeanfreau, </li><li class="list-inline-item cited-by__entry__author">William Jennings, </li><li class="list-inline-item cited-by__entry__author">Natasa Jenson, </li><li class="list-inline-item cited-by__entry__author">Keith R. Jerome, </li><li class="list-inline-item cited-by__entry__author">Jennifer A. Johnson, </li><li class="list-inline-item cited-by__entry__author">John Johnson, </li><li class="list-inline-item cited-by__entry__author">Danyel Johnson, </li><li class="list-inline-item cited-by__entry__author">Diane H. Johnson, </li><li class="list-inline-item cited-by__entry__author">Maria Johnson, </li><li class="list-inline-item cited-by__entry__author">Lisa Johnson, </li><li class="list-inline-item cited-by__entry__author">Erica Johnson, </li><li class="list-inline-item cited-by__entry__author">Kristen Johnson, </li><li class="list-inline-item cited-by__entry__author">Jennie Johnson, </li><li class="list-inline-item cited-by__entry__author">Carrie Johnston, </li><li class="list-inline-item cited-by__entry__author">William H. Jones, </li><li class="list-inline-item cited-by__entry__author">Kathleen S. Jones, </li><li class="list-inline-item cited-by__entry__author">Edward C. Jones-López, </li><li class="list-inline-item cited-by__entry__author">Bailey Jordan, </li><li class="list-inline-item cited-by__entry__author">Michal Juraska, </li><li class="list-inline-item cited-by__entry__author">Jarek Juraszek, </li><li class="list-inline-item cited-by__entry__author">Jessica E. Justman, </li><li class="list-inline-item cited-by__entry__author">Seyram Kaali, </li><li class="list-inline-item cited-by__entry__author">Scott Kahney, </li><li class="list-inline-item cited-by__entry__author">Spyros A. Kalams, </li><li class="list-inline-item cited-by__entry__author">Satoshi Kamidani, </li><li class="list-inline-item cited-by__entry__author">Sheetal Kandiah, </li><li class="list-inline-item cited-by__entry__author">Pamela Kane, </li><li class="list-inline-item cited-by__entry__author">Piush Kanodia, </li><li class="list-inline-item cited-by__entry__author">Shashi Kapadia, </li><li class="list-inline-item cited-by__entry__author">Lois Katz, </li><li class="list-inline-item cited-by__entry__author">Melinda Katz, </li><li class="list-inline-item cited-by__entry__author">Carol Kauffman, </li><li class="list-inline-item cited-by__entry__author">Daniel Kaul, </li><li class="list-inline-item cited-by__entry__author">Margaret Kautz, </li><li class="list-inline-item cited-by__entry__author">Westly Keating, </li><li class="list-inline-item cited-by__entry__author">Jia Jin&nbsp; Kee, </li><li class="list-inline-item cited-by__entry__author">Michael C. Keefer, </li><li class="list-inline-item cited-by__entry__author">Wendy A. Keitel, </li><li class="list-inline-item cited-by__entry__author">Colleen F. Kelley, </li><li class="list-inline-item cited-by__entry__author">Amy Kelley, </li><li class="list-inline-item cited-by__entry__author">Kary Kelly, </li><li class="list-inline-item cited-by__entry__author">Elizabeth J. Kelly, </li><li class="list-inline-item cited-by__entry__author">Sandra Kelman, </li><li class="list-inline-item cited-by__entry__author">Gerald Kelty, </li><li class="list-inline-item cited-by__entry__author">Ashley Kennedy, </li><li class="list-inline-item cited-by__entry__author">Christina Kennelly, </li><li class="list-inline-item cited-by__entry__author">Maryam Keshtkar-Jahromi, </li><li class="list-inline-item cited-by__entry__author">Jill Kessler, </li><li class="list-inline-item cited-by__entry__author">Nzeera Ketter, </li><li class="list-inline-item cited-by__entry__author">Najat Khan, </li><li class="list-inline-item cited-by__entry__author">Nitin Khandelwal, </li><li class="list-inline-item cited-by__entry__author">Shishir K. Khetan, </li><li class="list-inline-item cited-by__entry__author">Saadia Khizer, </li><li class="list-inline-item cited-by__entry__author">Hannah Kibuuka, </li><li class="list-inline-item cited-by__entry__author">Kristen Kiersey, </li><li class="list-inline-item cited-by__entry__author">Paul Kilgore, </li><li class="list-inline-item cited-by__entry__author">Anthony Kim, </li><li class="list-inline-item cited-by__entry__author">Kami Kim, </li><li class="list-inline-item cited-by__entry__author">Murray A. Kimmel, </li><li class="list-inline-item cited-by__entry__author">Michelle King, </li><li class="list-inline-item cited-by__entry__author">Jeffrey K. Kingsley, </li><li class="list-inline-item cited-by__entry__author">William Kirby, </li><li class="list-inline-item cited-by__entry__author">John A. Kirby, </li><li class="list-inline-item cited-by__entry__author">Beth D. Kirkpatrick, </li><li class="list-inline-item cited-by__entry__author">Judith L. Kirstein, </li><li class="list-inline-item cited-by__entry__author">Cissy Kityo Mutuluuza, </li><li class="list-inline-item cited-by__entry__author">Noah Kiwanuka, </li><li class="list-inline-item cited-by__entry__author">Francis Kiweewa, </li><li class="list-inline-item cited-by__entry__author">John S. Kizer, </li><li class="list-inline-item cited-by__entry__author">Terry D. Klein, </li><li class="list-inline-item cited-by__entry__author">Thomas C. Klein, </li><li class="list-inline-item cited-by__entry__author">Tracy R. Klein, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Klein, </li><li class="list-inline-item cited-by__entry__author">Susan Kline, </li><li class="list-inline-item cited-by__entry__author">David Kline, </li><li class="list-inline-item cited-by__entry__author">Jennifer Knishinsky, </li><li class="list-inline-item cited-by__entry__author">Jennifer Knowles, </li><li class="list-inline-item cited-by__entry__author">Laura Kogelman, </li><li class="list-inline-item cited-by__entry__author">Sharon Kohrs, </li><li class="list-inline-item cited-by__entry__author">Susan L. Koletar, </li><li class="list-inline-item cited-by__entry__author">James Kopp, </li><li class="list-inline-item cited-by__entry__author">Michael J. Koren, </li><li class="list-inline-item cited-by__entry__author">Chalit Kosolsak, </li><li class="list-inline-item cited-by__entry__author">Karen L. Kotloff, </li><li class="list-inline-item cited-by__entry__author">Angelica Kottkamp, </li><li class="list-inline-item cited-by__entry__author">Marguerite Koutsoukos, </li><li class="list-inline-item cited-by__entry__author">Jayasree Krishnankutty, </li><li class="list-inline-item cited-by__entry__author">Mara Kryvicky, </li><li class="list-inline-item cited-by__entry__author">James G. Kublin, </li><li class="list-inline-item cited-by__entry__author">Kristine J. Kucera, </li><li class="list-inline-item cited-by__entry__author">Darshna Kukian, </li><li class="list-inline-item cited-by__entry__author">Marcy Kulic, </li><li class="list-inline-item cited-by__entry__author">Rebecca J. Kurnat, </li><li class="list-inline-item cited-by__entry__author">Kelly Kush, </li><li class="list-inline-item cited-by__entry__author">Jitendra Singh Kushwaha, </li><li class="list-inline-item cited-by__entry__author">Mark E. Kutner, </li><li class="list-inline-item cited-by__entry__author">Ben Ladner, </li><li class="list-inline-item cited-by__entry__author">Cathy Laflan, </li><li class="list-inline-item cited-by__entry__author">Maryrose Laguio-Vila, </li><li class="list-inline-item cited-by__entry__author">Sherry Lamberth, </li><li class="list-inline-item cited-by__entry__author">Raphael J. Landovitz, </li><li class="list-inline-item cited-by__entry__author">Dakotah C. Lane, </li><li class="list-inline-item cited-by__entry__author">Thelma Laot, </li><li class="list-inline-item cited-by__entry__author">Anyela Lara, </li><li class="list-inline-item cited-by__entry__author">Matthew Laurens, </li><li class="list-inline-item cited-by__entry__author">Andrew Lauria, </li><li class="list-inline-item cited-by__entry__author">Daniel T. Lawler, </li><li class="list-inline-item cited-by__entry__author">Nga Le, </li><li class="list-inline-item cited-by__entry__author">Mathieu Le Gars, </li><li class="list-inline-item cited-by__entry__author">Vickie Leathers, </li><li class="list-inline-item cited-by__entry__author">Brett Leav, </li><li class="list-inline-item cited-by__entry__author">Logan Ledbetter, </li><li class="list-inline-item cited-by__entry__author">Julie E. Ledgerwood, </li><li class="list-inline-item cited-by__entry__author">Kia Lee, </li><li class="list-inline-item cited-by__entry__author">Jessica L. Lee, </li><li class="list-inline-item cited-by__entry__author">Marina Lee, </li><li class="list-inline-item cited-by__entry__author">Angela Lee, </li><li class="list-inline-item cited-by__entry__author">Mark Leibowitz, </li><li class="list-inline-item cited-by__entry__author">Natalia Leistner, </li><li class="list-inline-item cited-by__entry__author">Mark Lerman, </li><li class="list-inline-item cited-by__entry__author">Michael L. Levin, </li><li class="list-inline-item cited-by__entry__author">Brendan Levy, </li><li class="list-inline-item cited-by__entry__author">Phillip Levy, </li><li class="list-inline-item cited-by__entry__author">Wendell Lewis, </li><li class="list-inline-item cited-by__entry__author">Michael Lewis, </li><li class="list-inline-item cited-by__entry__author">Derek Lewis, </li><li class="list-inline-item cited-by__entry__author">Wendell Lewis, </li><li class="list-inline-item cited-by__entry__author">Maggie Lewis, </li><li class="list-inline-item cited-by__entry__author">Paola Lichtenberger, </li><li class="list-inline-item cited-by__entry__author">Amanda Lilienthal, </li><li class="list-inline-item cited-by__entry__author">Kathleen Linder, </li><li class="list-inline-item cited-by__entry__author">Carol Ann Linebarger, </li><li class="list-inline-item cited-by__entry__author">Kendra Lisec, </li><li class="list-inline-item cited-by__entry__author">Ryan Little, </li><li class="list-inline-item cited-by__entry__author">Susan J. Little, </li><li class="list-inline-item cited-by__entry__author">Albert Liu, </li><li class="list-inline-item cited-by__entry__author">Anna S. Lok, </li><li class="list-inline-item cited-by__entry__author">Evelyn Lomasney, </li><li class="list-inline-item cited-by__entry__author">James Longe, </li><li class="list-inline-item cited-by__entry__author">Carlos Lopez, </li><li class="list-inline-item cited-by__entry__author">Eduardo Lopez-Medina, </li><li class="list-inline-item cited-by__entry__author">Julia Lord, </li><li class="list-inline-item cited-by__entry__author">James Lovell, </li><li class="list-inline-item cited-by__entry__author">Ronald Lubelchek, </li><li class="list-inline-item cited-by__entry__author">John Lucaj, </li><li class="list-inline-item cited-by__entry__author">Njira Lucia Lugogo, </li><li class="list-inline-item cited-by__entry__author">Gary Luckasen, </li><li class="list-inline-item cited-by__entry__author">Gregg H. Lucksinger, </li><li class="list-inline-item cited-by__entry__author">Annie Luetkemeyer, </li><li class="list-inline-item cited-by__entry__author">Benjamin J. Luft, </li><li class="list-inline-item cited-by__entry__author">Rafael Lupercio, </li><li class="list-inline-item cited-by__entry__author">Alisha Lutat, </li><li class="list-inline-item cited-by__entry__author">Jill Maaske, </li><li class="list-inline-item cited-by__entry__author">Rosa MacBryde, </li><li class="list-inline-item cited-by__entry__author">Nolan Mackey, </li><li class="list-inline-item cited-by__entry__author">Rebecca P. Madan, </li><li class="list-inline-item cited-by__entry__author">Janine Maenza, </li><li class="list-inline-item cited-by__entry__author">Siham Mahgoub, </li><li class="list-inline-item cited-by__entry__author">Mamodikoe Makhene, </li><li class="list-inline-item cited-by__entry__author">Hussain Malbari, </li><li class="list-inline-item cited-by__entry__author">Elissa Malkin, </li><li class="list-inline-item cited-by__entry__author">Carlos Malvestutto, </li><li class="list-inline-item cited-by__entry__author">Stephanie Mamod, </li><li class="list-inline-item cited-by__entry__author">Millie Manalo, </li><li class="list-inline-item cited-by__entry__author">Jose C. Mancilla, </li><li class="list-inline-item cited-by__entry__author">Kishorchandra Mandaliya, </li><li class="list-inline-item cited-by__entry__author">Somnath Mangarule, </li><li class="list-inline-item cited-by__entry__author">Padma N. Mangu, </li><li class="list-inline-item cited-by__entry__author">Mary Beth Manning, </li><li class="list-inline-item cited-by__entry__author">Rickey D. Manning, </li><li class="list-inline-item cited-by__entry__author">Deb Manzo, </li><li class="list-inline-item cited-by__entry__author">Horacio Marafioti, </li><li class="list-inline-item cited-by__entry__author">Kristin Marks, </li><li class="list-inline-item cited-by__entry__author">Mary A. Marovich, </li><li class="list-inline-item cited-by__entry__author">Adrienna Marquez, </li><li class="list-inline-item cited-by__entry__author">Richard P. Marshall, </li><li class="list-inline-item cited-by__entry__author">Judith Martin, </li><li class="list-inline-item cited-by__entry__author">Troy Martin, </li><li class="list-inline-item cited-by__entry__author">Becky Martinez, </li><li class="list-inline-item cited-by__entry__author">Reuben Martinez, </li><li class="list-inline-item cited-by__entry__author">Javier Martínez, </li><li class="list-inline-item cited-by__entry__author">Silvano Omar Martínez Pérez, </li><li class="list-inline-item cited-by__entry__author">Catherine Mary Healy, </li><li class="list-inline-item cited-by__entry__author">John Mascola, </li><li class="list-inline-item cited-by__entry__author">Robin Mason, </li><li class="list-inline-item cited-by__entry__author">Roger Masotti, </li><li class="list-inline-item cited-by__entry__author">Paul G. Matherne, </li><li class="list-inline-item cited-by__entry__author">Christopher Matich, </li><li class="list-inline-item cited-by__entry__author">Monica Mauri, </li><li class="list-inline-item cited-by__entry__author">Ryan C. Maves, </li><li class="list-inline-item cited-by__entry__author">Michelle Maxwell, </li><li class="list-inline-item cited-by__entry__author">Celia Maxwell, </li><li class="list-inline-item cited-by__entry__author">Kenneth H. Mayer, </li><li class="list-inline-item cited-by__entry__author">Monica A. McArthur, </li><li class="list-inline-item cited-by__entry__author">Jennifer McCarter, </li><li class="list-inline-item cited-by__entry__author">Michael J. McCartney, </li><li class="list-inline-item cited-by__entry__author">R. Scott McClelland, </li><li class="list-inline-item cited-by__entry__author">Bruce McClenathan, </li><li class="list-inline-item cited-by__entry__author">Rachael McClennen, </li><li class="list-inline-item cited-by__entry__author">Andrew McConnell, </li><li class="list-inline-item cited-by__entry__author">Margaret E. McCort, </li><li class="list-inline-item cited-by__entry__author">M. Juliana McElrath, </li><li class="list-inline-item cited-by__entry__author">Charlene McEvoy, </li><li class="list-inline-item cited-by__entry__author">Alice McGarry, </li><li class="list-inline-item cited-by__entry__author">John W. McGettigan, </li><li class="list-inline-item cited-by__entry__author">Jonlyn McGettigan, </li><li class="list-inline-item cited-by__entry__author">Lora J. McGill, </li><li class="list-inline-item cited-by__entry__author">Eric McGrath, </li><li class="list-inline-item cited-by__entry__author">Mark M. McKenzie, </li><li class="list-inline-item cited-by__entry__author">Cecilia McKeown-Bragas, </li><li class="list-inline-item cited-by__entry__author">Irene McKnight, </li><li class="list-inline-item cited-by__entry__author">Morgan McLaughlin, </li><li class="list-inline-item cited-by__entry__author">Meredith McNairy, </li><li class="list-inline-item cited-by__entry__author">Kelly McQuarrie, </li><li class="list-inline-item cited-by__entry__author">Andrew McWilliams, </li><li class="list-inline-item cited-by__entry__author">Jodi Meck, </li><li class="list-inline-item cited-by__entry__author">Surisday Mederos, </li><li class="list-inline-item cited-by__entry__author">Amy Medina, </li><li class="list-inline-item cited-by__entry__author">Carmen Medina, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Meier, </li><li class="list-inline-item cited-by__entry__author">Thomas Mellman, </li><li class="list-inline-item cited-by__entry__author">Jessica M. Mena, </li><li class="list-inline-item cited-by__entry__author">Lisa Menard, </li><li class="list-inline-item cited-by__entry__author">Kathleen Menasche, </li><li class="list-inline-item cited-by__entry__author">Janet Mendez, </li><li class="list-inline-item cited-by__entry__author">Jorge F. Méndez Galván, </li><li class="list-inline-item cited-by__entry__author">Rafael Mendoza, </li><li class="list-inline-item cited-by__entry__author">Erika Mendoza, </li><li class="list-inline-item cited-by__entry__author">Sandra Mendoza, </li><li class="list-inline-item cited-by__entry__author">Rajan Merchant, </li><li class="list-inline-item cited-by__entry__author">Fernando L. Merino, </li><li class="list-inline-item cited-by__entry__author">David Metzger, </li><li class="list-inline-item cited-by__entry__author">Jay Meyer, </li><li class="list-inline-item cited-by__entry__author">Robert Meyer, </li><li class="list-inline-item cited-by__entry__author">Eric A. Meyerowitz, </li><li class="list-inline-item cited-by__entry__author">Nelson L. Michael, </li><li class="list-inline-item cited-by__entry__author">Randle Middleton, </li><li class="list-inline-item cited-by__entry__author">Maria Mileno, </li><li class="list-inline-item cited-by__entry__author">Matthew Miles, </li><li class="list-inline-item cited-by__entry__author">Chelsea Miles, </li><li class="list-inline-item cited-by__entry__author">Eric Miller, </li><li class="list-inline-item cited-by__entry__author">Jacqueline Miller, </li><li class="list-inline-item cited-by__entry__author">Vicki E. Miller, </li><li class="list-inline-item cited-by__entry__author">Meagan Miller, </li><li class="list-inline-item cited-by__entry__author">Paulina Miller, </li><li class="list-inline-item cited-by__entry__author">Jason Milligan, </li><li class="list-inline-item cited-by__entry__author">Ann M. Milliken, </li><li class="list-inline-item cited-by__entry__author">Jill Miracle, </li><li class="list-inline-item cited-by__entry__author">Vincent Mirkil, </li><li class="list-inline-item cited-by__entry__author">Mehdi Mirsaeidi, </li><li class="list-inline-item cited-by__entry__author">Carol L. Mitchell, </li><li class="list-inline-item cited-by__entry__author">Kazuyuki Mizuyama, </li><li class="list-inline-item cited-by__entry__author">Gowdhami Mohan, </li><li class="list-inline-item cited-by__entry__author">Satyajit Mohapatra, </li><li class="list-inline-item cited-by__entry__author">Sharzhaad Molina Guizar, </li><li class="list-inline-item cited-by__entry__author">Florence Momplaisir, </li><li class="list-inline-item cited-by__entry__author">Cynthia L. Monaco, </li><li class="list-inline-item cited-by__entry__author">Cynthia Montano-Pereira, </li><li class="list-inline-item cited-by__entry__author">Natasha Montoya, </li><li class="list-inline-item cited-by__entry__author">Candice Montros, </li><li class="list-inline-item cited-by__entry__author">Amaran Moodley, </li><li class="list-inline-item cited-by__entry__author">Fernanda Morales, </li><li class="list-inline-item cited-by__entry__author">Caitlin Moran, </li><li class="list-inline-item cited-by__entry__author">Catherine Moreau, </li><li class="list-inline-item cited-by__entry__author">Stephen Morris, </li><li class="list-inline-item cited-by__entry__author">Victoria Mosteller, </li><li class="list-inline-item cited-by__entry__author">Stefanie Mott, </li><li class="list-inline-item cited-by__entry__author">Connie Moya, </li><li class="list-inline-item cited-by__entry__author">Terri Moye, </li><li class="list-inline-item cited-by__entry__author">Kimberly Mueller, </li><li class="list-inline-item cited-by__entry__author">Nancy Mueller, </li><li class="list-inline-item cited-by__entry__author">Jacqueline Muenzner, </li><li class="list-inline-item cited-by__entry__author">Nelly Mugo, </li><li class="list-inline-item cited-by__entry__author">Sauda Muhammad, </li><li class="list-inline-item cited-by__entry__author">Kathleen M. Mullane, </li><li class="list-inline-item cited-by__entry__author">Mark J. Mulligan, </li><li class="list-inline-item cited-by__entry__author">Gysella Muniz, </li><li class="list-inline-item cited-by__entry__author">Sigridh Muñoz-Gómez, </li><li class="list-inline-item cited-by__entry__author">Sonal Munsiff, </li><li class="list-inline-item cited-by__entry__author">Deborah Murray, </li><li class="list-inline-item cited-by__entry__author">Monica Murray, </li><li class="list-inline-item cited-by__entry__author">Linda Murray, </li><li class="list-inline-item cited-by__entry__author">David B. Musante, </li><li class="list-inline-item cited-by__entry__author">Sharon Nachman, </li><li class="list-inline-item cited-by__entry__author">Shinya Nagamatsu, </li><li class="list-inline-item cited-by__entry__author">Sherif Naguib, </li><li class="list-inline-item cited-by__entry__author">Jerome G. Naifeh, </li><li class="list-inline-item cited-by__entry__author">S. Hasan Naqvi, </li><li class="list-inline-item cited-by__entry__author">Marshall Nash, </li><li class="list-inline-item cited-by__entry__author">Julio Nasim, </li><li class="list-inline-item cited-by__entry__author">Martha Nason, </li><li class="list-inline-item cited-by__entry__author">Videlis Nduba, </li><li class="list-inline-item cited-by__entry__author">Paul Nee, </li><li class="list-inline-item cited-by__entry__author">Rosa Negron, </li><li class="list-inline-item cited-by__entry__author">Marguerite Neill, </li><li class="list-inline-item cited-by__entry__author">Joy Nelson, </li><li class="list-inline-item cited-by__entry__author">Taylor Nelson, </li><li class="list-inline-item cited-by__entry__author">Tiffany Nemecek, </li><li class="list-inline-item cited-by__entry__author">Lori Nesbitt, </li><li class="list-inline-item cited-by__entry__author">Sonja Neumeister, </li><li class="list-inline-item cited-by__entry__author">Kathleen Neuzil, </li><li class="list-inline-item cited-by__entry__author">Hannah Nevarez, </li><li class="list-inline-item cited-by__entry__author">Joseph L. Newberg, </li><li class="list-inline-item cited-by__entry__author">Lauren Newhouse, </li><li class="list-inline-item cited-by__entry__author">Patrick Newingham, </li><li class="list-inline-item cited-by__entry__author">Fred E. Newton, </li><li class="list-inline-item cited-by__entry__author">Lucy Ng-Price, </li><li class="list-inline-item cited-by__entry__author">Kimberly Nieves, </li><li class="list-inline-item cited-by__entry__author">Chimeremma Nnadi, </li><li class="list-inline-item cited-by__entry__author">Kimberly Nofz, </li><li class="list-inline-item cited-by__entry__author">Nicole L. Nollen, </li><li class="list-inline-item cited-by__entry__author">Asif Noor, </li><li class="list-inline-item cited-by__entry__author">Fernando Noriega, </li><li class="list-inline-item cited-by__entry__author">Richard M. Novak, </li><li class="list-inline-item cited-by__entry__author">Patricia Nahirya Ntege, </li><li class="list-inline-item cited-by__entry__author">Paul J. Nugent, </li><li class="list-inline-item cited-by__entry__author">Claudio Nuñez Lagos, </li><li class="list-inline-item cited-by__entry__author">Cheryl Nuss, </li><li class="list-inline-item cited-by__entry__author">Chelsie Nutsch, </li><li class="list-inline-item cited-by__entry__author">Amesika Nyaku, </li><li class="list-inline-item cited-by__entry__author">Allison O'Brien, </li><li class="list-inline-item cited-by__entry__author">Enrique Ocaña, </li><li class="list-inline-item cited-by__entry__author">Amanda Occhino, </li><li class="list-inline-item cited-by__entry__author">Kimberly Offergeld, </li><li class="list-inline-item cited-by__entry__author">Brenda Okech, </li><li class="list-inline-item cited-by__entry__author">Tracy Okonya, </li><li class="list-inline-item cited-by__entry__author">Jason F. Okulicz, </li><li class="list-inline-item cited-by__entry__author">Oyebisi Olanrewaju, </li><li class="list-inline-item cited-by__entry__author">Shelby Olds, </li><li class="list-inline-item cited-by__entry__author">Marcia O'Leary, </li><li class="list-inline-item cited-by__entry__author">Patrick A. Oliver, </li><li class="list-inline-item cited-by__entry__author">Odette Olivieri, </li><li class="list-inline-item cited-by__entry__author">Jocelyn Zuleica Olmos Vega, </li><li class="list-inline-item cited-by__entry__author">Sarah Omodele, </li><li class="list-inline-item cited-by__entry__author">Allie Oplinger, </li><li class="list-inline-item cited-by__entry__author">Emily Oppenheim, </li><li class="list-inline-item cited-by__entry__author">Yaa D. Oppong, </li><li class="list-inline-item cited-by__entry__author">Jessica Ortega, </li><li class="list-inline-item cited-by__entry__author">Sandra Janeth Ortega Domínguez, </li><li class="list-inline-item cited-by__entry__author">Maricruz E. Ortegón, </li><li class="list-inline-item cited-by__entry__author">Masaru Oshita, </li><li class="list-inline-item cited-by__entry__author">Erica Osmundsen, </li><li class="list-inline-item cited-by__entry__author">Jaleh Ostovar, </li><li class="list-inline-item cited-by__entry__author">Quito Osuna&nbsp;Carr, </li><li class="list-inline-item cited-by__entry__author">Maria Otero, </li><li class="list-inline-item cited-by__entry__author">Janet Otto, </li><li class="list-inline-item cited-by__entry__author">Samuel Gurrion Ouma, </li><li class="list-inline-item cited-by__entry__author">Jeffrey S. Overcash, </li><li class="list-inline-item cited-by__entry__author">Temitope Oyedele, </li><li class="list-inline-item cited-by__entry__author">Janet Oyieko, </li><li class="list-inline-item cited-by__entry__author">Janeth Pacheco-Flores, </li><li class="list-inline-item cited-by__entry__author">Carmen A. Paez, </li><li class="list-inline-item cited-by__entry__author">Barbara A. Pahud, </li><li class="list-inline-item cited-by__entry__author">Ruth Paiano, </li><li class="list-inline-item cited-by__entry__author">Rolando Pajon, </li><li class="list-inline-item cited-by__entry__author">Yogesh K. Paliwal, </li><li class="list-inline-item cited-by__entry__author">Amit Paliwal, </li><li class="list-inline-item cited-by__entry__author">Steven Palmer, </li><li class="list-inline-item cited-by__entry__author">David Pampe, </li><li class="list-inline-item cited-by__entry__author">Menelas N. Pangalos, </li><li class="list-inline-item cited-by__entry__author">Lalitha Parameswaran, </li><li class="list-inline-item cited-by__entry__author">Erwin Pardo, </li><li class="list-inline-item cited-by__entry__author">Mercedes Paredes, </li><li class="list-inline-item cited-by__entry__author">Purvi Parikh, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Parker, </li><li class="list-inline-item cited-by__entry__author">Susan Parker, </li><li class="list-inline-item cited-by__entry__author">Kevin Parks, </li><li class="list-inline-item cited-by__entry__author">Reza Parungao, </li><li class="list-inline-item cited-by__entry__author">Alpa Patel, </li><li class="list-inline-item cited-by__entry__author">Priti Patel, </li><li class="list-inline-item cited-by__entry__author">Thomas Patterson, </li><li class="list-inline-item cited-by__entry__author">Jan Patterson, </li><li class="list-inline-item cited-by__entry__author">Walter Patton, </li><li class="list-inline-item cited-by__entry__author">Leena Paul, </li><li class="list-inline-item cited-by__entry__author">Corrina Pavetto, </li><li class="list-inline-item cited-by__entry__author">Juana R. Pavie, </li><li class="list-inline-item cited-by__entry__author">James Peacock, </li><li class="list-inline-item cited-by__entry__author">Michele Peake-Andrasik, </li><li class="list-inline-item cited-by__entry__author">Laura Pearlman, </li><li class="list-inline-item cited-by__entry__author">Alyssa-Kay Peay, </li><li class="list-inline-item cited-by__entry__author">David Pekala, </li><li class="list-inline-item cited-by__entry__author">Alison Pellecchia, </li><li class="list-inline-item cited-by__entry__author">Issac Pena-Renteria, </li><li class="list-inline-item cited-by__entry__author">Penny Peng, </li><li class="list-inline-item cited-by__entry__author">Noris Peraita, </li><li class="list-inline-item cited-by__entry__author">Henry Peralta, </li><li class="list-inline-item cited-by__entry__author">Donna Percy, </li><li class="list-inline-item cited-by__entry__author">Isabel Pereira, </li><li class="list-inline-item cited-by__entry__author">Ashley Perez, </li><li class="list-inline-item cited-by__entry__author">James T. Peterson, </li><li class="list-inline-item cited-by__entry__author">Jennifer Petts, </li><li class="list-inline-item cited-by__entry__author">Taryn Petty, </li><li class="list-inline-item cited-by__entry__author">Mai Pham, </li><li class="list-inline-item cited-by__entry__author">Sharine Phan, </li><li class="list-inline-item cited-by__entry__author">Amanda Philyaw, </li><li class="list-inline-item cited-by__entry__author">Sikhongi Phungwayo, </li><li class="list-inline-item cited-by__entry__author">Judy Pi, </li><li class="list-inline-item cited-by__entry__author">Shelby Pickle, </li><li class="list-inline-item cited-by__entry__author">Paul Pickrell, </li><li class="list-inline-item cited-by__entry__author">Terry Piedra, </li><li class="list-inline-item cited-by__entry__author">Kristen K. Pierce, </li><li class="list-inline-item cited-by__entry__author">Daniela Pineda Méndez, </li><li class="list-inline-item cited-by__entry__author">Ruth S. Pinilla, </li><li class="list-inline-item cited-by__entry__author">Simmy Pinto, </li><li class="list-inline-item cited-by__entry__author">Rebecca Pitotti, </li><li class="list-inline-item cited-by__entry__author">David Pitrak, </li><li class="list-inline-item cited-by__entry__author">April Pixler, </li><li class="list-inline-item cited-by__entry__author">Stanford Plavin, </li><li class="list-inline-item cited-by__entry__author">Laura Polakowski, </li><li class="list-inline-item cited-by__entry__author">Terry L. Poling, </li><li class="list-inline-item cited-by__entry__author">Philip Ponce, </li><li class="list-inline-item cited-by__entry__author">Laura Porterfield, </li><li class="list-inline-item cited-by__entry__author">Svitlana Postol, </li><li class="list-inline-item cited-by__entry__author">Amy Potts, </li><li class="list-inline-item cited-by__entry__author">Richard Powell, </li><li class="list-inline-item cited-by__entry__author">Margaret Powers-Fletcher, </li><li class="list-inline-item cited-by__entry__author">E. Javier Pretell Alva, </li><li class="list-inline-item cited-by__entry__author">Patty Price-Abbott, </li><li class="list-inline-item cited-by__entry__author">Veronica Procasky, </li><li class="list-inline-item cited-by__entry__author">John Pullman, </li><li class="list-inline-item cited-by__entry__author">Lawrence J. Purpura, </li><li class="list-inline-item cited-by__entry__author">Marie-Laure Py, </li><li class="list-inline-item cited-by__entry__author">Evelyn Quevedo, </li><li class="list-inline-item cited-by__entry__author">Kim Quillin, </li><li class="list-inline-item cited-by__entry__author">Donald Quinn, </li><li class="list-inline-item cited-by__entry__author">Jalima Quintero, </li><li class="list-inline-item cited-by__entry__author">Vanessa Raabe, </li><li class="list-inline-item cited-by__entry__author">Frederick Raiser, </li><li class="list-inline-item cited-by__entry__author">Sabina Raja, </li><li class="list-inline-item cited-by__entry__author">Vivek Rajasekhar, </li><li class="list-inline-item cited-by__entry__author">Danielle Raley, </li><li class="list-inline-item cited-by__entry__author">Mayur Ramesh, </li><li class="list-inline-item cited-by__entry__author">Natalie Ramirez, </li><li class="list-inline-item cited-by__entry__author">Shelly Ramirez, </li><li class="list-inline-item cited-by__entry__author">Wanda Ramon, </li><li class="list-inline-item cited-by__entry__author">James Ramsey, </li><li class="list-inline-item cited-by__entry__author">Bruce G. Rankin, </li><li class="list-inline-item cited-by__entry__author">Heather Rattenbury-Shaw, </li><li class="list-inline-item cited-by__entry__author">Paulina Rebolledo, </li><li class="list-inline-item cited-by__entry__author">Sergio E. Recuenco, </li><li class="list-inline-item cited-by__entry__author">Chinthaparthi Prabhakar Reddy, </li><li class="list-inline-item cited-by__entry__author">Patty Reed, </li><li class="list-inline-item cited-by__entry__author">Maria M. Regalado, </li><li class="list-inline-item cited-by__entry__author">Malina Regalado, </li><li class="list-inline-item cited-by__entry__author">María José Reyes Fentanes, </li><li class="list-inline-item cited-by__entry__author">Humberto Reynales, </li><li class="list-inline-item cited-by__entry__author">Michele D. Reynolds, </li><li class="list-inline-item cited-by__entry__author">Trina L. Reynolds, </li><li class="list-inline-item cited-by__entry__author">Michelle Reynolds, </li><li class="list-inline-item cited-by__entry__author">Margaret Rhee, </li><li class="list-inline-item cited-by__entry__author">Tamara Richards, </li><li class="list-inline-item cited-by__entry__author">Sha-Wanda Richmond, </li><li class="list-inline-item cited-by__entry__author">Sharon A. Riddler, </li><li class="list-inline-item cited-by__entry__author">Robert A. Riesenberg, </li><li class="list-inline-item cited-by__entry__author">Dolores Rijos, </li><li class="list-inline-item cited-by__entry__author">Joshua Rindt, </li><li class="list-inline-item cited-by__entry__author">Enrique Rivas, </li><li class="list-inline-item cited-by__entry__author">Juan J. Rivera, </li><li class="list-inline-item cited-by__entry__author">María I. Rivera, </li><li class="list-inline-item cited-by__entry__author">Juana Rivera, </li><li class="list-inline-item cited-by__entry__author">Gina Rivero, </li><li class="list-inline-item cited-by__entry__author">Rafael Rivero, </li><li class="list-inline-item cited-by__entry__author">Zainab Rizvi, </li><li class="list-inline-item cited-by__entry__author">Barbara Rizzardi, </li><li class="list-inline-item cited-by__entry__author">Denise Roadman, </li><li class="list-inline-item cited-by__entry__author">Merlin L. Robb, </li><li class="list-inline-item cited-by__entry__author">Afsoon Roberts, </li><li class="list-inline-item cited-by__entry__author">Toni Robinson, </li><li class="list-inline-item cited-by__entry__author">Dawn Robison, </li><li class="list-inline-item cited-by__entry__author">Elizabeth E. Robison, </li><li class="list-inline-item cited-by__entry__author">Shannon Rodman, </li><li class="list-inline-item cited-by__entry__author">Jessica Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Carina A. Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Edith Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Rachel Rokser, </li><li class="list-inline-item cited-by__entry__author">Charlotte-Paige Rolle, </li><li class="list-inline-item cited-by__entry__author">Stephanie Rolsma, </li><li class="list-inline-item cited-by__entry__author">Peter Ronco, </li><li class="list-inline-item cited-by__entry__author">Melody Ronk, </li><li class="list-inline-item cited-by__entry__author">Adam Rosen, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Rosen, </li><li class="list-inline-item cited-by__entry__author">David Rosenberg, </li><li class="list-inline-item cited-by__entry__author">A. Lina Rosengren, </li><li class="list-inline-item cited-by__entry__author">Christiana A. Rostad, </li><li class="list-inline-item cited-by__entry__author">Joan Rothenberg, </li><li class="list-inline-item cited-by__entry__author">Rambod Rouhbakhsh, </li><li class="list-inline-item cited-by__entry__author">Nadine Rouphael, </li><li class="list-inline-item cited-by__entry__author">Crystal Rowell, </li><li class="list-inline-item cited-by__entry__author">Pavitra Roychoudhury, </li><li class="list-inline-item cited-by__entry__author">Rola G. Rucker, </li><li class="list-inline-item cited-by__entry__author">Monica Ruiz, </li><li class="list-inline-item cited-by__entry__author">Vida Veronica Ruiz Herrera, </li><li class="list-inline-item cited-by__entry__author">Javier Ruiz-Guiñazú, </li><li class="list-inline-item cited-by__entry__author">Guillermo M. Ruiz-Palacios, </li><li class="list-inline-item cited-by__entry__author">Karen Ruperto, </li><li class="list-inline-item cited-by__entry__author">Richard Rupp, </li><li class="list-inline-item cited-by__entry__author">Sarah E. Rutstein, </li><li class="list-inline-item cited-by__entry__author">Natasha Rybak, </li><li class="list-inline-item cited-by__entry__author">Martin F. Ryser, </li><li class="list-inline-item cited-by__entry__author">Jerald Sadoff, </li><li class="list-inline-item cited-by__entry__author">Michelle Saemann, </li><li class="list-inline-item cited-by__entry__author">Beth E. Safirstein, </li><li class="list-inline-item cited-by__entry__author">Nafisa Saleem, </li><li class="list-inline-item cited-by__entry__author">Jamshid Saleh, </li><li class="list-inline-item cited-by__entry__author">Mansoor Saleh, </li><li class="list-inline-item cited-by__entry__author">Kacie Sales, </li><li class="list-inline-item cited-by__entry__author">Amy Salzl, </li><li class="list-inline-item cited-by__entry__author">Denise Sample, </li><li class="list-inline-item cited-by__entry__author">Robert Samuels, </li><li class="list-inline-item cited-by__entry__author">Rosario Sanchez, </li><li class="list-inline-item cited-by__entry__author">Martha Sanchez, </li><li class="list-inline-item cited-by__entry__author">Erica Sanchez, </li><li class="list-inline-item cited-by__entry__author">Pedro Sánchez, </li><li class="list-inline-item cited-by__entry__author">Laura Ruy Sanchez Guerrero, </li><li class="list-inline-item cited-by__entry__author">Nelia Sanchez-Crespo, </li><li class="list-inline-item cited-by__entry__author">John Sanders, </li><li class="list-inline-item cited-by__entry__author">Lisa J. Sanders, </li><li class="list-inline-item cited-by__entry__author">Rica Santiago, </li><li class="list-inline-item cited-by__entry__author">Fredric Santiago, </li><li class="list-inline-item cited-by__entry__author">María E. Santolaya, </li><li class="list-inline-item cited-by__entry__author">Nessryne Sater, </li><li class="list-inline-item cited-by__entry__author">Stephen Savarino, </li><li class="list-inline-item cited-by__entry__author">Fredrick Sawe, </li><li class="list-inline-item cited-by__entry__author">Carolyn Scatamacchia, </li><li class="list-inline-item cited-by__entry__author">Timothy W. Schacker, </li><li class="list-inline-item cited-by__entry__author">Gert Scheper, </li><li class="list-inline-item cited-by__entry__author">Linda M. Schipani, </li><li class="list-inline-item cited-by__entry__author">Christy Schmeck, </li><li class="list-inline-item cited-by__entry__author">Robert Schmidt, </li><li class="list-inline-item cited-by__entry__author">William Schnitz, </li><li class="list-inline-item cited-by__entry__author">Florian Schödel, </li><li class="list-inline-item cited-by__entry__author">Debra B. Schroeck, </li><li class="list-inline-item cited-by__entry__author">Lode Schuerman, </li><li class="list-inline-item cited-by__entry__author">Hanneke Schuitemaker, </li><li class="list-inline-item cited-by__entry__author">Howard I. Schwartz, </li><li class="list-inline-item cited-by__entry__author">Adam Schwartz, </li><li class="list-inline-item cited-by__entry__author">Howard Schwartz, </li><li class="list-inline-item cited-by__entry__author">Jennifer Schwartz, </li><li class="list-inline-item cited-by__entry__author">Tiffany Schwasinger-Schmidt, </li><li class="list-inline-item cited-by__entry__author">Michael Sciaudone, </li><li class="list-inline-item cited-by__entry__author">Hyman Scott, </li><li class="list-inline-item cited-by__entry__author">Tameika Scott, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Secord, </li><li class="list-inline-item cited-by__entry__author">Nathan Segall, </li><li class="list-inline-item cited-by__entry__author">William Seger, </li><li class="list-inline-item cited-by__entry__author">Shannen Seversen, </li><li class="list-inline-item cited-by__entry__author">Beverly E. Sha, </li><li class="list-inline-item cited-by__entry__author">Mitul Shah, </li><li class="list-inline-item cited-by__entry__author">Jinen Shah, </li><li class="list-inline-item cited-by__entry__author">Samira Shairi, </li><li class="list-inline-item cited-by__entry__author">Shivanjali Shankaran, </li><li class="list-inline-item cited-by__entry__author">Amie Shannon, </li><li class="list-inline-item cited-by__entry__author">Adrienne E. Shapiro, </li><li class="list-inline-item cited-by__entry__author">Stephan C. Sharp, </li><li class="list-inline-item cited-by__entry__author">Marian E. Shaw, </li><li class="list-inline-item cited-by__entry__author">Rozeli Shelly, </li><li class="list-inline-item cited-by__entry__author">Sandra Shelton, </li><li class="list-inline-item cited-by__entry__author">Lawrence Sher, </li><li class="list-inline-item cited-by__entry__author">Amy Sherman, </li><li class="list-inline-item cited-by__entry__author">Neil P. Sheth, </li><li class="list-inline-item cited-by__entry__author">Steven Shinn, </li><li class="list-inline-item cited-by__entry__author">Tammi L. Shlotzhauer, </li><li class="list-inline-item cited-by__entry__author">Kathryn Shoemaker, </li><li class="list-inline-item cited-by__entry__author">Timothy Shope, </li><li class="list-inline-item cited-by__entry__author">Bo Shopsin, </li><li class="list-inline-item cited-by__entry__author">Steven Shoptaw, </li><li class="list-inline-item cited-by__entry__author">Rajeev Shrestha, </li><li class="list-inline-item cited-by__entry__author">Georgi Shukarev, </li><li class="list-inline-item cited-by__entry__author">Farhan Siddiqui, </li><li class="list-inline-item cited-by__entry__author">Marc Siegel, </li><li class="list-inline-item cited-by__entry__author">Silva Sieger, </li><li class="list-inline-item cited-by__entry__author">Dianca Sierra, </li><li class="list-inline-item cited-by__entry__author">Abraham Siika, </li><li class="list-inline-item cited-by__entry__author">William P. Silver, </li><li class="list-inline-item cited-by__entry__author">Todd Simmons, </li><li class="list-inline-item cited-by__entry__author">Gary Simon, </li><li class="list-inline-item cited-by__entry__author">Matthew D. Sims, </li><li class="list-inline-item cited-by__entry__author">Leonard Singer, </li><li class="list-inline-item cited-by__entry__author">Chandramani Singh, </li><li class="list-inline-item cited-by__entry__author">Veer Bahadur Singh, </li><li class="list-inline-item cited-by__entry__author">Justin Singletary, </li><li class="list-inline-item cited-by__entry__author">Nuchra Sirisuphmitr, </li><li class="list-inline-item cited-by__entry__author">Stephanie Skipper, </li><li class="list-inline-item cited-by__entry__author">Stacy Slechta, </li><li class="list-inline-item cited-by__entry__author">Teresa S. Sligh, </li><li class="list-inline-item cited-by__entry__author">William B. Smith, </li><li class="list-inline-item cited-by__entry__author">Mary Smith, </li><li class="list-inline-item cited-by__entry__author">Derek M. Smith, </li><li class="list-inline-item cited-by__entry__author">Michael J. Smith, </li><li class="list-inline-item cited-by__entry__author">Katherine Smith, </li><li class="list-inline-item cited-by__entry__author">Candace Smith, </li><li class="list-inline-item cited-by__entry__author">Kimberly Snell, </li><li class="list-inline-item cited-by__entry__author">M. Mahdee Sobhanie, </li><li class="list-inline-item cited-by__entry__author">Magdalena E. Sobieszczyk, </li><li class="list-inline-item cited-by__entry__author">Obiageli Sogbetun, </li><li class="list-inline-item cited-by__entry__author">Joel Solis, </li><li class="list-inline-item cited-by__entry__author">Cora Sonnier, </li><li class="list-inline-item cited-by__entry__author">Carrie Sopher, </li><li class="list-inline-item cited-by__entry__author">Adriana Sordo Duran, </li><li class="list-inline-item cited-by__entry__author">Brit Sovic, </li><li class="list-inline-item cited-by__entry__author">Stephen A. Spector, </li><li class="list-inline-item cited-by__entry__author">Steven Sperber, </li><li class="list-inline-item cited-by__entry__author">Bart Spiessens, </li><li class="list-inline-item cited-by__entry__author">Stephanie&nbsp; Sproule, </li><li class="list-inline-item cited-by__entry__author">Saranya Sridhar, </li><li class="list-inline-item cited-by__entry__author">Jonathan Staben, </li><li class="list-inline-item cited-by__entry__author">Jessica Stahl, </li><li class="list-inline-item cited-by__entry__author">Amber Stanford, </li><li class="list-inline-item cited-by__entry__author">Lisa Stangl, </li><li class="list-inline-item cited-by__entry__author">Ariana C. Stanton, </li><li class="list-inline-item cited-by__entry__author">Katherine Stapleton, </li><li class="list-inline-item cited-by__entry__author">Jack Stapleton, </li><li class="list-inline-item cited-by__entry__author">Thomas Starkey, </li><li class="list-inline-item cited-by__entry__author">Richard Starlin, </li><li class="list-inline-item cited-by__entry__author">Amy Starr, </li><li class="list-inline-item cited-by__entry__author">Ryan P. Starr, </li><li class="list-inline-item cited-by__entry__author">Kenneth Steil, </li><li class="list-inline-item cited-by__entry__author">Carolene Stephenson, </li><li class="list-inline-item cited-by__entry__author">Kathryn E. Stephenson, </li><li class="list-inline-item cited-by__entry__author">Stephanie Sterling, </li><li class="list-inline-item cited-by__entry__author">Lisa Stevens Rameaka, </li><li class="list-inline-item cited-by__entry__author">Brittany Stewart, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Stoddard, </li><li class="list-inline-item cited-by__entry__author">Robert Striker, </li><li class="list-inline-item cited-by__entry__author">Frank Struyf, </li><li class="list-inline-item cited-by__entry__author">Suzanna Studdard, </li><li class="list-inline-item cited-by__entry__author">Laura Stulken, </li><li class="list-inline-item cited-by__entry__author">Mildred Stull, </li><li class="list-inline-item cited-by__entry__author">Rodney E. Sturgeon, </li><li class="list-inline-item cited-by__entry__author">May-Yin Suen, </li><li class="list-inline-item cited-by__entry__author">Danny Sugimoto, </li><li class="list-inline-item cited-by__entry__author">Amit Suresh&nbsp;Bhate, </li><li class="list-inline-item cited-by__entry__author">Janice Suyehira, </li><li class="list-inline-item cited-by__entry__author">Kazuo Suzuki, </li><li class="list-inline-item cited-by__entry__author">Shobha Swaminathan, </li><li class="list-inline-item cited-by__entry__author">Suzanne Swan, </li><li class="list-inline-item cited-by__entry__author">Edith Swann, </li><li class="list-inline-item cited-by__entry__author">Austin Swanson, </li><li class="list-inline-item cited-by__entry__author">Christy Sweet, </li><li class="list-inline-item cited-by__entry__author">Elisa Swieboda, </li><li class="list-inline-item cited-by__entry__author">Scott N. Syndergaard, </li><li class="list-inline-item cited-by__entry__author">Karla Beatriz Tafur Bances, </li><li class="list-inline-item cited-by__entry__author">Therese Takas, </li><li class="list-inline-item cited-by__entry__author">Zudi-Mwak Takizala, </li><li class="list-inline-item cited-by__entry__author">Simbarashe G. Takuva, </li><li class="list-inline-item cited-by__entry__author">Kawsar R. Talaat, </li><li class="list-inline-item cited-by__entry__author">Dipesh Tamrakar, </li><li class="list-inline-item cited-by__entry__author">Chen S. Tan, </li><li class="list-inline-item cited-by__entry__author">Cayce Tangemen, </li><li class="list-inline-item cited-by__entry__author">Tamzin Tanner, </li><li class="list-inline-item cited-by__entry__author">Milagritos Tapia, </li><li class="list-inline-item cited-by__entry__author">Denis Tarakjian, </li><li class="list-inline-item cited-by__entry__author">Karen Tashima, </li><li class="list-inline-item cited-by__entry__author">David Tatelbaum, </li><li class="list-inline-item cited-by__entry__author">Fernanda Tavares Da-Silva, </li><li class="list-inline-item cited-by__entry__author">Edward M. Tavel, </li><li class="list-inline-item cited-by__entry__author">Kimberly L. Taylor, </li><li class="list-inline-item cited-by__entry__author">Brandie Taylor, </li><li class="list-inline-item cited-by__entry__author">Barbara S. Taylor, </li><li class="list-inline-item cited-by__entry__author">David Taylor, </li><li class="list-inline-item cited-by__entry__author">Sharita Tedder-Edwards, </li><li class="list-inline-item cited-by__entry__author">Meghan Teherani, </li><li class="list-inline-item cited-by__entry__author">Leslie Tharenos, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Thessing, </li><li class="list-inline-item cited-by__entry__author">Meagan Thomas, </li><li class="list-inline-item cited-by__entry__author">LaTeshia Thomas-Seaton, </li><li class="list-inline-item cited-by__entry__author">Amy Thompson, </li><li class="list-inline-item cited-by__entry__author">Karl M. Thompson, </li><li class="list-inline-item cited-by__entry__author">Teri Thompson-Seim, </li><li class="list-inline-item cited-by__entry__author">Isaac Thomsen, </li><li class="list-inline-item cited-by__entry__author">Hong V Tieu, </li><li class="list-inline-item cited-by__entry__author">Lucas Otieno Tina, </li><li class="list-inline-item cited-by__entry__author">Ramy J. Toma, </li><li class="list-inline-item cited-by__entry__author">Joanne E. Tomassini, </li><li class="list-inline-item cited-by__entry__author">Christian Tomaszewski, </li><li class="list-inline-item cited-by__entry__author">Lee Tomatsu, </li><li class="list-inline-item cited-by__entry__author">Ryan Tomlinson, </li><li class="list-inline-item cited-by__entry__author">Xiaomi Tong, </li><li class="list-inline-item cited-by__entry__author">Tina Tong, </li><li class="list-inline-item cited-by__entry__author">Juan P. Torres, </li><li class="list-inline-item cited-by__entry__author">Julian A. Torres, </li><li class="list-inline-item cited-by__entry__author">Dalia Tovar, </li><li class="list-inline-item cited-by__entry__author">Carolyn Tran, </li><li class="list-inline-item cited-by__entry__author">John J. Treanor, </li><li class="list-inline-item cited-by__entry__author">Carla Truyers, </li><li class="list-inline-item cited-by__entry__author">Sade Tukuru, </li><li class="list-inline-item cited-by__entry__author">Christine B. Turley, </li><li class="list-inline-item cited-by__entry__author">Mark A. Turner, </li><li class="list-inline-item cited-by__entry__author">Stefanie Tyson, </li><li class="list-inline-item cited-by__entry__author">Akiyoshi Uchiyama, </li><li class="list-inline-item cited-by__entry__author">Robert J. Ulrich, </li><li class="list-inline-item cited-by__entry__author">Lisa S. Usdan, </li><li class="list-inline-item cited-by__entry__author">Gregory C. Utz, </li><li class="list-inline-item cited-by__entry__author">Timothy P. Vachris, </li><li class="list-inline-item cited-by__entry__author">Bruno Valenti, </li><li class="list-inline-item cited-by__entry__author">Insiya Valika, </li><li class="list-inline-item cited-by__entry__author">Mimi Van Der Leden, </li><li class="list-inline-item cited-by__entry__author">Ilse Van Dromme, </li><li class="list-inline-item cited-by__entry__author">Wesley Van Ever, </li><li class="list-inline-item cited-by__entry__author">Johan Van Hoof, </li><li class="list-inline-item cited-by__entry__author">Griet Van Roey, </li><li class="list-inline-item cited-by__entry__author">An Vandebosch, </li><li class="list-inline-item cited-by__entry__author">Sergio L. Vargas, </li><li class="list-inline-item cited-by__entry__author">Tilly Varughese, </li><li class="list-inline-item cited-by__entry__author">Eduardo Gabriel Vázquez Saldaña, </li><li class="list-inline-item cited-by__entry__author">Norma Vega, </li><li class="list-inline-item cited-by__entry__author">Karen Sofia Vega Orozco, </li><li class="list-inline-item cited-by__entry__author">Diana Vegas, </li><li class="list-inline-item cited-by__entry__author">Hector Velasquez, </li><li class="list-inline-item cited-by__entry__author">Michele Vertucci, </li><li class="list-inline-item cited-by__entry__author">Veronica Viar, </li><li class="list-inline-item cited-by__entry__author">Roberto A. Viau Colindres, </li><li class="list-inline-item cited-by__entry__author">Nicholas A. Viens, </li><li class="list-inline-item cited-by__entry__author">Tonya Villafana, </li><li class="list-inline-item cited-by__entry__author">Sandra M. Villagómez Martínez, </li><li class="list-inline-item cited-by__entry__author">Marysol Villegas, </li><li class="list-inline-item cited-by__entry__author">Johan Vingerhoets, </li><li class="list-inline-item cited-by__entry__author">Mary Vogler, </li><li class="list-inline-item cited-by__entry__author">Mandy Vowell, </li><li class="list-inline-item cited-by__entry__author">Keith W. Vrbicky, </li><li class="list-inline-item cited-by__entry__author">Deo Wabwire, </li><li class="list-inline-item cited-by__entry__author">Larkin T. Wadsworth, </li><li class="list-inline-item cited-by__entry__author">Tami Wahlin, </li><li class="list-inline-item cited-by__entry__author">Anne Wajja, </li><li class="list-inline-item cited-by__entry__author">Paul H. Wakefield, </li><li class="list-inline-item cited-by__entry__author">Anna Wald, </li><li class="list-inline-item cited-by__entry__author">Shannon Walker, </li><li class="list-inline-item cited-by__entry__author">James Walker, </li><li class="list-inline-item cited-by__entry__author">Stephen R. Walsh, </li><li class="list-inline-item cited-by__entry__author">Edward E. Walsh, </li><li class="list-inline-item cited-by__entry__author">Mary C. Walsh, </li><li class="list-inline-item cited-by__entry__author">Emmanuel B. Walter, </li><li class="list-inline-item cited-by__entry__author">Ayanna Walters, </li><li class="list-inline-item cited-by__entry__author">Tina Wang, </li><li class="list-inline-item cited-by__entry__author">Ashley Warden, </li><li class="list-inline-item cited-by__entry__author">T. Anh Wartel, </li><li class="list-inline-item cited-by__entry__author">Michael Waters, </li><li class="list-inline-item cited-by__entry__author">Breanz Watkins, </li><li class="list-inline-item cited-by__entry__author">Angella Webb, </li><li class="list-inline-item cited-by__entry__author">Hala Webster, </li><li class="list-inline-item cited-by__entry__author">Jessica L. Weidler, </li><li class="list-inline-item cited-by__entry__author">Thomas Weiss, </li><li class="list-inline-item cited-by__entry__author">Margaret Wells, </li><li class="list-inline-item cited-by__entry__author">Andrea Wendrow, </li><li class="list-inline-item cited-by__entry__author">Melody Werne, </li><li class="list-inline-item cited-by__entry__author">Whitney West, </li><li class="list-inline-item cited-by__entry__author">Jordan L. Whatley, </li><li class="list-inline-item cited-by__entry__author">Jennifer A. Whitaker, </li><li class="list-inline-item cited-by__entry__author">Julie White, </li><li class="list-inline-item cited-by__entry__author">Jewel J. White, </li><li class="list-inline-item cited-by__entry__author">Toni White, </li><li class="list-inline-item cited-by__entry__author">Priyantha N. Wijewardane, </li><li class="list-inline-item cited-by__entry__author">Timothy Wilkin, </li><li class="list-inline-item cited-by__entry__author">Bethanie Wilkinson, </li><li class="list-inline-item cited-by__entry__author">Samantha Williams, </li><li class="list-inline-item cited-by__entry__author">Barton G. Williams, </li><li class="list-inline-item cited-by__entry__author">Hayes Williams, </li><li class="list-inline-item cited-by__entry__author">Greg Wilson, </li><li class="list-inline-item cited-by__entry__author">Christine Wilson, </li><li class="list-inline-item cited-by__entry__author">Natasha Wilson, </li><li class="list-inline-item cited-by__entry__author">Clint Wilson, </li><li class="list-inline-item cited-by__entry__author">Jennifer Winbigler, </li><li class="list-inline-item cited-by__entry__author">Peter J. Winkle, </li><li class="list-inline-item cited-by__entry__author">Patricia L. Winokur, </li><li class="list-inline-item cited-by__entry__author">John Witbeck, </li><li class="list-inline-item cited-by__entry__author">David Wohl, </li><li class="list-inline-item cited-by__entry__author">Wayne Woo, </li><li class="list-inline-item cited-by__entry__author">Leana Woodside, </li><li class="list-inline-item cited-by__entry__author">Glenn Wortman, </li><li class="list-inline-item cited-by__entry__author">Yi H. Wu, </li><li class="list-inline-item cited-by__entry__author">Paul E. Wylie, </li><li class="list-inline-item cited-by__entry__author">Kinara S. Yang, </li><li class="list-inline-item cited-by__entry__author">Fan Yang, </li><li class="list-inline-item cited-by__entry__author">Anelgine C. Yoon, </li><li class="list-inline-item cited-by__entry__author">Jill York, </li><li class="list-inline-item cited-by__entry__author">Cheryl Young, </li><li class="list-inline-item cited-by__entry__author">Juan Luis Yrivarren Giorza, </li><li class="list-inline-item cited-by__entry__author">Joseph Yusin, </li><li class="list-inline-item cited-by__entry__author">Luz Zapata, </li><li class="list-inline-item cited-by__entry__author">Zindy Yazmín Zárate Hinojosa, </li><li class="list-inline-item cited-by__entry__author">Rebecca Zash, </li><li class="list-inline-item cited-by__entry__author">Elodie Zaworski, </li><li class="list-inline-item cited-by__entry__author">Arthur L. Zemanek, </li><li class="list-inline-item cited-by__entry__author">Kate Zenlea, </li><li class="list-inline-item cited-by__entry__author">Karla Zepeda, </li><li class="list-inline-item cited-by__entry__author">Marcus J. Zervos, </li><li class="list-inline-item cited-by__entry__author">Nan Zhai, </li><li class="list-inline-item cited-by__entry__author">Kevin Zhang, </li><li class="list-inline-item cited-by__entry__author">Nianxian Zhang, </li><li class="list-inline-item cited-by__entry__author">Honghong Zhou, </li><li class="list-inline-item cited-by__entry__author">James Zhou, </li><li class="list-inline-item cited-by__entry__author">Andrea Zimmer, </li><li class="list-inline-item cited-by__entry__author">Barry S. Zingman, </li><li class="list-inline-item cited-by__entry__author">Carmen D. Zorrilla, </li></ul><span class="cited-by__entry__title">Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data, </span><span class="cited-by__entry__series-title">JAMA Network Open, </span><span class="cited-by__entry__volume"><strong>8</strong>, </span><span class="cited-by__entry__issue">5, </span><span class="cited-by__entry__page-range">(e2512763), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1001/jamanetworkopen.2025.12763" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1001/jamanetworkopen.2025.12763</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1001/jamanetworkopen.2025.12763" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Xingchi Liu, </li><li class="list-inline-item cited-by__entry__author">Xu Yang, </li><li class="list-inline-item cited-by__entry__author">Lu Tao, </li><li class="list-inline-item cited-by__entry__author">Xuanchen Li, </li><li class="list-inline-item cited-by__entry__author">Guoqiang Chen, </li><li class="list-inline-item cited-by__entry__author">Qi Liu, </li></ul><span class="cited-by__entry__title">Nano/Micro-Enabled Modification and Innovation of Conventional Adjuvants for Next-Generation Vaccines, </span><span class="cited-by__entry__series-title">Journal of Functional Biomaterials, </span><span class="cited-by__entry__volume"><strong>16</strong>, </span><span class="cited-by__entry__issue">5, </span><span class="cited-by__entry__page-range">(185), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/jfb16050185" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/jfb16050185</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/jfb16050185" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Aviraj K. S, </li><li class="list-inline-item cited-by__entry__author">Apoorva Wasnik, </li><li class="list-inline-item cited-by__entry__author">Lalima Gupta, </li><li class="list-inline-item cited-by__entry__author">Ayushi Ranjan, </li><li class="list-inline-item cited-by__entry__author">Harshini Suresh, </li></ul><span class="cited-by__entry__title">Effectiveness of interventions to improve vaccine efficacy: a systematic review and meta-analysis, </span><span class="cited-by__entry__series-title">Systematic Reviews, </span><span class="cited-by__entry__volume"><strong>14</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1186/s13643-025-02856-6" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1186/s13643-025-02856-6</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1186/s13643-025-02856-6" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Katia Alves, </li><li class="list-inline-item cited-by__entry__author">Alex Kouassi, </li><li class="list-inline-item cited-by__entry__author">Joyce S. Plested, </li><li class="list-inline-item cited-by__entry__author">Raj Kalkeri, </li><li class="list-inline-item cited-by__entry__author">Katherine Smith, </li><li class="list-inline-item cited-by__entry__author">Muneer Kaba, </li><li class="list-inline-item cited-by__entry__author">Joy Nelson, </li><li class="list-inline-item cited-by__entry__author">Mingzhu Zhu, </li><li class="list-inline-item cited-by__entry__author">Shane Cloney-Clark, </li><li class="list-inline-item cited-by__entry__author">Zhaohui Cai, </li><li class="list-inline-item cited-by__entry__author">Raburn M. Mallory, </li><li class="list-inline-item cited-by__entry__author">Fernando Noriega, </li></ul><span class="cited-by__entry__title">Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study, </span><span class="cited-by__entry__series-title">Vaccine, </span><span class="cited-by__entry__volume"><strong>55</strong>, </span><span class="cited-by__entry__page-range">(127046), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.vaccine.2025.127046" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.vaccine.2025.127046</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.vaccine.2025.127046" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Hao Wu, </li><li class="list-inline-item cited-by__entry__author">Ruiqi Weng, </li><li class="list-inline-item cited-by__entry__author">Jiaxuan Li, </li><li class="list-inline-item cited-by__entry__author">Zhiwei Huang, </li><li class="list-inline-item cited-by__entry__author">Xiaotian Tie, </li><li class="list-inline-item cited-by__entry__author">Jianhua Li, </li><li class="list-inline-item cited-by__entry__author">Keda Chen, </li></ul><span class="cited-by__entry__title">Self-Assembling protein nanoparticle platform for multivalent antigen delivery in vaccine development, </span><span class="cited-by__entry__series-title">International Journal of Pharmaceutics, </span><span class="cited-by__entry__volume"><strong>676</strong>, </span><span class="cited-by__entry__page-range">(125597), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.ijpharm.2025.125597" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.ijpharm.2025.125597</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.ijpharm.2025.125597" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Pragya D Yadav, </li><li class="list-inline-item cited-by__entry__author">Deepak Y Patil, </li></ul><span class="cited-by__entry__title">Interim analysis of SARS-CoV-2 vaccine NVX-CoV2601 as a heterologous booster dose, </span><span class="cited-by__entry__series-title">The Lancet Infectious Diseases, </span><span class="cited-by__entry__volume"><strong>25</strong>, </span><span class="cited-by__entry__issue">5, </span><span class="cited-by__entry__page-range">(484-485), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/S1473-3099(25)00005-2" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/S1473-3099(25)00005-2</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/S1473-3099(25)00005-2" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Katia Alves, </li><li class="list-inline-item cited-by__entry__author">Karen Kotloff, </li><li class="list-inline-item cited-by__entry__author">R Scott McClelland, </li><li class="list-inline-item cited-by__entry__author">Alex Kouassi, </li><li class="list-inline-item cited-by__entry__author">Joyce S Plested, </li><li class="list-inline-item cited-by__entry__author">Raj Kalkeri, </li><li class="list-inline-item cited-by__entry__author">MingZhu Zhu, </li><li class="list-inline-item cited-by__entry__author">Shane Cloney-Clark, </li><li class="list-inline-item cited-by__entry__author">Zhaohui Cai, </li><li class="list-inline-item cited-by__entry__author">Katherine Smith, </li><li class="list-inline-item cited-by__entry__author">Muneer Kaba, </li><li class="list-inline-item cited-by__entry__author">Joy Nelson, </li><li class="list-inline-item cited-by__entry__author">E Adrianne Hammershaimb, </li><li class="list-inline-item cited-by__entry__author">Raburn M Mallory, </li><li class="list-inline-item cited-by__entry__author">Fernando Noriega, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Adelglass, </li><li class="list-inline-item cited-by__entry__author">Adebayo Akinsola, </li><li class="list-inline-item cited-by__entry__author">Brandon Alleman, </li><li class="list-inline-item cited-by__entry__author">Codey Bell, </li><li class="list-inline-item cited-by__entry__author">Laurence Chu, </li><li class="list-inline-item cited-by__entry__author">Matthew Davis, </li><li class="list-inline-item cited-by__entry__author">Sue Fanning, </li><li class="list-inline-item cited-by__entry__author">David Ferrera, </li><li class="list-inline-item cited-by__entry__author">George Freeman, </li><li class="list-inline-item cited-by__entry__author">Linda Gorgos, </li><li class="list-inline-item cited-by__entry__author">Ripley Hollister, </li><li class="list-inline-item cited-by__entry__author">Michael Jacobs, </li><li class="list-inline-item cited-by__entry__author">Craig Julien, </li><li class="list-inline-item cited-by__entry__author">Karen Kotloff, </li><li class="list-inline-item cited-by__entry__author">Robert Lockwood, </li><li class="list-inline-item cited-by__entry__author">R. Scott McClelland, </li><li class="list-inline-item cited-by__entry__author">Jara McDonald, </li><li class="list-inline-item cited-by__entry__author">Abel Murillo, </li><li class="list-inline-item cited-by__entry__author">Robert Noveck, </li><li class="list-inline-item cited-by__entry__author">Paul Pickrell, </li><li class="list-inline-item cited-by__entry__author">William Seger, </li><li class="list-inline-item cited-by__entry__author">Stacy Slechta, </li><li class="list-inline-item cited-by__entry__author">William Smith, </li><li class="list-inline-item cited-by__entry__author">Harry Studdard, </li><li class="list-inline-item cited-by__entry__author">Ronald Surowitz, </li><li class="list-inline-item cited-by__entry__author">Milagritos Tapia, </li><li class="list-inline-item cited-by__entry__author">Eduardo Uribe, </li><li class="list-inline-item cited-by__entry__author">Keith Vrbicky, </li><li class="list-inline-item cited-by__entry__author">Larkin Wadsworth, </li><li class="list-inline-item cited-by__entry__author">Kem Yenal, </li><li class="list-inline-item cited-by__entry__author">Pedro Ylisastigui, </li></ul><span class="cited-by__entry__title">Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study, </span><span class="cited-by__entry__series-title">The Lancet Infectious Diseases, </span><span class="cited-by__entry__volume"><strong>25</strong>, </span><span class="cited-by__entry__issue">5, </span><span class="cited-by__entry__page-range">(585-594), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/S1473-3099(24)00670-4" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/S1473-3099(24)00670-4</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/S1473-3099(24)00670-4" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry--see-more"><a href="javascript:void(0)" data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2116185%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2022.386.issue-6%3Bjournal%3Ajournal%3Anejms" class="cited-by__see-more">See more</a></li></ol></div><div class="cited-by__spinner justify-content-center align-items-center d-none"><div role="status" class="spinner-border text-gray"><span class="sr-only">Loading...</span></div></div></div></section>

        </div>
    

</section></section></div><div id="core-collateral-fulltext-options" role="tabpanel" data-core-tabs="core-collateral-fulltext-options" tabindex="-1" aria-labelledby="pane-core-collateral-fulltext-options"><header><h2 id="pane-core-collateral-fulltext-options"><i class="icon-eye" aria-hidden="true"></i>View Options</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div class="section--wrapper"><h3>View options</h3><section class="format--pdf"><h4> <abbr title="Portable Document Format">PDF</abbr></h4><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2116185" class="btn btn--pdf" aria-label="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2116185" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2116185.pdf"><i aria-hidden="true" class="icon-pdf"></i><span>View PDF</span></a></section></div><!-- Its needed to duplicate this for PB check Collateral.js as well--></div><div id="core-collateral-media" role="tabpanel" data-core-tabs="core-collateral-media" tabindex="-1" aria-labelledby="pane-core-collateral-media"><header><h2 id="pane-core-collateral-media"><i class="icon-photo" aria-hidden="true"></i>Media</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-figures" role="tab" id="tab-figures-label" aria-selected="true" class="active">Figures</button><button aria-controls="tab-other" role="tab" id="tab-other-label" tabindex="-1" aria-selected="false" class="inactive" aria-disabled="true">Other</button></div><section id="tab-figures" aria-labelledby="tab-figures-label" role="tabpanel" tabindex="0"><h3>Figures</h3><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#figures"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-f0"><figure class="graphic"><a class="open-in-viewer" href="#f0" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f0.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/b7302d10-3534-4e82-b303-ec5864588849/assets/images/large/nejmoa2116185_f0.jpg" height="3416" width="2640" aria-labelledby="f0" loading="lazy"></a><figcaption>Download a PDF of the <a href="#ap0">Research Summary</a>.</figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f0"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f0.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f1"><figure class="graphic"><a class="open-in-viewer" href="#f1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f1.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/83aa99a0-c09a-495e-97e9-ffb8a3711e31/assets/images/large/nejmoa2116185_f1.jpg" height="3343" width="2640" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Screening, Randomization, and Follow-up.</div><div class="notes"><div role="doc-footnote">The full analysis population included all participants who underwent randomization and received at least one dose of vaccine or placebo, regardless of protocol violations or missing data; participants in the full analysis population are included in the analysis according to the group to which they were randomly assigned. The safety analysis population included all participants who received at least one dose of vaccine or placebo. The per-protocol efficacy analysis population included all participants who underwent randomization and received both doses as assigned, were seronegative for anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein and had a SARS-CoV-2 RNA reverse-transcriptase–polymerase-chain-reaction (RT-PCR)–negative nasal swab at baseline, and did not have a censoring event at any time before 7 days after the second injection. Data from participants at two sites (193 assigned to receive NVX-CoV2373 and 93 assigned to receive placebo) were excluded from analyses because of Good Clinical Practice quality concerns. The window for the first dose of vaccine or placebo was December 20, 2020, to February 18, 2021.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f1"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f2"><figure class="graphic"><a class="open-in-viewer" href="#f2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f2.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/fad7cf1b-de92-43b1-8169-9e46f8f8da1d/assets/images/large/nejmoa2116185_f2.jpg" height="3399" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Overall Efficacy of NVX-CoV2373 against Covid-19.</div><div class="notes"><div role="doc-footnote">Shown is the cumulative incidence of symptomatic (mild, moderate, or severe) coronavirus disease 2019 (Covid-19). Panel A shows all participants in the full analysis population during the period of surveillance that started at the first dose of NVX-CoV2373 or placebo. Panel B shows all participants in the per-protocol efficacy analysis population during the period of surveillance starting 7 days after the second dose (i.e., up to 28 days after the first dose) through approximately 3 months of follow-up, until unblinding, or until receipt of a vaccine under emergency use authorization. Panel C shows all participants in the full analysis population during the period of surveillance that started 7 days after the second dose. Panel D shows all participants in the per-protocol efficacy analysis population with cases of Covid-19 due to variants that are not considered variants of concern (VOC) or variants of interest (VOI). Panel E shows all participants in the per-protocol efficacy analysis population with cases of Covid-19 due to VOC or VOI.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f2"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f3"><figure class="graphic"><a class="open-in-viewer" href="#f3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f3.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/ff51d420-fc15-47a3-bf05-300515e5b9ea/assets/images/large/nejmoa2116185_f3.jpg" height="1377" width="2640" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Vaccine Efficacy of NVX-CoV2373 in Specific Subgroups (Per-Protocol Efficacy Analysis Population).</div><div class="notes"><div role="doc-footnote">Vaccine efficacy was defined as 1 minus the relative risk (NVX-CoV2373 minus placebo). Non-White race included end-point cases in participants from all other races to ensure that these subgroups would be large enough for meaningful analyses. The assessment of coexisting conditions is based on the Centers for Disease Control and Prevention definitions<sup><a href="#core-r18" role="doc-biblioref" data-xml-rid="r18" id="core-body-ref-r18-3" href-manipulated="true" aria-label="Reference 18" data-to-manipulate="false">18</a></sup> of persons at risk for complications of Covid-19. Participants at overall high risk for Covid-19 included those 65 years of age or older and those of any age with chronic health conditions or an increased risk for Covid-19 because of work or living conditions.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f3"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f3.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f4"><figure class="graphic"><a class="open-in-viewer" href="#f4" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f4.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/b6d2d735-3357-45f6-acc5-1ec22fe11d6f/assets/images/large/nejmoa2116185_f4.jpg" height="3438" width="1717" aria-labelledby="f4" loading="lazy"></a><figcaption><div class="caption">Solicited Local and Systemic Adverse Events (Safety Analysis Population).</div><div class="notes"><div role="doc-footnote">The percentage of participants in each group with solicited local and systemic adverse events during the 7 days after each dose is plotted according to Food and Drug Administration toxicity grade, either as any grade (mild, moderate, severe, or potentially life-threatening) or as grade 3 or higher (severe or potentially life-threatening).<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19" id="core-body-ref-r19-2" href-manipulated="true" aria-label="Reference 19" data-to-manipulate="false">19</a></sup> An expanded x axis is used for events of grade 3 or higher to highlight differences between small percentages.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f4"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f4" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f4.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></section><section id="tab-other" aria-labelledby="tab-other-label" role="tabpanel" tabindex="-1"><h3>Other</h3></section></div><div id="core-collateral-tables" role="tabpanel" data-core-tabs="core-collateral-tables" tabindex="-1" aria-labelledby="pane-core-collateral-tables"><header><h2 id="pane-core-collateral-tables"><i class="icon-tables" aria-hidden="true"></i>Tables</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><!-- There is no content. --><div class="section--wrapper"><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#tables"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-t1"><figure class="table"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2116185_t1.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2116185/asset/1255cb77-e117-4314-8f64-a8caab2503d0/assets/images/large/nejmoa2116185_t1.jpg" height="2802" width="1999" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Characteristic</th><th class="txxx-borders">NVX-CoV2373<br>(N=17,312)</th><th class="txxx-borders">Placebo<br>(N=8140)</th><th class="txxr-borders">Total<br>(N=25,452)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging03 shading" data-xml-align="left">Median age (range) — yr</td><td class="xxxx-borders shading">47.0 (18–95)</td><td class="xxxx-borders shading">47.0 (18–90)</td><td class="xxxr-borders shading">47.0 (18–95)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Age group — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">18 to 64 yr</td><td class="xxxx-borders shading">15,264 (88.2)</td><td class="xxxx-borders shading">7,194 (88.4)</td><td class="xxxr-borders shading">22,458 (88.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">≥65 yr</td><td class="xxxx-borders">2,048 (11.8)</td><td class="xxxx-borders">946 (11.6)</td><td class="xxxr-borders">2,994 (11.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Sex — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Male</td><td class="xxxx-borders">9,050 (52.3)</td><td class="xxxx-borders">4,131 (50.7)</td><td class="xxxr-borders">13,181 (51.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Female</td><td class="xxxx-borders shading">8,262 (47.7)</td><td class="xxxx-borders shading">4,009 (49.3)</td><td class="xxxr-borders shading">12,271 (48.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Race or ethnic group — no. (%)<a href="#core-t1fn2" role="doc-noteref">†</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">White</td><td class="xxxx-borders shading">13,140 (75.9)</td><td class="xxxx-borders shading">6,184 (76.0)</td><td class="xxxr-borders shading">19,324 (75.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Black or African American</td><td class="xxxx-borders">1,893 (10.9)</td><td class="xxxx-borders">900 (11.1)</td><td class="xxxr-borders">2,798 (11.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">American Indian or Alaska Native, including Mexican Natives</td><td class="xxxx-borders shading">1,074 (6.2)</td><td class="xxxx-borders shading">498 (6.1)</td><td class="xxxr-borders shading">1,572 (6.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Asian</td><td class="xxxx-borders">761 (4.4)</td><td class="xxxx-borders">366 (4.5)</td><td class="xxxr-borders">1,127 (4.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Multiple</td><td class="xxxx-borders shading">293 (1.7)</td><td class="xxxx-borders shading">132 (1.6)</td><td class="xxxr-borders shading">425 (1.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Native Hawaiian or other Pacific Islander</td><td class="xxxx-borders">47 (0.3)</td><td class="xxxx-borders">10 (0.1)</td><td class="xxxr-borders">57 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Not reported</td><td class="xxxx-borders shading">104 (0.6)</td><td class="xxxx-borders shading">45 (0.6)</td><td class="xxxr-borders shading">149 (0.6)</td></tr><tr data-type="row"><td class="xxlx-borders hanging13">Hispanic or Latino</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">No</td><td class="xxxx-borders shading">13,538 (78.2)</td><td class="xxxx-borders shading">6,379 (78.4)</td><td class="xxxr-borders shading">19,917 (78.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">Yes</td><td class="xxxx-borders">3,733 (21.6)</td><td class="xxxx-borders">1,751 (21.5)</td><td class="xxxr-borders">5,484 (21.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">Not reported</td><td class="xxxx-borders shading">22 (0.1)</td><td class="xxxx-borders shading">9 (0.1)</td><td class="xxxr-borders shading">31 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">Unknown</td><td class="xxxx-borders">19 (0.1)</td><td class="xxxx-borders">1 (&lt;0.1)</td><td class="xxxr-borders">20 (0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Overall high risk of Covid-19 — no. (%)<a href="#core-t1fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Yes</td><td class="xxxx-borders">16,493 (95.3)</td><td class="xxxx-borders">7,737 (95.0)</td><td class="xxxr-borders">24,230 (95.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">No</td><td class="xxxx-borders shading">819 (4.7)</td><td class="xxxx-borders shading">403 (5.0)</td><td class="xxxr-borders shading">1,222 (4.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">High risk of severe Covid-19 — no. (%)<a href="#core-t1fn4" role="doc-noteref">§</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Yes</td><td class="xxxx-borders shading">9,046 (52.3)</td><td class="xxxx-borders shading">4,294 (52.8)</td><td class="xxxr-borders shading">13,340 (52.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">No</td><td class="xxxx-borders">8,266 (47.7)</td><td class="xxxx-borders">3,846 (47.2)</td><td class="xxxr-borders">12,112 (47.6)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Coexisting conditions — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Any</td><td class="xxxx-borders">8,117 (46.9)</td><td class="xxxx-borders">3,910 (48.0)</td><td class="xxxr-borders">12,027 (47.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Obesity</td><td class="xxxx-borders shading">6,400 (37.0)</td><td class="xxxx-borders shading">3,070 (37.7)</td><td class="xxxr-borders shading">9,470 (37.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Chronic lung disease</td><td class="xxxx-borders">2,442 (14.1)</td><td class="xxxx-borders">1,218 (15.0)</td><td class="xxxr-borders">3,660 (14.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Diabetes mellitus type 2</td><td class="xxxx-borders shading">1,303 (7.5)</td><td class="xxxx-borders shading">677 (8.3)</td><td class="xxxr-borders shading">1,980 (7.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Cardiovascular disease</td><td class="xxxx-borders">191 (1.1)</td><td class="xxxx-borders">91 (1.1)</td><td class="xxxr-borders">282 (1.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Chronic kidney disease</td><td class="xxxx-borders shading">109 (0.6)</td><td class="xxxx-borders shading">50 (0.6)</td><td class="xxxr-borders shading">159 (0.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging03" data-xml-align="left">HIV infection — no. (%)</td><td class="xxxx-borders">128 (0.7)</td><td class="xxxx-borders">38 (0.5)</td><td class="xxxr-borders">166 (0.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Country — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">United States</td><td class="xxxx-borders">16,294 (94.1)</td><td class="xxxx-borders">7,638 (93.8)</td><td class="xxxr-borders">23,932 (94.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging13 shading" data-xml-align="left">Mexico</td><td class="xbxx-borders shading">1,018 (5.9)</td><td class="xbxx-borders shading">502 (6.2)</td><td class="xbxr-borders shading">1,520 (6.0)</td></tr></tbody></table></div><figcaption><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t1fn1" role="paragraph" data-to-manipulate="true">The per-protocol efficacy analysis population included all participants who underwent randomization and received both doses as assigned, were seronegative for anti–SARS-CoV-2 nucleoprotein and had a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA RT-PCR–negative nasal swab at baseline, and did not have a censoring event at any time before 7 days after the second injection. HIV denotes human immunodeficiency virus.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t1fn2" role="paragraph" data-to-manipulate="true">Race and ethnic group were reported by the participants.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="core-t1fn3" role="paragraph" data-to-manipulate="true">Participants at overall high risk included those 65 years of age or older and those of any age with chronic health conditions or an increased risk for Covid-19 because of work or living conditions.</div></div><div role="doc-footnote" data-has="label"><div class="label">§</div><div id="core-t1fn4" role="paragraph" data-to-manipulate="true">Participants were classified as having a high risk of severe Covid-19 if they had one or more of the following coexisting conditions: obesity (defined as a body-mass index [the weight in kilograms divided by the square of the height in meters] of ≥30.0), chronic lung disease, diabetes mellitus type 2, cardiovascular disease, or chronic kidney disease.</div></div></div></figcaption></a><figcaption><div class="caption">Demographic and Clinical Characteristics of the Participants at Baseline (Per-Protocol Efficacy Analysis Population).<a href="#core-t1fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t1"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2116185_t1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></div></div><div id="core-collateral-share" role="tabpanel" data-core-tabs="core-collateral-share" tabindex="-1" aria-labelledby="pane-core-collateral-share"><header><h2 id="pane-core-collateral-share"><i class="icon-share" aria-hidden="true"></i>Share</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>Share</h3><div class="section--wrapper"><section><h4>CONTENT LINK</h4><div id="share-self"><p data-id="article-share-self-link" class="share-self__source">https://www.nejm.org/doi/full/10.1056/NEJMoa2116185</p><button data-id="article-share-access" aria-label="CONTENT LINK" class="share-self__action btn btn--inverse"><i aria-hidden="true" class="icon-copy-o"></i><span>Copy Link</span></button><div aria-live="polite" class="share-self__status"><p class="share-self__success"><i aria-hidden="true" class="icon-check_circle"></i><span>Copied!</span></p><p class="share-self__failed"><i aria-hidden="true" class="icon-x_btnclose"></i><span>Copying failed.</span></p></div></div></section><section data-location="share_tools_article"><h4>Share</h4><div class="share-buttons a2a a2a_kit" style="line-height: 16px;"><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i><span>Facebook</span></a><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i><span>X (formerly Twitter)</span></a><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i><span>LinkedIn</span></a><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i><span>email</span></a><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i><span>Bluesky</span></a></div></section></div></div><div data-location="references_article" id="core-collateral-references" role="tabpanel" aria-labelledby="pane-core-collateral-references" data-core-tabs="core-collateral-references" tabindex="-1"><header><h2 id="pane-core-collateral-references"><i aria-hidden="true" class="icon-references"></i>References</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>References</h3><div role="list" class="section--wrapper"><div role="listitem" data-has="label"><div class="label">1.</div><div id="core-r1" class="citations"><div class="citation"><div class="citation-content">Slaoui M, Hepburn M. Developing safe and effective Covid vaccines — Operation Warp Speed’s strategy and approach. <em>N Engl J Med</em> 2020;383:1701-1703.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r1-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_2_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMp2027405&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32846056/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000587740100007" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Developing+safe+and+effective+Covid+vaccines+%E2%80%94+Operation+Warp+Speed%E2%80%99s+strategy+and+approach.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=1701-1703&amp;doi=10.1056%2FNEJMp2027405&amp;pmid=32846056" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r1-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r1-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] response in vaccine development. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] (FDA) and funding agency guidance, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="core-r2" class="citations"><div class="citation"><div class="citation-content">Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. <em>N Engl J Med</em> 2021;384:403-416.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r2-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_3_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2035389&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33378609/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000629333200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+the+mRNA-1273+SARS-CoV-2+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=403-416&amp;doi=10.1056%2FNEJMoa2035389&amp;pmid=33378609" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r2-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] on the ancestral strain, as an antigen. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r2-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] been reported for other Covid-19 vaccines. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] messenger RNA vaccines in the United States </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="core-r3" class="citations"><div class="citation"><div class="citation-content">Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <em>N Engl J Med</em> 2020;383:2603-2615.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2034577&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33301246/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000605648000010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2603-2615&amp;doi=10.1056%2FNEJMoa2034577&amp;pmid=33301246" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] on the ancestral strain, as an antigen. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] messenger RNA vaccines in the United States </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="core-r4" class="citations"><div class="citation"><div class="citation-content">Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. <em>Lancet</em> 2021;397:671-681.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)00234-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33545094/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000620991800029" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+an+rAd26+and+rAd5+vector-based+heterologous+prime-boost+COVID-19+vaccine%3A+an+interim+analysis+of+a+randomised+controlled+phase+3+trial+in+Russia.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=671-681&amp;doi=10.1016%2FS0140-6736%2821%2900234-8&amp;pmid=33545094" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="core-r5" class="citations"><div class="citation"><div class="citation-content">Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. <em>Lancet</em> 2021;397:99-111.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(20)32661-1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33306989/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000607269000027" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+ChAdOx1+nCoV-19+vaccine+%28AZD1222%29+against+SARS-CoV-2%3A+an+interim+analysis+of+four+randomised+controlled+trials+in+Brazil%2C+South+Africa%2C+and+the+UK.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=99-111&amp;doi=10.1016%2FS0140-6736%2820%2932661-1&amp;pmid=33306989" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="core-r6" class="citations"><div class="citation"><div class="citation-content">SARS-CoV-2 variant classifications and definitions. Atlanta: Centers for Disease Control and Prevention, 2021 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html">https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r6-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variant+classifications+and+definitions&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r6-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r8-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] of concern or variants of interest). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r6-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] at the time of end-point case accrual, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r8-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] protein–based vaccine-induced immunity. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="core-r7" class="citations"><div class="citation"><div class="citation-content">Harvey WT, Carabelli AM, Jackson B, et al. SARS-CoV-2 variants, spike mutations and immune escape. <em>Nat Rev Microbiol</em> 2021;19:409-424.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r7-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41579-021-00573-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34075212/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000656810800002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants%2C+spike+mutations+and+immune+escape.&amp;publication_year=2021&amp;journal=Nat+Rev+Microbiol&amp;pages=409-424&amp;doi=10.1038%2Fs41579-021-00573-0&amp;pmid=34075212" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r7-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r8-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] of concern or variants of interest). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r8-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] protein–based vaccine-induced immunity. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="core-r8" class="citations"><div class="citation"><div class="citation-content">Krause PR, Fleming TR, Longini IM, et al. SARS-CoV-2 variants and vaccines. <em>N Engl J Med</em> 2021;385:179-186.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r8-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_9_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMsr2105280&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34161052/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000667320500001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+and+vaccines.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=179-186&amp;doi=10.1056%2FNEJMsr2105280&amp;pmid=34161052" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r8-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r8-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] of concern or variants of interest). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r8-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] protein–based vaccine-induced immunity. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="core-r9" class="citations"><div class="citation"><div class="citation-content">Holder J. Tracking coronavirus vaccinations around the world. <em>New York Times</em>. 2021 (<a href="https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html">https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r9"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Tracking+coronavirus+vaccinations+around+the+world.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="core-r10" class="citations"><div class="citation"><div class="citation-content">Keech C, Albert G, Cho I, et al. Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine. <em>N Engl J Med</em> 2020;383:2320-2332.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_11_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2026920&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32877576/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000627165900011" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Phase+1%E2%80%932+trial+of+a+SARS-CoV-2+recombinant+spike+protein+nanoparticle+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2320-2332&amp;doi=10.1056%2FNEJMoa2026920&amp;pmid=32877576" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="core-r11" class="citations"><div class="citation"><div class="citation-content">Formica N, Mallory R, Albert G, et al. Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: a phase 2 randomized placebo-controlled trial. <em>PLoS Med</em> 2021;18(10):e1003769-e1003769.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1003769" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34597298/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000750871900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Different+dose+regimens+of+a+SARS-CoV-2+recombinant+spike+protein+vaccine+%28NVX-CoV2373%29+in+younger+and+older+adults%3A+a+phase+2+randomized+placebo-controlled+trial.&amp;publication_year=2021&amp;journal=PLoS+Med&amp;pages=e1003769-e1003769&amp;doi=10.1371%2Fjournal.pmed.1003769&amp;pmid=34597298" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="core-r12" class="citations"><div class="citation"><div class="citation-content">Shinde V, Bhikha S, Hoosain Z, et al. Efficacy of NVX-CoV2373 Covid-19 vaccine against the B.1.351 variant. <em>N Engl J Med</em> 2021;384:1899-1909.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r12-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_13_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2103055&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33951374/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647808400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+NVX-CoV2373+Covid-19+vaccine+against+the+B.1.351+variant.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1899-1909&amp;doi=10.1056%2FNEJMoa2103055&amp;pmid=33951374" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r12-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] concern in a phase 2b trial in South Africa </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] of variants beyond the prototype strain. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="core-r13" class="citations"><div class="citation"><div class="citation-content">Heath PT, Galiza EP, Baxter DN, et al. Safety and efficacy of the NVX-CoV2373 Covid-19 vaccine. <em>N Engl J Med</em> 2021;385:1172-1183.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r13-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_14_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2107659&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34192426/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000669588900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+NVX-CoV2373+Covid-19+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1172-1183&amp;doi=10.1056%2FNEJMoa2107659&amp;pmid=34192426" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r13-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r13-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] in a phase 3 trial in the United Kingdom. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r13-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 3 trial conducted in the United Kingdom </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r13-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] similar to that among younger adults. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="core-r14" class="citations"><div class="citation"><div class="citation-content">Nexstrain. Genomic epidemiology of novel coronavirus — global subsampling. 2021 (<a href="https://nextstrain.org/ncov/gisaid/global">https://nextstrain.org/ncov/gisaid/global</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r14-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Genomic+epidemiology+of+novel+coronavirus+%E2%80%94+global+subsampling&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r14-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r14-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and B.1.429 (epsilon), and B.1.526 (iota). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] were alpha, beta, gamma, epsilon, and iota. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] throughout the United States or Mexico, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="core-r15" class="citations"><div class="citation"><div class="citation-content">Guidance for industry: development and licensure of vaccines to prevent COVID-19. Silver Spring, MD: Food and Drug Administration, June 2020 (<a href="https://www.fda.gov/media/139638/download">https://www.fda.gov/media/139638/download</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r15-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Guidance+for+industry%3A+development+and+licensure+of+vaccines+to+prevent+COVID-19&amp;publication_year=2020" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r15-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r15-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] (FDA) and funding agency guidance, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] (defined with the use of FDA criteria </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for vaccine efficacy of 50% or greater. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] requested for emergency use authorization </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="core-r16" class="citations"><div class="citation"><div class="citation-content">Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&amp;D. <em>Science</em> 2020;368:948-950.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abc5312" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32393526/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000538332600030" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+strategic+approach+to+COVID-19+vaccine+R%26D.&amp;publication_year=2020&amp;journal=Science&amp;pages=948-950&amp;doi=10.1126%2Fscience.abc5312&amp;pmid=32393526" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="core-r17" class="citations"><div class="citation"><div class="citation-content">Joffe S, Babiker A, Ellenberg SS, et al. Data and safety monitoring of COVID-19 vaccine clinical trials. <em>J Infect Dis</em> 2021 May 19 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiab263" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34008027/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000753487400002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Data+and+safety+monitoring+of+COVID-19+vaccine+clinical+trials.&amp;publication_year=2021&amp;journal=J+Infect+Dis&amp;doi=10.1093%2Finfdis%2Fjiab263&amp;pmid=34008027" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="core-r18" class="citations"><div class="citation"><div class="citation-content">People with certain medical conditions. Atlanta: Centers for Disease Control and Prevention, 2021 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html">https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r18-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=People+with+certain+medical+conditions&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r18-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r18-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] complications according to CDC criteria, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r18-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] Latino. One or more coexisting conditions </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f3" role="menuitem" data-target="#fv-body-ref-r18-3"><i aria-hidden="true" class="icon-return"></i><span>c [...] Disease Control and Prevention definitions </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="core-r19" class="citations"><div class="citation"><div class="citation-content">Center for Biologics Evaluation and Research. Guidance for industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. Silver Spring, MD: Food and Drug Administration, September 2007 (<a href="https://www.fda.gov/media/73679/download">https://www.fda.gov/media/73679/download</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r19-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Guidance+for+industry%3A+toxicity+grading+scale+for+healthy+adult+and+adolescent+volunteers+enrolled+in+preventive+vaccine+clinical+trials&amp;publication_year=2007" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r19-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] for severity (according to FDA criteria </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f4" role="menuitem" data-target="#fv-body-ref-r19-2"><i aria-hidden="true" class="icon-return"></i><span>b [...] (severe or potentially life-threatening). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="core-r20" class="citations"><div class="citation"><div class="citation-content">Coronavirus (COVID-19) update. Silver Spring, MD: Food and Drug Administration, July 13, 2021 (<a href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-13-2021">https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-13-2021</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r20-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Coronavirus+%28COVID-19%29+update&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r20-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] No episodes of the Guillain–Barré syndrome </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] observation with other Covid-19 vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="core-r21" class="citations"><div class="citation"><div class="citation-content">Myocarditis and pericarditis after mRNA COVID-19 vaccination. Atlanta: Centers for Disease Control and Prevention, 2021 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html">https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r21-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Myocarditis+and+pericarditis+after+mRNA+COVID-19+vaccination&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r21-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r21-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] no imbalance in myocarditis or pericarditis </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] observation with other Covid-19 vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="core-r22" class="citations"><div class="citation"><div class="citation-content">Hunter PR. Thrombosis after covid-19 vaccination. <em>BMJ</em> 2021;373:n958-n958.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r22-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.n958" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33853865/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640565900003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Thrombosis+after+covid-19+vaccination.&amp;publication_year=2021&amp;journal=BMJ&amp;pages=n958-n958&amp;doi=10.1136%2Fbmj.n958&amp;pmid=33853865" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r22-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r22-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] immune thrombosis with thrombocytopenia </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] observation with other Covid-19 vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="core-r23" class="citations"><div class="citation"><div class="citation-content">Falsey AR, Sobieszczyk ME, Hirsch I, et al. Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine. <em>N Engl J Med</em> 2021;385:2348-2360.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r23"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_24_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2116185&amp;key=10.1056%2FNEJMoa2105290&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34587382/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000701157100001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Phase+3+safety+and+efficacy+of+AZD1222+%28ChAdOx1+nCoV-19%29+Covid-19+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=2348-2360&amp;doi=10.1056%2FNEJMoa2105290&amp;pmid=34587382" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="core-r24" class="citations"><div class="citation"><div class="citation-content">Follmann D, Fintzi J, Fay MP, et al. A deferred-vaccination design to assess durability of COVID-19 vaccine effect after the placebo group is vaccinated. <em>Ann Intern Med</em> 2021;174:1118-1125.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.7326/M20-8149" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33844575/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000695277800022" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+deferred-vaccination+design+to+assess+durability+of+COVID-19+vaccine+effect+after+the+placebo+group+is+vaccinated.&amp;publication_year=2021&amp;journal=Ann+Intern+Med&amp;pages=1118-1125&amp;doi=10.7326%2FM20-8149&amp;pmid=33844575" target="_blank">Google Scholar</a></div></div></div></div></div></div></div></div><aside data-core-aside="right-rail">



        
        <div id="DTM_Position_MedRectangle" class="ad">
 <!--emptycomment-->
</div>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="relatedArticlesWidget" data-widget-id="8206d5cd-cb8c-4ff9-8c46-3d22e0dee215" data-location="recirc_curatedRelated_article">
        



        
        

        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <div id="nejm_jobs" class="nejm_jobs"> <!-- top red rectangle --><div id="nejm-widget" class="nejm-widget" style="display: block;"><div class="nejm-widget_logo">	<a target="nejm-win" href="https://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" src="https://apps1.nejmcareercenter.org/images/nejmCCID-JobsWidget.gif" width="140" height="36">	</a></div><div class="nejm-widget_cont"> <!-- content --><div class="nejm-widget_title">PHYSICIAN JOBS</div><div class="nejm-widget_date">June 10, 2025</div><div class="nejm-widget_item"><div><span> Danbury, Connecticut</span></div><div><span>Hematology / Oncology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/891336/hematologist-opportunity-danbury-connecticut-60-miles-from-new-york-city/?query=fjwp&amp;rid=12925">Hematologist Opportunity - Danbury, Connecticut - 60 Miles From New York City</a></div></div><div class="nejm-widget_item"><div><span> Loma Linda, California</span></div><div><span>Hematology / Oncology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/883932/academic-medical-hematologist-oncologist-opportunity-in-southern-california/?query=fjwp&amp;rid=69418">Academic Medical Hematologist/Oncologist Opportunity in Southern California</a></div></div><div class="nejm-widget_item"><div><span> Massachusetts</span></div><div><span>Anesthesiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/883455/anesthesiologist-and-academic-appointment-umass-chan-medical/?query=fjwf&amp;rid=705">Anesthesiologist and Academic Appointment - UMass Chan Medical</a></div></div><div class="nejm-widget_item"><div><span> Illinois</span></div><div><span>Hematology / Oncology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/888986/medical-oncology-700k-never-ending-base-salary-30-min-to-champaign-il/?query=fjwf&amp;rid=5263">Medical Oncology | $700K Never-Ending Base Salary | 30 min to Champaign, IL</a></div></div><div class="nejm-widget_item"><div><span> Illinois</span></div><div><span>Emergency Medicine</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/880514/emergency-medicine-nocturnist-part-time-position-in-illinois-150k-loan-repay/?query=fjwf&amp;rid=5127">Emergency Medicine - Nocturnist Part-Time Position in Illinois - 150K Loan Repay</a></div></div><div class="nejm-widget_item"><div><span> Carmel, Indiana</span></div><div><span>Hospitalist</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/887222/hospitalist-day-float-position-with-variety-of-schedule-options/?query=fjwf&amp;rid=227332">Hospitalist: Day Float position with variety of schedule options</a></div></div></div> <!-- content --> <!-- footer --></div> <!-- nejm-widget --></div><script src="https://apps1.nejmcareercenter.org/?width=300&amp;sp=all"></script>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="literatumAd" data-widget-id="001e4aa7-b6fe-4b21-9d5b-5bde81227c67" id="ad-article-right-rail-300x250-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <a href="/action/clickThrough?id=128720&amp;url=https%3A%2F%2Fstore.nejm.org%2Fsignup%2Fnejmai%2Fregister%2Faifallpdf24%3Fpromo%3DOAFQF4NA%26query%3Dcm-rr%26utm_source%3Dnejm%26utm_medium%3Dcm%26utm_campaign%3Daifallpdf24&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2116185&amp;pubId=41284168&amp;placeholderId=101337&amp;productId=1007" target="_blank"><img src="/sda/128720/NEJ-AI-Fall24-300x250---002.jpg" width="300" height="250"></a>
            
        </div>
    

    

    



        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <script src="https://widgets.nejm.org/onepub-widgets/loader/webcomponents-loader.js" async="" nonce="94d6bd5503420304-SJC">
<script src="https://widgets.nejm.org/onepub-widgets/loader/polyfill-support.js"  nonce="94d6bd5503420304-SJC"></script>
<script src="https://widgets.nejm.org/onepub-widgets/more-like-this.js" type="module" nonce="94d6bd5503420304-SJC"></script>

<more-like-this class="onepub-widget" dataid="onepub-more-like-this" collections="catalyst-article, clinician-article, evidence-article, nejm-ai-article, nejm-article" headertitle="More Like This" maxitems="5"><!----><div class="more-like-this onepub-more-like-this_"><!--?lit$532749496$--><onepub-fonts><wc-fetch></wc-fetch><!--?lit$532749496$--><div class="mlt-wrapper"><div class="mlt-header-container"><div class="mlt-header-content-left"><div class="mlt-header-title-container"><span class="mlt-header-title">More Like This</span></div><!--?lit$532749496$--></div></div><div class="mlt-body"><!--?lit$532749496$--><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$532749496$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$532749496$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$532749496$-->Sep 23, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2107659?query=recirc_Semantic" target="_self">Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine</a></div><div class="mlt-article-authors"><!--?lit$532749496$-->P.T. Heath and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$532749496$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$532749496$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$532749496$-->May 20, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2103055?query=recirc_Semantic" target="_self">Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant</a></div><div class="mlt-article-authors"><!--?lit$532749496$-->V. Shinde and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$532749496$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$532749496$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$532749496$-->Dec 10, 2020</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2026920?query=recirc_Semantic" target="_self">Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine</a></div><div class="mlt-article-authors"><!--?lit$532749496$-->C. Keech and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$532749496$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$532749496$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$532749496$-->Feb 16, 2023</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2211031?query=recirc_Semantic" target="_self">Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age</a></div><div class="mlt-article-authors"><!--?lit$532749496$-->F.M. Muñoz and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$532749496$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$532749496$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$532749496$-->Nov 17, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2210058?query=recirc_Semantic" target="_self">Covid-19 Vaccine Protection among Children and Adolescents in Qatar</a></div><div class="mlt-article-authors"><!--?lit$532749496$-->H. Chemaitelly and Others</div></div><!----></div><div class="mlt-footer"></div></div></onepub-fonts><style>:host{display:block}@keyframes fadeIn{0%{opacity:0}100%{opacity:1}}.more-like-this{max-width:25rem}.more-like-this *{font-variant-numeric:lining-nums}.mlt-wrapper{animation:fadeIn 1s}.mlt-header-container{border-bottom:#4d4d4d solid .0625rem;border-top:#4d4d4d solid .125rem}.mlt-header-title{color:#1a1a1a;display:block;font-family:var(--sans-serif);font-size:1rem;font-weight:700;letter-spacing:.02rem;line-height:1.5rem;padding-bottom:.94rem;padding-top:.94rem;text-transform:uppercase}.mlt-header-description{color:#333;display:block;font-family:ff-scala-sans-pro;font-size:.75rem;letter-spacing:.05rem;margin-top:-.5rem;padding-bottom:1rem;text-transform:uppercase}.mlt-article-container{border-bottom:#e5e5e5 solid .0625rem;margin-top:1.38rem}.mlt-article-container-header{font-family:var(--sans-serif);font-size:.6875rem;letter-spacing:.04em;line-height:1.125rem;margin:0 0 1rem;text-transform:uppercase}.mlt-article-type{font-weight:700;line-height:1.25rem;letter-spacing:.04rem;text-decoration:none}.mlt-article-type:hover{text-decoration:underline}.nejm{color:#f30}.nejm-ai{color:#006197}.nejm-catalyst{color:#5708a6}.nejm-evidence{color:#69a323}.mlt-article-site-label::after,.mlt-article-type::after{border-right:1px solid #e5e5e5;content:'';display:inline;padding:.1875rem .375rem .125rem 0;margin:0 .375rem 0 0}.mlt-article-pubdate{color:#666;font-style:normal;font-weight:700;line-height:1.25rem;letter-spacing:.04em}.mlt-article-authors{color:#666;font-family:var(--sans-serif);font-size:1rem;font-style:normal;font-weight:400;letter-spacing:normal;line-height:1.5rem;margin-bottom:1.38rem}.mlt-article-site-label{color:#666;font-style:normal;font-weight:700;letter-spacing:.04em}.mlt-article-title{margin-bottom:.5rem}.mlt-article-title>a{background-image:linear-gradient(#f30,#f30);background-position:0 90%;background-repeat:no-repeat;background-size:0 0;color:#1a1a1a;font-family:var(--quadraat-web);font-size:1.25rem;font-style:normal;font-weight:700;letter-spacing:normal;line-height:1.8rem;margin:1.5rem 0 .35rem 0;text-decoration:none;transition:background .25s ease-in-out}.mlt-article-title>a:hover{background-position:0 98%;background-size:100% .125rem;text-decoration:none}.skeleton-card{box-shadow:0 0 4px 1px rgba(0,0,0,.1);margin:1rem 0;padding:1rem}</style></div></more-like-this>




        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>










    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="ad06db99-f228-4c92-9ad7-c4ae0fdbdbf1" id="bc-web-rec">
        



        
        <!-- BlueConic TEST empty HTML widget with DIV wrapper with id=bc-web-rec -->

        </div>
    

</aside></article><div data-extent="article-wrapper"><div class="core-container"></div><div class="after-credits"><div class="core-container"><a href="/doi/pdf/10.1056/NEJMoa2116185?download=true" id="downloadPdfUrl" data-doi="10.1056/NEJMoa2116185" data-behavior="trackDownloadEvent" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2116185.pdf"><span>Download PDF</span></a></div></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1056/NEJMoa2116185"}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><div class="articles-nav"></div><template id="figure_nav_template"><nav><a href="#" title="Open in viewer" class="open-in-viewer"><i aria-hidden="true" class="icon-expand"></i></a></nav></template><template id="fv_panel_template" data-sharesocial="Share"><div class="fv__panel js--hidden"><div class="fv__panel__text"><div class="fv__panel__contentTitle"></div><div class="fv__panel__contentText"></div></div></div></template>
<template id="fv_directory_template" data-overlay="View figure"><div class="fv__directory"><div class="fv__header"><nav class="tab__nav"></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"></div></div></template><template id="fv_directory_tabItem_template" data-figures="Figures" data-others="Others" data-tables="Tables"><button role="tab" data-toggle="tab" class="tab__nav__item"></button></template>
<template id="fv_lightbox_template" data-sr-back="Go to figure location within the article" data-sr-closealt="Close" data-sr-download="Toggle download panel" data-sr-download-pptx="Download PPT" data-sr-info="Toggle information panel" data-sr-panel="Close panel" data-sr-share="Toggle share panel" data-sr-zoom="Zoom" data-text-close="Back to article" data-text-nav-figures="All figures" data-text-nav-others="All others" data-text-nav-tables="All tables" data-text-viewall="View all material" data-title-back="Back to article" data-title-closealt="Close" data-title-download="Download" data-title-download-pptx="Download PPT" data-title-info="Info" data-title-share="Share" data-title-zoom="Zoom"></template>
<template id="fv_toolbar_template"><div class="fv__toolbar__info"><strong class="fv__toolbar__contentTitle uppercase"></strong><p class="fv__toolbar__contentText"></p></div></template><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-references="References" data-figure="Go to Figure" data-media="Go to Media" data-more="More" data-original="Go to original" data-table="Go to Table" data-inviewer="Open in Viewer" data-allinviewer="Open all in viewer"><svg data-tags="copyright" viewBox="0 0 24 24"><path d="M12 20.016q3.281 0 5.648-2.368T20.016 12t-2.368-5.648T12 3.984 6.352 6.352 3.984 12t2.368 5.648T12 20.016zm0-18q4.125 0 7.055 2.93T21.985 12t-2.93 7.055T12 21.985t-7.055-2.93T2.015 12t2.93-7.055T12 2.015zm-.14 7.125q-1.876 0-1.876 2.718v.282q0 2.718 1.875 2.718.704 0 1.172-.398t.469-1.008h1.781q0 1.172-1.031 2.063-.984.843-2.39.843-1.876 0-2.86-1.125t-.984-3.093v-.282q0-1.921.937-3 1.125-1.265 2.906-1.265 1.547 0 2.438.89.984.985.984 2.297H13.5q0-.328-.14-.61-.235-.468-.329-.562-.469-.468-1.172-.468z"></path></svg><span>Request permissions</span><i aria-hidden="true" class="icon-open_in_new"></i></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template>

        <div role="navigation" aria-label="Sticky Navigation" class="st-header"><div class="st-header__content"><div class="st-header__item st-header__menu"></div><div class="st-header__current st-header__item"><div class="st-header__label">Now Reading:</div><div class="st-header__title">Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico</div></div><div class="st-header__share st-header__item"><div class="share-dropblock dropdown"><a id="sticky-header-dropBlock" href="#" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="dropdown-toggle"><span title="" data-toggle="tooltip" data-trigger="hover" data-original-title="Share options"><span class="sr-only">Share</span><i aria-hidden="true" class="icon-share"></i></span></a><div aria-labelledby="sticky-header-dropBlock" data-location="share_tools_article" class="dropdown-menu"><ul class="rlist--inline a2a a2a_kit" style="line-height: 16px;"><li><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i></a></li><li><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i></a></li><li><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i></a></li><li><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i></a></li><li><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i></a></li></ul></div></div></div><div class="st-header__nav st-header__item"><div class="content-navigation"><a href="/doi/full/10.1056/NEJMoa2108337" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>PREVIOUS ARTICLE</h6><div>Cemented or Uncemented Hemiarthroplasty for Intracapsular Hip Fracture</div></div></div><i aria-hidden="true" class="icon-arrow-left"></i><span>Previous</span></a><a href="/doi/full/10.1056/NEJMoa2112187" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>NEXT ARTICLE</h6><div>Survival with Cemiplimab in Recurrent Cervical Cancer</div></div></div><span>Next</span><i aria-hidden="true" class="icon-arrow-right"></i></a></div></div></div><div class="st-header__track"><div id="progress-tracker" class="st-header__tracker" style="width: 0px;"></div></div></div><div class="fv figureViewer js--has-focus-mode"><div class="fv__directory" data-core-tabs="default" style="display: flex;"><div class="fv__header"><nav class="tab__nav" role="tablist"><button role="tab" data-toggle="tab" class="tab__nav__item active" aria-controls="#tab-pane-figures" aria-selected="true">Figures</button><button role="tab" data-toggle="tab" class="tab__nav__item" aria-controls="#tab-pane-tables" tabindex="-1" aria-selected="false">Tables</button></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"><div class="tab__pane fv__list fv__list--figures" id="tab-pane-figures" aria-label="All figures" tabindex="0" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f0" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f0.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/b7302d10-3534-4e82-b303-ec5864588849/assets/images/large/nejmoa2116185_f0.jpg" height="3416" width="2640" aria-labelledby="f0" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title"></div><div class="fv__item__description"><figcaption>Download a PDF of the <a href="#ap0">Research Summary</a>.</figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f1" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f1.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/83aa99a0-c09a-495e-97e9-ffb8a3711e31/assets/images/large/nejmoa2116185_f1.jpg" height="3343" width="2640" aria-labelledby="f1" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 1</div><div class="fv__item__description"><figcaption><div class="caption">Screening, Randomization, and Follow-up.</div><div class="notes"><div role="doc-footnote">The full analysis population included all participants who underwent randomization and received at least one dose of vaccine or placebo, regardless of protocol violations or missing data; participants in the full analysis population are included in the analysis according to the group to which they were randomly assigned. The safety analysis population included all participants who received at least one dose of vaccine or placebo. The per-protocol efficacy analysis population included all participants who underwent randomization and received both doses as assigned, were seronegative for anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein and had a SARS-CoV-2 RNA reverse-transcriptase–polymerase-chain-reaction (RT-PCR)–negative nasal swab at baseline, and did not have a censoring event at any time before 7 days after the second injection. Data from participants at two sites (193 assigned to receive NVX-CoV2373 and 93 assigned to receive placebo) were excluded from analyses because of Good Clinical Practice quality concerns. The window for the first dose of vaccine or placebo was December 20, 2020, to February 18, 2021.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f2" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f2.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/fad7cf1b-de92-43b1-8169-9e46f8f8da1d/assets/images/large/nejmoa2116185_f2.jpg" height="3399" width="2640" aria-labelledby="f2" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 2</div><div class="fv__item__description"><figcaption><div class="caption">Overall Efficacy of NVX-CoV2373 against Covid-19.</div><div class="notes"><div role="doc-footnote">Shown is the cumulative incidence of symptomatic (mild, moderate, or severe) coronavirus disease 2019 (Covid-19). Panel A shows all participants in the full analysis population during the period of surveillance that started at the first dose of NVX-CoV2373 or placebo. Panel B shows all participants in the per-protocol efficacy analysis population during the period of surveillance starting 7 days after the second dose (i.e., up to 28 days after the first dose) through approximately 3 months of follow-up, until unblinding, or until receipt of a vaccine under emergency use authorization. Panel C shows all participants in the full analysis population during the period of surveillance that started 7 days after the second dose. Panel D shows all participants in the per-protocol efficacy analysis population with cases of Covid-19 due to variants that are not considered variants of concern (VOC) or variants of interest (VOI). Panel E shows all participants in the per-protocol efficacy analysis population with cases of Covid-19 due to VOC or VOI.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f3" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f3.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/ff51d420-fc15-47a3-bf05-300515e5b9ea/assets/images/large/nejmoa2116185_f3.jpg" height="1377" width="2640" aria-labelledby="f3" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 3</div><div class="fv__item__description"><figcaption><div class="caption">Vaccine Efficacy of NVX-CoV2373 in Specific Subgroups (Per-Protocol Efficacy Analysis Population).</div><div class="notes"><div role="doc-footnote">Vaccine efficacy was defined as 1 minus the relative risk (NVX-CoV2373 minus placebo). Non-White race included end-point cases in participants from all other races to ensure that these subgroups would be large enough for meaningful analyses. The assessment of coexisting conditions is based on the Centers for Disease Control and Prevention definitions<sup><a href="#core-r18" role="doc-biblioref" data-xml-rid="r18" id="fv-body-ref-r18-3" href-manipulated="true" aria-label="Reference 18" data-to-manipulate="false">18</a></sup> of persons at risk for complications of Covid-19. Participants at overall high risk for Covid-19 included those 65 years of age or older and those of any age with chronic health conditions or an increased risk for Covid-19 because of work or living conditions.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f4" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2116185_f4.jpg"><img src="/cms/10.1056/NEJMoa2116185/asset/b6d2d735-3357-45f6-acc5-1ec22fe11d6f/assets/images/large/nejmoa2116185_f4.jpg" height="3438" width="1717" aria-labelledby="f4" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 4</div><div class="fv__item__description"><figcaption><div class="caption">Solicited Local and Systemic Adverse Events (Safety Analysis Population).</div><div class="notes"><div role="doc-footnote">The percentage of participants in each group with solicited local and systemic adverse events during the 7 days after each dose is plotted according to Food and Drug Administration toxicity grade, either as any grade (mild, moderate, severe, or potentially life-threatening) or as grade 3 or higher (severe or potentially life-threatening).<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19" id="fv-body-ref-r19-2" href-manipulated="true" aria-label="Reference 19" data-to-manipulate="false">19</a></sup> An expanded x axis is used for events of grade 3 or higher to highlight differences between small percentages.</div></div></figcaption></div></div></div><div class="tab__pane fv__list fv__list--tables" id="tab-pane-tables" aria-label="All tables" tabindex="-1" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t1" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 1</div><div class="fv__item__description"><figcaption><div class="caption">Demographic and Clinical Characteristics of the Participants at Baseline (Per-Protocol Efficacy Analysis Population).<a href="#fv-t1fn1" role="doc-noteref">*</a></div></figcaption></div></div></div></div></div></div><div class="references-pop-up fade" aria-hidden="true"><div class="references-pop-up__heading text-dark d-flex align-items-center"><div class="references-pop-up__title flex-grow-1">Reference <span class="references-pop-up__heading-number">1</span></div><a class="references-pop-up__close text-dark" href="#" title="close pop-up" tabindex="-1" aria-hidden="true"><i class="icon-close" aria-hidden="true"></i></a></div><div class="references-pop-up__items citations to-citation__accordion external-links"></div></div></main>
    

</div>

                    
                        



        
        <div class="ng-page_layout ng-page_layout-fullWidth"><div class="container-fluid"><div class="row"><div class="col-12">



        
        




        
        <div class="ng-page_layout-contentSpacing"></div>










    
    
        <div data-widget-def="oneSearchMultiSearch" data-widget-id="778b3ad8-1a8d-43d8-8196-63b03df4a138" data-location="recirc_inIssue_bottom_article">
        



        
        <div class="os-ms os-ms-more-from-issue"><h3 class="ng-subsection-title"><a href="/toc/nejm/386/6" class="ng-subsection-title_link animation-icon-shift"><span class="ng-subsection-title_text">More from Vol. 386 No. 6</span><span class="ng-subsection-title_icon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-longArrowRight"></use></svg></span></span></a></h3><ul class="os-ms-more-from-issue_list"><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Feb 10, 2022</span></li><li data-toggle="tooltip" data-original-title="Visual Abstract" class="issue-item_meta-item"><span role="img" aria-label="Visual Abstract" tabindex="0" class="issue-item_visualAbstract"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-visual"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2112651" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">P. Schmid and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Feb 10, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2116044" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">A. Jayk Bernal and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Feb 10, 2022</span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2112187" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Survival with Cemiplimab in Recurrent Cervical Cancer</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">K.S. Tewari and Others</span></div></div></div></div></div></li></ul></div>

        </div>
    

</div></div></div></div>

                    
                        



        
        <div class="ng-page_layout-bottomAd"><div class="container-fluid"><div class="row"><div class="col-12">









    
    
        <div data-widget-def="literatumAd" data-widget-id="7e022d0d-4a48-44a7-af66-033cf5c13eb8" id="ad-article-bottom-FULLx320-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <!-- START: Circulation Footer 3 -->
<aside class="g-cta-subscribe">
	<style>
.bads_footer-banner24-ONJQNRF1{background:url(/pb-assets/contextual_messaging/footer-yel-background-2x-1513629627453.jpg) center center no-repeat;padding:20px;display:block;margin:0;min-height:inherit;background-size:cover;text-decoration:none!important;color:#1a1a1a;text-align:left}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:42px;line-height:44px;letter-spacing:.2px;margin:0 0 20px;font-family:ff-quadraat-web-pro,sans-serif;font-weight:600}.bads_footer-banner24-ONJQNRF1-inner{max-width:1300px;margin:0 auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions .a-btn{width:130px;padding-left:12px}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{position:static;color:#000;font-size:18px;line-height:27px;border:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:20px 0 20px 0;list-style-type:none;padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login a{color:#0a68ad}.bads_clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.bads_clearfix{display:block}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{float:left;width:50%;padding:30px 0}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{float:left;padding-left:30px;width:50%}.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{display:block;max-width:100%;height:auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:18px;text-transform:uppercase;line-height:24px;font-weight:600;margin:-15px 0 0;letter-spacing:.2px}@media only screen and (max-width:480px){.bads_footer-banner24-ONJQNRF1-inner .bads_device-img,.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{width:100%;float:none}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{padding-left:0}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:27px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding-top:0;padding-bottom:0}.bads_footer-banner24-ONJQNRF1{height:auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:0 0 12px;list-style-type:none}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{line-height:25px;font-size:15px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1 .bads_device-img{width:280px!important;margin:0 auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 3px;font-size:14px}}@media only screen and (min-width:480px) and (max-width:1024px){.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:30px;margin-bottom:15px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{font-size:14px}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:13px;margin-top:0}}@media only screen and (min-width:1025px) and (max-width:1200px){.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:10px 0}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 5px}}@media only screen and (min-width:1401px){.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{float:right}}
	</style>
	<div class="bads_footer-banner24-ONJQNRF1">
	  <div class="bads_footer-banner24-ONJQNRF1-inner bads_clearfix">
		 <div class="bads_subs-btn">
			<p class="g-cta-subscribe__title">Tap into groundbreaking research and clinically relevant insights</p>
			<ul class="g-cta-subscribe__actions">
				<li class="g-cta-subscribe__actions-primary">
				  <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2116185%26promo%3DONFQNRF1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2116185&amp;pubId=41284168&amp;placeholderId=101336&amp;productId=1035" class="ng-btn_primary ng-btn_iconRight"><span class="ng-btn_text">Subscribe </span><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#arrows-longArrowRight"></use></svg></span></a>
				</li>
			</ul>
			<p class="g-cta-subscribe__login">Already a subscriber? <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dactivate%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2116185%26promo%3DONFQANR4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2116185&amp;pubId=41284168&amp;placeholderId=101336&amp;productId=1035">Activate</a> your online access.</p>
		 </div>

		<div class="bads_device-img">
		   <img src="/sda/127716/footer-devices-2x.png" alt="Devices">
		</div>
	   </div>
	</div>
</aside>
<!--/END: Circulation Footer 3 -->
            
        </div>
    

    

    



        </div>
    

</div></div></div></div>

                    
                        



        
        <footer class="ng-footer footer__top" style="position: relative;"><div data-location="footer" class="ng-footer_columns"><div class="container-fluid"><div class="row"><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">ARTICLE CATEGORIES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item">
        <a href="/browse/nejm-article-category/research" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Research</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/review" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reviews</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/clinical-cases" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Clinical Cases</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/perspective" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Perspective</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/commentary" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Commentary</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/other" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Other</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/medical-article-index" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Browse all Articles</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/toc/nejm/current" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Current Issue</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/loi/nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Issue Index</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">RESOURCES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Authors &amp; Reviewers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Submit a Manuscript</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Subscribers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://tools.ovid.com/ovidtools/nejm.html" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Administrators</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/media" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Media</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/how-to-advertise" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertisers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/information-for-subscription-agents" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Agents</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/permissions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Permissions &amp; Licensing</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/reprints" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reprints</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a>
    </li>
</ul>
</div></div></div><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="About us">ABOUT US</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/about-nejm/about-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">About NEJM</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmgroup.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM Group</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Products &amp; Services</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/editors-and-publishers" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Editors &amp; Publishers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/advertising-policies" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertising Policies</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/contact-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text" aria-label="Contact us">Contact Us</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions?#Accessibility" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Accessibility</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">FAQs</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/help" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Help</span></a></li>
    <li class="ng-footer_column-list-item"><a href="mailto:sitefeedback@nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Site Feedback</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">SUBSCRIPTIONS</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Subscribe</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=renew&amp;product=nejm&amp;promo=ONFLNRR3&amp;prc=ONFARN52" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Renew</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=activate&amp;promo=ONFLNAA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Activate Subscription</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC4" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Manage Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=paybill&amp;product=nejm&amp;promo=BNFLPBA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Pay Bill</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.wolterskluwer.com/en/solutions/ovid/nejm-complete-collection" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Sales</span></a></li>    
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/special-content" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Special Content</span></a></li>
</ul>
</div></div></div><div class="col-lg-4 col-md-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">STAY CONNECTED</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/emails?section=NEJM" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Email Alerts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Apps</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Podcasts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">RSS Feed</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/institutional-access" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Remote Access</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="Follow us">FOLLOW US</h4>
<ul class="ng-footer_column-list">
<li class="ng-footer_column-list-item"><a href="https://www.facebook.com/TheNewEnglandJournalofMedicine" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-facebook"></use></svg></span></span><span class="ng-footer_column-link-text">Facebook</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://twitter.com/nejm" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-twitter"></use></svg></span></span><span class="ng-footer_column-link-text">X (formerly Twitter)</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.instagram.com/nejm/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-instagram"></use></svg></span></span><span class="ng-footer_column-link-text">Instagram</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.youtube.com/user/NEJMvideo" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-youtube"></use></svg></span></span><span class="ng-footer_column-link-text">Youtube</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.linkedin.com/company/nejm-group" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-linkedin"></use></svg></span></span><span class="ng-footer_column-link-text">LinkedIn</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://bsky.app/profile/nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-bluesky"></use></svg></span></span><span class="ng-footer_column-link-text">Bluesky</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.tiktok.com/@nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-tiktok"></use></svg></span></span><span class="ng-footer_column-link-text">TikTok</span></a></li>
</ul>
</div></div></div></div></div></div><div data-location="footer" class="ng-footer_journals"><div class="container-fluid"><div class="row"><div class="col-12">



        
        <h4 class="ng-footer_journals-label">JOURNALS</h4>
<ul class="ng-footer_journals-list">
<li class="ng-footer_journals-item"><a href="https://www.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">The New England Journal of Medicine</a></li>
<li class="ng-footer_journals-item"><a href="https://catalyst.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Catalyst Innovations in Care Delivery</a></li>
<li class="ng-footer_journals-item"><a href="https://evidence.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Evidence</a></li>
<li class="ng-footer_journals-item"><a href="https://ai.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM AI</a></li>
</ul>
</div></div></div></div><div data-location="legal" class="ng-footer_bottom"><div class="container-fluid"><div class="row"><div class="col-lg-7 col-md-6 ng-footer_bottom-left">



        
        <p>Copyright © 2025 <a href="https://www.massmed.org/" target="_blank" rel="noopener" class="ng-footer_bottom-link"><b>Massachusetts Medical Society</b></a>. All rights reserved, including those for text and data mining, AI training, and similar technologies. Electronic ISSN 1533-4406. Print ISSN 0028-4793.The content of this site is intended for health care professionals.</p>
</div><div class="col-lg-5 col-md-6 ng-footer_bottom-right">



        
        <style>
  #teconsent a {
    color: #666;
    text-decoration: none;
  }
  #teconsent a:hover {
    color: #666;
    text-decoration: underline;
  }
</style>
<ul class="ng-footer_bottom-list">
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/copyright-information.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Copyright</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/terms-of-use.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Terms</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/privacy-policy.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Privacy Policy</a></li>
<li class="ng-footer_bottom-list-item"><span id="teconsent" consent="undefined" aria-label="Open Cookie Preferences Modal" role="complementary"><a role="link" id="icon-id01387606137792773" tabindex="0" lang="en" aria-haspopup="dialog" aria-label="Cookie Preferences, opens a dedicated popup modal window" class="truste_cursor_pointer">Cookie Preferences</a></span></li>
</ul>
<a href="https://www.nejmgroup.org/" title="NEJM Group" target="_blank" rel="noopener" class="ng-footer_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/logo_group.svg" alt="NEJM Group logo" class="ng-footer_logo" loading="lazy" width="103" height="40"></a>
</div></div></div></div><div data-show-after="400" class="back-to-top back-to-top--align-right  "><button data-snap="footer__top" class="back-to-top__action position-relative p-0 m-0 border-0 d-flex flex-column align-items-center justify-content-center"><svg viewBox="0 0 36 36" class="position-relative"><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" class="back-to-top__action__ring-bg"></path><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" stroke-dasharray="0, 100" class="back-to-top__action__ring"></path></svg><span class="back-to-top__action-icon position-absolute d-flex"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-up"></use></svg></span></span><span class="sr-only">Back to top</span></button></div></footer>

                    
                        



        
        <!-- TrustArc: Banner -->
<div id="consent_blackbar"><style>  #consent_blackbar{    position:relative;    width:100%;    z-index: 999999;  }    #trustarc-banner-overlay {  background-color: rgb(0, 0, 0);   opacity: 0.3;   position: fixed;   z-index: 1000000;   width: 100%;  height: 100%;   top: 0px;   left: 0px;   overflow: hidden;}.truste-title {  /*font-family: "Source Sans Pro", sans-serif;  font-size: 23px;  font-style: normal;  font-stretch: normal;*/  color: #222;  margin-bottom: 20px;  text-align: center;/*  font-weight:bold;*/}.truste-footer {  margin: 0 auto;      }.truste-left {  margin: 0px 0px 15px 15px;/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;    */}.truste-banner { margin: 0 auto; }.truste-messageColumn {/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;*/  color: #666666;  margin: 0px;}#truste-consent-button, #truste-consent-required {    background-color: #FF1E00;    color: #F2F1F1;    padding: 5px 10px;    border: 1px solid #FF1E00;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }      #truste-show-consent {    background-color: #FF1E00;    color: #F2F1F1;    border: 1px solid #FF1E00;    padding: 5px 10px;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }div.truste-consent-track-class {  position: fixed;  z-index:9999999;   background: #666;   border: 1px solid #333;    /*padding: 10px 60px;*/    bottom:0px;    right:0px;    left:0px;    margin: 10px;}.truste-left {  margin: 0;}div.text-content {  display: flex;  flex-direction: column;  align-self: baseline;}#truste-consent-text {    /*font-family: "Source Sans Pro", sans-serif;    font-size: 16px;*/    color: #fff;    margin: 15px 0px;}.truste-footer {  padding-top: 15px;}#truste-consent-content {  margin: 0 auto;    padding: 0 10px;    max-width: 1366px;}.truste-consent-footer {  display: none;}.flex-container {  display: block;  align-items: center;  justify-content: space-between;}#truste-consent-buttons {  float: right;  margin: 10px 5px 10px 0px;}#truste-show-consent { background: #F30 !important;}#truste-consent-button, #truste-consent-required { background: #F30 !important; } /* MEDIA QUERIES */  @media screen and (max-width: 500px) {  #truste-consent-track {    padding: 5px 20px;  }  }@media screen and (max-width: 375px) {  .truste-buttonsColumn {    float: none;    margin: 0;  }  #truste-consent-button, #truste-consent-required, #truste-show-consent {    width: 100%;    margin-bottom: 5px;  }          #truste-consent-buttons {  float: none;  margin: 10px 0px 10px 0px;	}}</style><div id="truste-consent-track" style="display: block; opacity: 1;">  <div id="trustarc-banner-overlay"></div>  <div class="truste-consent-track-class">    <div id="truste-consent-content" class="truste-banner">        <div class="flex-container">          <div class="text-content">            <div id="truste-consent-text" class="truste-messageColumn">This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or manage your own preferences.                       </div>          </div>          <div id="truste-consent-buttons" class="truste-buttonsColumn">            <button id="truste-show-consent" aria-haspopup="dialog">Manage Settings</button>      <button id="truste-consent-button">Accept</button>      <!-- <button id="truste-consent-required">Decline All</button> -->          </div>        </div>                <div style="clear:both;"></div>    </div>  </div></div><!--emptycomment--></div>
<!-- /TrustArc: Banner -->

                    
                        



        
        <link rel="stylesheet" href="https://cssjs.nejm.org/mmsWidgets.css"><script nonce="94d6bd5503420304-SJC" type="text/javascript" src="https://cssjs.nejm.org/mmsWidgets.js"></script><script nonce="94d6bd5503420304-SJC" type="text/javascript">var litSSO = {
    "ucid": null,
    "accessToken": null,
    "authState": null
};

var loginUri = '/action/doSsoLogin';
var logoutUri = '/action/doLogout';

displayAuthenticatedMessage();

mmsWidgets.init({
    clientId: 'qsra7g4d6jwdsgn3zbe6udp6r6278mr9',
    origin: 'NEJM',
    xdReceiver: 'http://www.nejm.org/pb-assets/sso/xd.html',
    isFullPageSignIn: isSignInPage(),
    debug: true,

    onReady: function (e) {
        console.log('<<<<<<<<<< client: received onReady event.');
        $("A.litSsoLogin").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0) {
                mmsWidgets.signIn(e);
                return false;
            }
        });
        $("A.litSsoLogout").click(function (e) {
            mmsWidgets.signOut(e);
            return false;
        });
        $("A.litSsoCreate").click(function (e) {
            mmsWidgets.showRegModal(e);
            return false;
        });
        $("A.litSsoSubscribe").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0)
                location.assign(e.currentTarget.href);
            return false;
        });
        if (window.doSSOLogin) {
            window.setTimeout(function () {
                mmsWidgets.signIn();
            }, 500);
        }
        ;
    },
    onLoginSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLoginSuccess event.' + JSON.stringify(e));

        const redirectUrl = getRedirectUri(window.location.search, location.href.replace(window.location.origin, ""));
        document.cookie = "skipSso=; expires=; path=/";
        if (!litSSO.ucid || e.ucid != litSSO.ucid || !litSSO.accessToken || e.accessToken != litSSO.accessToken) {
            location.assign(loginUri + "?ucid=" + e.profile.ucid
                + "&accessToken=" + e.accessToken
                + "&authState=" + e.authState
                + "&email=" + encodeURIComponent(e.profile.email)
                + "&givenNames=" + e.profile.givenName
                + "&surname=" + e.profile.familyName
                + "&redirectUri=" + redirectUrl
                + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                + "&rememberMe=" + e.rememberMe);
        }
    },
    onAuthStateReady: function (e) {
        console.log('<<<<<<<<<< client: received onAuthStateReady event.' + JSON.stringify(e))

        var isMmsSsoAuthenticated = (e.authState && e.authState !== "anonymous" && e.authState !== "lead" && e.ucid && e.accessToken) ? true : false;
        var isLitSsoAuthenticated = (litSSO.ucid && litSSO.accessToken && litSSO.authState) ? true : false;
        console.log('           isMmsSsoAuthenticated=' + isMmsSsoAuthenticated + ', isLitSsoAuthenticated=' + isLitSsoAuthenticated);

        if (isMmsSsoAuthenticated) {
            if (!isLitSsoAuthenticated || litSSO.ucid != e.ucid) {
                if (window.skipSso)
                    document.cookie = "skipSso=" + encodeURIComponent(e.ucid) + "; expires=; path=/";

                if (!window.skipSso && document.cookie.indexOf("skipSso=" + encodeURIComponent(e.ucid)) == -1) {
                    location.assign(loginUri + "?ucid=" + e.profile.ucid
                        + "&accessToken=" + e.accessToken
                        + "&authState=" + e.authState
                        + "&email=" + encodeURIComponent(e.profile.email)
                        + "&givenNames=" + e.profile.givenName
                        + "&surname=" + e.profile.familyName
                        + "&redirectUri=" + location.href.replace(window.location.origin, "")
                        + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                        + "&rememberMe=" + e.rememberMe);
                } else
                    console.log('**** client: Skip SSO ****');
            } else if (e.accessToken !== litSSO.accessToken)
                updateLitSession(e.ucid, e.accessToken);
        } else if (isLitSsoAuthenticated)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));

        if (document.getElementById("ssoerr-ucid"))
            document.getElementById("ssoerr-ucid").innerHTML = e.ucid;

    },
    onRegistrationSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onRegistrationSuccess event.' + JSON.stringify(e))
        document.cookie = "skipSso=; expires=; path=/";
        var uccLastUpdatedDate = '1812-01-01 00:00:00.1 +0000';
        location.assign(loginUri + "?ucid=" + e.profile.ucid
            + "&accessToken=" + e.accessToken
            + "&authState=" + e.authState
            + "&email=" + encodeURIComponent(e.profile.email)
            + "&givenNames=" + e.profile.givenName
            + "&surname=" + e.profile.familyName
            + "&redirectUri=" + location.href.replace(window.location.origin, "")
            + "&uccLastUpdatedDate=" + encodeURIComponent(uccLastUpdatedDate)
            + "&rememberMe=" + e.rememberMe);
    },
    onLogoutSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLogoutSuccess event.' + JSON.stringify(e))

        document.cookie = "skipSso=; expires=; path=/";
        location.assign(logoutUri);
    },
});

function updateLitSession(ucid, accessToken) {
    $.ajax({
        method: "GET",
        url: "/action/doSsoSessionUpdate",
        data: {ucid: ucid, accessToken: accessToken},
        success: function (callData, textStatus) {
            console.log("Session accessToken updated")
            litSSO.accessToken = accessToken
        },
        error: function (jqXHR, textStatus, errorThrown) {
            alert("Your website session has expired and will now be reset.")
            console.log("Session update failed: " + jqXHR.responseText)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));
        }
    });
}

function getRedirectUri(location, fallback) {
    const urlParams = new URLSearchParams(location);
    const uriUrlParam = urlParams.get('uri');
    if (uriUrlParam)
        return encodeURIComponent(uriUrlParam);
    else
        return encodeURIComponent(fallback);
}

function isSignInPage() {
    return document.querySelector('meta[name="pbContext"]').content.indexOf("customPage:string:/sign-in") > -1;
}

function displayAuthenticatedMessage() {
    if (isSignInPage()) {
        var div = document.getElementById('authMsg');
        if ("" === "PersonUser") {
            div.innerHTML += "You are already signed in to " + window.location.origin.replace("https://", "").replace("www.", "") + ". If you would like to sign in with a different email address, please use the form below.";
        } else {
            div.innerHTML = '';
        }
    }
}</script>

                    
                
            </div>
        </div><iframe name="trustarc_notice" id="trustarcNoticeFrame" title="Trustarc Cross-Domain Consent Frame" src="https://consent.trustarc.com/get?name=crossdomain.html&amp;domain=nejm.com" style="display: none;"></iframe><script src="https://consent.trustarc.com/asset/notice.js/v/v1.7-1576" async="async" crossorigin="" importance="high" nonce="94d6bd5503420304-SJC"></script>
        


        
        

            <script src="/products/mms-nextgen/mms/releasedAssets/js/build.lazyload.bundle-c8c4e7d20884f81951fb.js" nonce="94d6bd5503420304-SJC"></script>

        <script src="/products/mms-nextgen/mms/releasedAssets/js/main.bundle-3819a02ec7bc2aca01ec.js" nonce="94d6bd5503420304-SJC"></script>
        


<div id="adModal" tabindex="-1" aria-labelledby="exampleModalCenterTitle" class="ng-modal modal" style="display: none;" aria-hidden="true">
    <div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered ad-promoLayer">
        <div class="ng-modal_content modal-content p-0">
            <div class="ng-modal_body modal-body m-0">
                <div class="ng-modal_header modal-header">
                    <button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#close"></use></svg></span></span>
                    </button>
                </div>

            </div>
        </div>
    </div>
</div>
<script type="text/javascript" src="/wro/1125813~product.js" nonce="94d6bd5503420304-SJC"></script>








<input id="showLayers" type="hidden" value="true">

    <!-- placeholder id=null, description=ad-layer-config -->
    <!-- placeholder id=null, description=ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=ad-layer-promo-1 -->

    <input id="firstAd" type="hidden" value="">
    <input id="secondAd" type="hidden" value="">

    
    
    

    
    
    <input id="IsInstitution" type="hidden" value="false">
    <input id="IsSubscriber" type="hidden" value="true">
    <input id="CustomerId" type="hidden" value="">


<script type="text/javascript" nonce="94d6bd5503420304-SJC">
  jQuery.extend(jQuery.mmsLayers.config, {
    rules: [{
      "name": "Launch Layer Ad",
      "frequency": 30,
      "showOnPage": 5,
      "enabled": false,
      "cookieName": "MarketingLaunchLayer",
      "styleClass": "launchLayer"
    },
    {
      "name": "Promo Layer Ad",
      "frequency": 14,
      "enabled": true,
      "cookieName": "PromoLayer",
      "styleClass": "promoLayer"
    },
    {
      "name": "Interstitial Ad",
      "frequency": 7,
      "enabled": false,
      "cookieName": "InterstitialAd"
    },
    {
      "name": "Iperceptions - Ion Layer Ad",
      "showOnPage": 1,
      "enabled": false,
      "test": false,
      "cookieName":"Iperceptions"
    }]
 });
</script>

















    <script type="text/javascript" nonce="94d6bd5503420304-SJC">
        $(document).ready(() => setTimeout(() => {
            let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" "));
            $.get("/resource/lodash?t="+_bnt);
        },4000));
    </script>












    

    
    

    
    
    
    
        
            
                <script type="text/javascript" src="/wro/1125813~article-metrics.js" nonce="94d6bd5503420304-SJC"></script>
            
            
            
        
    




<script type="text/javascript" src="/wro/1125813~full-text-analytics.js" nonce="94d6bd5503420304-SJC"></script>


    


            <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94d6bd54fb290304',t:'MTc0OTUzNjE4Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94d6bd54fb290304&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;f55e150c7a5f4a4ab9ef82f4a1c9c43c&quot;}" crossorigin="anonymous"></script><div style="display:none;" id="signInEmbedded" class="ucc-fullpage-signin ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Sign In</h1>
  </div>    
  <div class="capture_signin">
    {* #signInForm *}
    <div class="ucc-form-inner-wrapper">
      {* signInEmailAddress *}
      {* currentPassword *}
      <div style="padding-top:10px;">
          <div class="capture_form_item capture_form_rememberme">
          <label class="ucc-form-checkbox">                
            <input checked="checked" id="ucc-remember-me-cb-embedded" name="ucc-remember-me-cb-embedded" type="checkbox" value="true">
            <span>Remember Me</span>
          </label>                           
          </div>
          <div class="capture_form_item capture_form_forgotpwd">
            <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
          </div>
      </div>
      <div class="capture_form_item">      
        <button id="ucc-sign-in-submit-embedded" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
      </div>
      <div class="capture_form_item capture_form_footer">
        <div class="ucc-no-acct-msg">Don't have an account?</div>
        <div class="ucc-no-acct-msg-2">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
          <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
        </div>
      </div>
      <div class="capture_form_item capture_form_submit">
        
      </div>      
    </div>
    {* /signInForm *}
  </div>
</div><div style="display:none;" id="forgotPassword" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Forgot Password</h1>
  </div>   
  <div class="ucc-form-inner-wrapper">
  <p style="color:black">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
  </div> 
  <div class="capture_forgotpassword">
    {* #forgotPasswordForm *}      
      <div class="ucc-form-inner-wrapper">
        {* forgotPasswordEmailAddress *}
        {* captcha *}
        <div class="capture_form_item" style="padding-top: 20px;">        
          <input id="ucc-widget-forgotpwd-submit" value="Continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
        </div>
      </div>
    {* /forgotPasswordForm *}
  </div>
  </div><div style="display:none;" id="forgotPasswordSuccess" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Create New Password</h1>
  </div>    
  <div class="capture_forgotpassword">
      <div class="ucc-form-inner-wrapper">
        <p style="padding-top: 30px; padding-bottom: 30px;">We've sent an email with instructions to create a new password. Your existing password has not been changed.</p>        
        <div class="capture_form_item">      
          <button class="capture_btn capture_primary capture-full-width-btn" onclick="janrain.capture.ui.modal.close()">CLOSE</button>
        </div>
      </div>
  </div>
  </div><div style="display:none;" id="resetPassword" class="ucc-widgets-nejm-next">
      <div class="row">      
        <div class="col-md-8 col-md-offset-2 reset-pwd-info"><p>To reset your password, enter a new password twice and click the 'Reset Password' button.</p></div>
      </div>
      <div class="col-md-4 col-md-offset-4">
        {* #changePasswordFormNoAuth *}
          {* newPassword *}
          {* newPasswordConfirm *}     
          <div class="capture_form_item">
            <input value="RESET PASSWORD" type="submit" class="capture_btn capture_primary capture-full-width-btn">
          </div>
          {* /changePasswordFormNoAuth *}
      </div>
    </div><div style="display:none;" id="resetPasswordSuccess">
        <div class="reset-pwd-info">
          <div class="reset-pwd-success-welcome"></div>
          <p class="reset-pwd-success-msg">Your password has been reset. You will need to <a href="/signin" onclick="mmsWidgets.signIn(event)">sign in</a> again using your new password to access site content and features.</p>
          <p class="reset-pwd-success-nav"></p>
        </div>      
    </div><div style="display:none;" id="resetPasswordRequestCode" class="ucc-widgets-nejm-next">
        {* #resetPasswordForm *}
        <div class="capture_form_error">The link that you followed to reset your password has expired.</div>
          <div class="col-md-8 col-md-offset-2">
            <p class="reset-pwd-info">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
          </div>
          <div class="col-md-4 col-md-offset-4">
            {* signInEmailAddress *}
            <div class="capture_form_item">
              <input value="continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
            </div>
          </div>
        {* /resetPasswordForm *}
    </div><div style="display:none;" id="resetPasswordRequestCodeSuccess">
      <div class="reset-pwd-info">
        <p>If the address matches an existing account, you will receive an email with instructions to reset your password.</p>
        <p class="reset-pwd-success-nav"></p>
      </div>
  </div>

        
        
    

<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div id="janrainEngageEmbed" style="display: none;"><div class="janrainContent" style="width: 380px !important; height: 156px !important; padding-left: 5px !important; padding-right: 5px !important; box-sizing: content-box !important; background-color: rgb(255, 255, 255) !important; border: 1px solid rgb(192, 192, 192) !important; border-radius: 10px !important; overflow: hidden !important; position: relative !important;"><div id="janrainView"><div class="janrainHeader" style="background-color: rgb(255, 255, 255) !important; font-size: 14px !important; color: rgb(102, 102, 102) !important; position: relative !important; height: 20px !important; left: -5px !important; padding: 5px 5px 0px !important; white-space: nowrap !important; width: 380px !important; z-index: 100 !important; border-radius: 10px 10px 0px 0px !important; text-align: left !important;"><div style="padding-left: 1px !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important;">Sign in using your account with</div></div><div id="janrainProviderPages" style="padding-top: 5px; left: 5px; position: absolute;"><div class="janrainPage" pageindex="0"><ul class="providers" id="janrainProviders_0" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-aol" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="1" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-aol" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-aol" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">AOL</span></a></li><li id="janrain-openid" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="3" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-openid" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-openid" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">OpenID</span></a></li></ul><ul class="providers" id="janrainProviders_1" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-yahoo" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="2" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-yahoo" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-yahoo" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">Yahoo!</span></a></li></ul></div></div><div style="background-color: rgb(255, 255, 255) !important; width: 380px !important; height: 10px !important; position: absolute !important; left: 0px !important; padding-left: 5px !important; padding-right: 5px !important; padding-bottom: 5px !important; bottom: 0px !important; font-size: 10px !important; text-align: left !important; color: rgb(102, 102, 102) !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; border-radius: 0px 0px 10px 10px !important;"><div style="padding-left: 1px !important;"><a href="http://janrain.com/products/engage/social-login?utm_source=mms.rpxnow.com&amp;utm_medium=Partner&amp;utm_campaign=attribution" target="_blank">Social Login by Janrain</a></div></div></div></div></div><iframe name="captureIFrame_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-transactionid="s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" id="captureIFrame_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" src="about:blank" class="" data-captureiframeloadeventbound="yes" style="display: none;"></iframe><div id="janrainModalOverlay" style="inset: 0px; position: fixed; background-color: rgb(0, 0, 0); opacity: 0.4; display: none; z-index: 1000;"></div><div id="janrainModal" style="width: 380px; height: 131px; position: absolute; z-index: 1000; display: none;"><a href="#" class="janrain_modal_closebutton" style="position: absolute; cursor: pointer; z-index: 1000;">X</a><div style="display: block;" id="signIn" class="ucc-widgets-nejm-next janrain-capture-ui capture-ui-content capture_screen_container" data-capturescreenname="signIn" data-captureventadded="true">
    <div class="capture_header">
      <h1>Sign In</h1>
    </div>    
    <div class="capture_signin">
      <form id="capture_signIn_signInForm" name="signInForm" data-capturefield="signInForm" action="https://mms.us.janraincapture.com/widget/traditional_signin.jsonp" class="capture_form capture_signInForm" method="POST" novalidate="novalidate" data-transactionid="s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" target="captureIFrame_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" accept-charset="UTF-8" next="{&quot;noop&quot;:&quot;&quot;}"><div id="capture_signIn_signInForm_defaultSavedProfileMessage"></div><div id="capture_signIn_signInForm_errorMessages"></div><input id="capture_signIn_utf8" data-capturefield="undefined" value="✓" type="hidden" class="capture_utf8" name="utf8"><input id="capture_signIn_screen_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="signIn" type="hidden" class="capture_screen_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="capture_screen"><input id="capture_signIn_js_version_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="d445bf4" type="hidden" class="capture_js_version_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="js_version"><input id="capture_signIn_transactionId_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" type="hidden" class="capture_transactionId_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="capture_transactionId"><input id="capture_signIn_form_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="signInForm" type="hidden" class="capture_form_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="form"><input id="capture_signIn_flow_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="standard" type="hidden" class="capture_flow_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="flow"><input id="capture_signIn_client_id_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="qsra7g4d6jwdsgn3zbe6udp6r6278mr9" type="hidden" class="capture_client_id_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="client_id"><input id="capture_signIn_redirect_uri_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="https://www.nejm.org" type="hidden" class="capture_redirect_uri_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="redirect_uri"><input id="capture_signIn_response_type_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="code" type="hidden" class="capture_response_type_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="response_type"><input id="capture_signIn_flow_version_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="20240514181256512029" type="hidden" class="capture_flow_version_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="flow_version"><input id="capture_signIn_settings_version_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="" type="hidden" class="capture_settings_version_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="settings_version"><input id="capture_signIn_locale_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="en-US" type="hidden" class="capture_locale_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="locale"><input id="capture_signIn_recaptcha_version_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" data-capturefield="undefined" value="2" type="hidden" class="capture_recaptcha_version_s6tw8di0ytb9dv7la9g9wj3dk72vaf1eh0rl2clm" name="recaptchaVersion">
      <div class="ucc-form-inner-wrapper">
        <div id="capture_signIn_form_item_signInEmailAddress" class="capture_form_item capture_email capture_form_item_signInEmailAddress" data-capturefield="undefined"><label for="capture_signIn_signInEmailAddress">Email Address</label><input id="capture_signIn_signInEmailAddress" data-capturefield="signInEmailAddress" value="" type="email" class="capture_signInEmailAddress capture_required capture_text_input" placeholder="Email Address" name="signInEmailAddress"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="signInEmailAddress">Validating</div><div class="capture_tip_error" data-elementname="signInEmailAddress"></div></div>
        <div id="capture_signIn_form_item_currentPassword" class="capture_form_item capture_password capture_form_item_currentPassword" data-capturefield="undefined"><label for="capture_signIn_currentPassword">Password</label><input id="capture_signIn_currentPassword" data-capturefield="currentPassword" value="" type="password" class="capture_currentPassword capture_required capture_text_input" placeholder="Password" name="currentPassword"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="currentPassword">Validating</div><div class="capture_tip_error" data-elementname="currentPassword"></div></div>
        <div style="padding-top:10px;">
            <div class="capture_form_item capture_form_rememberme">
                <label class="ucc-form-checkbox">                
                    <input checked="checked" id="ucc-remember-me-cb" name="ucc-remember-me-cb" type="checkbox" value="true">
                    <span>Remember Me</span>
                </label>          
            </div>
            <div class="capture_form_item capture_form_forgotpwd">
              <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
            </div>
        </div>
        <div class="capture_form_item">
          <button id="ucc-sign-in-submit" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
        </div>
       
        <div class="capture_form_item">
          <div class="ucc-no-acct-msg">Don't have an account?</div>
          <div class="ucc-no-acct-msg-2" id="signInModalCreateAccountLink">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

          <div class="ucc-no-acct-msg-2" id="signInModalCloseLink" style="display:none">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

        </div>
     
        <div class="capture_form_item capture_form_submit">
          
        </div>      
      </div>
      </form>
    </div>
  </div></div><script type="text/javascript" src="https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1056/nejmoa2116185?callback=_altmetric.embed_callback&amp;domain=www.nejm.org&amp;cache_until=3-10"></script><ijk-ijmzosazlwjw></ijk-ijmzosazlwjw><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div></body></html>